Publications

Publication TitleDisease AreaPublication LinkConference
Quality of life in post-menopausal women in five European countriesMenopauseISPOR US, 2001
Chronic obstructive pulmonary disease - the patient perspectiveChronic obstructive pulmonary diseaseERS, 2001
Disability, resource utilisation and work absences associated with osteoarthritis and rheumatoid arthritis - an international database analysisRheumatoid arthritisISPOR EU, 2001
Quality of life of menopausal age women in EuropeMenopauseN/A
Doctor/patient prescribing dynamics: impact on prescribing of better understanding of subjective and clinical evaluation of the patient and burden of diseaseVariousPBIRG, 2003
Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme IAsthmaERS, 2003
Differences between doctors' and patients' perceptions of osteoporosis symptoms in five countriesOsteoporosisECCEO, 2003
Differences between doctor and patient recall of events in and investigations for osteoporosis in five countriesOsteoporosisECCEO, 2003
The detrimental impact of symptoms on quality of life of patients across severity levels: respiratory disease specific programme IIIAsthmaATS, 2004
Differences between doctor and patient recall of events in and investigations for osteoporosis in five countriesOsteoporosisISPOR US, 2004
COPD in primary care - international survey DSP III (patient population description)Chronic obstructive pulmonary diseaseERS, 2004
Quality of life and asthma control with low-dose inhaled corticosteroidsAsthmaView PublicationN/A
Resource use in patients with exacerbations of asthma with different underlying degrees of severity in five European countriesAsthmaISPOR EU, 2004
Unscheduled healthcare resource use among patients considered to have mild asthmaAsthmaATS, 2005
Patient advocacy - an emerging challenge for innovative market researchVariousPBIRG, 2005
Health status and its determinants in COPD patientsChronic obstructive pulmonary diseaseATS, 2005
Unscheduled healthcare resource use among asthma patients receiving low-dose inhaled corticosteroids maintenance treatmentAsthmaView PublicationN/A
The human impact of severe persistent allergic asthma: results from a multinational studyAsthmaISPOR EU, 2005
The economic and human impact of poor control in patients with severe persistant allergic asthma: results from a multinational studyAsthmaBTS, 2005
Assessing symptomatic burden of patients suffering from allergic rhinitisAllergic rhinitisAAAAI, 2006
Allergic rhinitis and its impact on cost, productivity and healthcare resource use of patientsAllergic rhinitisAAAAI, 2006
Symptomatic burden of allergic rhinitis among children/adolescentsAllergic rhinitisEAACI, 2006
Symptomatic burden of allergic rhinitis among adultsAllergic rhinitisEAACI, 2006
Patient satisfaction with osteoarthritis treatments and key attributes of the satisfactionOsteoarthritisEULAR, 2006
Impact of osteoarthritis symptoms on patient QoLOsteoarthritisEULAR, 2006
Comparing the burden of allergic rhinitis in primary care and specialist settingsAllergic rhinitisEAACI, 2006
Analysis of a multinational, cross-sectional survey of physician perceptions of negative symptoms of schizophreniaSchizophreniaNCDEU, 2006
Negative symptoms of schizophrenia: analysis of a multinational, cross-sectional survey of physician perceptionsSchizophreniaCINP, 2006
Negative symptoms of schizophrenia: analysis of a multinational, cross-sectional survey of physician perceptionsSchizophreniaECNP, 2006
Impact on resource use and quality of life of incomplete patient compliance with instructions for taking bisphosphonate medication for osteoporosisOsteoporosisASBMR, 2006
Resource use among patients with schizophrenia in five European countriesSchizophreniaISPOR EU, 2006
Quality of life in patients with bipolar disorder in five European countriesBipolar disorderISPOR EU, 2006
Impact of negative symptoms on functioning of patients with schizophrenia in five European countriesSchizophreniaISPOR EU, 2006
Higher psoriasis disease severity is associated with increased healthcare resource utilization and employment disadvantages in EuropePsoriasisEADV, 2006
Higher psoriasis disease severity is associated with increased co-morbidities in EuropePsoriasisEADV, 2006
Analysis of a multinational, cross-sectional survey of physician observations and perceptions of patients with negative symptoms of schizophreniaSchizophreniaISPOR EU, 2006
Proportion of psoriasis patients with BSA > 20% patients treated with topicals alonePsoriasisAAD, 2007
Poor quality of life is associated with increased health care resource utilization independent of disease severity in European plaque psoriasis patientsPsoriasisAAD, 2007
Physician and patient perception differ for symptoms associated with allergic rhinitisAllergic rhinitisAAAAI, 2007
Health care resource utilization and disease burden among European psoriasis and psoriatic arthritis patientsPsoriatic arthritisAAD, 2007
Do allergic rhinitis patients achieve 24-hour symptom controlAllergic rhinitisAAAAI, 2007
Patterns of glycaemic control across UK and Europe - a patient record studyDiabetesDUKPC, 2007
Impact of incomplete patient compliance With medication instructions for bisphosphonate therapy on healthcare utilization and quality of lifeOsteoporosisECCEO, 2007
Quality of life and resource use in patients with bipolar disorder in the United States and five European countriesBipolar disorderAPA, 2007
Plaque psoriasis patients with more than 10 years of disease history are almost 5 times more likely to have psoriatic arthritis than those with less than 5 years of diseasePsoriasisEADV, 2007
Patients with plaque psoriasis tend to rate their disease as more severe than their dermatologistsPsoriasisEADV, 2007
Negative symptoms of schizophrenia and their impact on functioning in US and European patientsSchizophreniaAPA, 2007
Impact of positive and negative symptoms of schizophrenia on resource use in the United States and EuropeSchizophreniaAPA, 2007
Physician and patient perception differ for symptoms associated with allergic rhinitis in five European countriesAllergic rhinitisEAACI, 2007
Impact of allergic rhinitis on patients' quality of life in five European countriesAllergic rhinitisEAACI, 2007
Compliance with medication in rhinitis patients is poor and over-estimated by physiciansBipolar disorderISBD, 2007
Allergic rhinitis: the impact of discordant perspectives of patient and physician on treatment decisionsAllergic rhinitisView PublicationN/A
A survey of dermatologist perception of psoriasis severity and resultant prescribing patternsPsoriasisAAD, 2007
Impact of increasing body mass index on medical resources for patients with type 2 diabetes - a retrospective analysis in the United StatesMetabolic syndromeEASD, 2007
Physician observations and perceptions of positive and negative symptoms of schizophrenia: a multinational, cross-sectional surveySchizophreniaView PublicationN/A
Time from psoriatic arthritis symptoms to diagnosis by management style between a dermatologist and rheumatologist in the EUPsoriasisWCD, 2007
Real-world antipyschotic prescribing patterns for schizophrenia treatment across EuropeSchizophreniaECNP, 2007
Impact on health care cost of increasing body mass index for people with type 2 diabetes - a cross-sectional study in the USAMetabolic syndromeISPOR EU, 2007
Impact of socio-economic factors on patients' knowledge of their condition, involvement in treatment decisions and the subsequent compliance with their treatment regimenAsthmaISPOR EU, 2007
Impact of increasing BMI on medical resources for patients with type 2 diabetes - a retrospective analysis in the USAMetabolic syndromeISPOR EU, 2007
Carer burden in dementiaDementiaECNP, 2007
Behavioural and functional symptoms in patients with Alzheimer's diseaseDementiaECNP, 2007
A multinational assessment of quality of life and resource use by bipolar disorder patients in Europe and the United StatesBipolar disorderECNP, 2007
A survey of the burden of allergic rhinitis in EuropeAllergic rhinitisView PublicationN/A
Physician and patient survey of allergic rhinitis: methodologyAllergic rhinitisView PublicationN/A
A survey of the burden of allergic rhinitis in the USAAllergic rhinitisView PublicationN/A
Real-world usage of valproate in bipolar disorder: results of a cross-sectional survey of European psychiatristsBipolar disorderISBD, 2008
Quality of life and resource use in patients with bipolar disorder in Europe and the United StatesBipolar disorderISAD, 2008
Is pharmacy care or self-medication sufficient for rhinitis patients?Allergic rhinitisAAAAI, 2008
Compliance with medication in rhinitis patients is poor and over-estimated by physiciansAllergic rhinitisAAAAI, 2008
Factors associated with treatment nonadherence among US bipolar disorder patientsBipolar disorderView PublicationN/A
Resource utilization among patients with metabolic syndrome: isolated versus multiple lipid disordersMetabolic syndromeEAS, 2008
Multinational study of asthma medications prescribed at discharge from the emergency departmentAsthmaATS, 2008
Multinational approach to acute asthma care for adults admitted to the emergency departmentAsthmaATS, 2008
Major depressive disorder: burden of illness across US and EUMajor depressive disorderAPA, 2008
Generalized anxiety disorder: burden of illness across US and EUGeneralized anxiety disorderAPA, 2008
The effects of obesity on concomitant conditions and resource use among patients with cardiometabolic risk factorsMetabolic syndromeADA, 2008
Relationship between body mass index and risk factors, conditions, resource use and productivity among patients with cardiometabolic risk factorsMetabolic syndromeADA, 2008
Physician perception of patient weight in primary care practiceMetabolic syndromeADA, 2008
Impact of body mass index on health-related quality of life for persons with type 2 diabetes in the USADiabetesADA, 2008
Psoriasis treatment patterns - results of a cross-sectional survey of dermatologistsPsoriasisView PublicationN/A
The burden of allergic rhinitis as reported by UK patients compared with their doctorsAllergic rhinitisView PublicationN/A
Real-world physician and patient behaviour across countries: disease-specific programmes - a means to understandMethodologyView PublicationN/A
Increasing dependence on others is associated with increased resource use in dementiaDementiaICAPD, 2009
Impact of OAB on aspects of daily life: results of a European surveyOveractive bladderEAU, 2009
The asthma control test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional surveyAsthmaView PublicationN/A
The perceived difficulty and importance of weight control for patients with type 2 diabetes: data from the US and EuropeDiabetesAHA-QCOR, 2009
Factors associated with nursing home placement in Alzheimer's diseaseDementiaAAN, 2009
Perception versus reality - categorisation of patient weight by type 2 diabetes patients and their physicians in the US and EuropeDiabetesISPOR US, 2009
Factors impacting the health related quality of life in female breast cancer patients - an observational, cross-sectional studyBreast cancerISPOR US, 2009
Quality of life and work productivity in allergic rhinitis patients suffering from both nasal and ocular symptoms - an observational, cross-sectional study in 4 countries in EuropeAllergic rhinitisEAACI, 2009
Impact of perceived weight and level of lifestyle control on health-related quality of life in patients with type 2 diabetes: data from US and EuropeDiabetesADA, 2009
Impact of ocular symptoms on resource utilisation and work productivity in managment of AR - an observational, cross-sectional study in 4 countries in EuropeAllergic rhinitisEAACI, 2009
Quality of life and work productivity in allergic rhinitis patients suffering from both nasal and ocular symptoms - an observational, cross-sectional study in 4 countries in EuropeAllergic rhinitisISPOR EU, 2009
Predictors for development of stricture/obstruction in patients with Crohn's diseaseInflammatory Bowel DiseaseACG, 2009
Moderate to severe rheumatoid arthritis is associated with significant work and activity impairment in Brazil - findings from an observational studyRheumatoid arthritisACR/ARHP, 2009
Medical resource utlilization and workdays lost in a European survey of patients with fibromyalgiaFibromyalgiaACR/ARHP, 2009
Medical resource utilisation and workdays lost in patients with fibromyalgiaFibromyalgiaISPOR EU, 2009
Impact of ocular symptoms on resource utilisation and work productivity in managment of AR - an observational, cross-sectional study in 4 coutnries in EuropeAllergic rhinitisISPOR EU, 2009
Impact of dementia upon caregiver employment and quality of lifeDementiaISPOR EU, 2009
Impact of cough and/or sputum symptoms on the burden of COPD: a cross-sectional, observational studyChronic obstructive pulmonary diseaseISPOR EU, 2009
Impact of cough and/or sputum symptoms on health-related quality of life in COPD patients: an observational, cross-sectional studyChronic obstructive pulmonary diseaseISPOR EU, 2009
Predictors of Hepatitis C treatment outcome in genotype 1 patients in a real-world settingHepatitis C virusBSG, 2010
Health-related quality of life and healthcare resource use in European patients with plaque psoriasis - an association independent of observed disease severityPsoriasisView PublicationN/A
Impact of rheumatoid arthritis severity on HRQoL in BrazilRheumatoid arthritisPANLAR, 2010
The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinicsPsoriatic arthritisView PublicationN/A
Do patients on intra-nasal fluticasone furoate, mometasone furoate and fluticasone proprionate experience similar numbers of symptom-free days and quality of life? a cross-sectional study in 3 European countriesAllergic rhinitisEAACI, 2010
Pulmonary function testing in the emergency department and medications prescribed at discharge results of MAMBO studyAsthmaView PublicationN/A
Patient and physician satisfaction with osteoarthritis treatment in Germany, Spain and the UKOsteoarthritisIASP WCP, 2010
Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivityOsteoarthritisView PublicationN/A
Status and treatment of type 2 diabetes in ChinaDiabetesISPOR APAC, 2010
Prevalence of thrombocytopenia in patients with chronic hepatitis C infection in GermanyHepatitis C virusDGVS, 2010
Key attributes of inhalers for patients versus physiciansAsthmaERS, 2010
Glycaemic control is worse and complications more prevalent in type 2 diabetes patients with a higher BMI in ChinaDiabetesISPOR APAC, 2010
The patient-physician partnership in asthma: real-world observations associated with clinical and patient-reported outcomesAsthmaView PublicationN/A
Quantifying the patient-reported burden of herpes zoster and post-herpetic neuralgia in the UK - practical considerationsPost-herpetic neuralgiaISOQOL, 2010
Emergence of walking and mobility problems among patients with multiple sclerosis and its impact on quality of life: a cross-sectional assessment in 5 EU countriesMultiple sclerosisECTRIMS, 2010
The effects of isolated versus multiple lipid disorders on resource utilization among metabolic syndrome patients with lipid abnormalities despite lipid-modifying treatmentMetabolic syndromeView PublicationN/A
Relationship of patient-reported chronic low back pain severity with other patient-reported outcomesChronic lower back painASRA, 2010
Relationship between patient-reported chronic low back pain severity and medication resourcesChronic lower back painASRA, 2010
Herpes zoster and post-herpetic neuralgia - considerations for a prospective, cross-sectional patient reported outcomes studyPost-herpetic neuralgiaISPOR EU, 2010
Association of patient-reported inhaler satisfaction with physician-perceived compliance with asthma treatment - results of a cross-sectional study in five European countriesAsthmaISPOR EU, 2010
Presence of cardiovascular comorbidities and prior medical history affect cardioversion treatment patterns among patients with acute atrial fibrillationAtrial fibrillationAHA, 2011
Influence of atrial fibrillation and cardioversion treatment patterns on perceived health-related qualiy of life among patients with acute atrial fibrillationAtrial fibrillationAHA, 2011
Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomesAsthmaView PublicationN/A
Prevalence and impact of night-time symptoms in COPD patients - results of a cross-sectional study in five European countriesChronic obstructive pulmonary diseaseWACF, 2011
Concordance between physicians' and patients' ratings of cognitive impairments and functioning associated with schizophreniaSchizophreniaICSR, 2011
Characteristics of COPD patients experiencing night-time symptoms - results of a cross-sectional study in five European countriesChronic obstructive pulmonary diseaseWACF, 2011
Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in EnglandDupuytren's contractureView PublicationN/A
Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients-an observational, cross sectional study in four countries in EuropeAllergic rhinitisView PublicationN/A
Treatment patterns and characteristics of European castration-resistant prostate cancer (CRPC) patientsProstate cancerAUA, 2011
Real-life outcomes in 2nd line advanced or metastatic non-small cell lung cancer (NSCLC): a pilot study in France and Germany analysing erloginib versus chemotherapyNon-small cell lung cancerISPOR US, 2011
Real life outcomes in 1st line non-squamous non-small cell lung cancer (NSCLC): a pilot study in France and Germany analysing bevacizumab-based versus non-bevacizumab-based treatmentsNon-small cell lung cancerISPOR US, 2011
Real life outcomes and health-related quality of life (HRQOL) in 1st line non-squamous non-small cell lung cancer (NSCLC): a European pilot study analysing bevacizumab-based versus non-bevacizumab-based treatmentsNon-small cell lung cancerISPOR US, 2011
Impact of walking and mobility problems on requirement for healthcare among multiple sclerosis patientsMultiple sclerosisISPOR US, 2011
Impact of cognitive impairment on function, medical resource utilisation, adherence and health-related quality of life in patients with schizophreniaSchizophreniaISPOR US, 2011
Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in EnglandDupuytren's contractureView PublicationN/A
Cardioversion treatment patterns and outcomes among acute atrial fibrillation patients in 5 European marketsAtrial fibrillationISPOR US, 2011
Burden of walking problems in multiple sclerosis: analysis of caregiver and indirect costsMultiple sclerosisISPOR US, 2011
Delays in insulin initiationDiabetesADA, 2011
Relationship between patient-reported disease severity and other clinical outcomes in osteoarthritis - a European perspectiveOsteoarthritisView PublicationN/A
Smoking and treatment among asthma patients in South KoreaSmokingERS, 2011
Association of patient-reported osteoarthritis severity with other patient-reported outcomes in the European clinical settingOsteoarthritisWCO, 2011
Psychometric validation of the hamburg quality of life questionnaire (HAQUAMS) in Germany, Italy, Spain, France, UK and the United StatesMultiple sclerosisECTRIMS, 2011
Mapping the EQ-5D index from the I-QOL in patients with neurogenic and ideopathic overactive bladder (OAB): results of a cross-sectional study in the US and 4 European countriesOveractive bladderISPOR EU, 2011
Mapping FACT-P to country specific patient health status measured by EQ-5D in metastatic castrate resistance prostate cancer patientsProstate cancerView PublicationN/A
HRQoL and clinical impact of mild patient-reported hypoglycaemic episodes in five European countries: extent of agreement between physician and patient-reported hypoglycaemic episodesDiabetesISPOR EU, 2011
Burden of hospitalisation in patients with advanced lung cancer in France and GermanyNon-small cell lung cancerISPOR EU, 2011
Burden of herpes zoster and post-herpetic neuralgia - findings from a cross-sectional patient-reported outcomes studyPost-herpetic neuralgiaISPOR EU, 2011
Relationship between patient-reported chronic low back pain severity and medication resourcesChronic lower back painView PublicationN/A
Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathyNeuropathic painView PublicationN/A
Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and complianceDiabetesView PublicationN/A
Reasons for switching antimuscarinic therapy: results from a European cross-sectional survey of physicians, and patients with OABOveractive bladderEAU, 2012
The burden of multiple sclerosis-related spasticity on indirect costs and requirement for non-professional care: results of a cross-sectional study in the USAMultiple sclerosisAAN, 2012
Impact of spasticity on healthcare resource utilisation: results of a cross-sectional study in the USAMultiple sclerosisAAN, 2012
Identifying disease characteristics associated with suboptimal care for COPD patients currently managed in primary care receiving inhaled corticosteroid and long-acting beta agonist FDCsChronic obstructive pulmonary diseaseIPCRG, 2012
Real-world use of permixon in benign prostatic hyperplasia - determining appropriate monotherapy and combination treatmentBenign prostatic hypertrophyView PublicationN/A
Symptoms, consultations and cormorbidities in real-world COPD patients classified by the GOLD 2011 strategyChronic obstructive pulmonary diseaseCOPD, 2012
Impact of morning symptoms on working lives of COPD patientsChronic obstructive pulmonary diseaseCOPD, 2012
Healthcare resource utilization and QoL in patients with OAB due to NDO in the UKOveractive bladderISPOR US, 2012
Healthcare resource utilisation is higher among UK neuropathic pain patients who have been treated for 12 months or longerNeuropathic painWSPC, 2012
An assessment of impairment of productivity among systemic lupus erythematosus patientsSystemic lupus erythematosus EULAR, 2012
A cross-national study of carer burden in dementiaDementiaAAIC, 2012
A cross-national study of augmentation of cholinesterase inhibitors with memantine in ADDementiaAAIC, 2012
The impact of satisfaction/dissatisfaction with current medication on the quality of life of patients with neuropathic painNeuropathic painIASP WCP, 2012
Does level of knowledge/understanding of their diabetes affect outcomes in patients on insulinDiabetesAADE, 2012
The distribution of a COPD population in the GOLD assessment framework by exacerbationsChronic obstructive pulmonary diseaseERS, 2012
The distribution of a COPD population based on the GOLD assessment frameworkChronic obstructive pulmonary diseaseERS, 2012
Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategyChronic obstructive pulmonary diseaseERS, 2012
Physician and patient perceptions and beliefs regarding insulin initiation and use in patients with type 2 diabetes (T2DM) in ChinaDiabetesISPOR APAC, 2012
Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment frameworkChronic obstructive pulmonary diseaseERS, 2012
Impact of morning symptoms experienced by COPD patients on exacerbation risk, rescue inhaler usage and normal daily activitiesChronic obstructive pulmonary diseaseERS, 2012
Antiviral treatment rates in thrombocytopenic Hepatitis C patients - results of a retrospective chart review in five EU countriesHepatitis C virusEASL/AASLD, 2012
Social and economic burden of walking and mobility problems in multiple sclerosisMultiple sclerosisView PublicationN/A
The burden of multiple sclerosis-related spasticity on indirect costs and requirement for non-professional care: results of a cross-sectional study in the USAMultiple sclerosisECTRIMS, 2012
Onset of multiple sclerosis-related spasticity and its impact on health-related quality of life as measured by EQ-5D and HAQUAMSMultiple sclerosisECTRIMS, 2012
Incremental burden of disease in patients diagnosed with pulmonary arterial hypertension receiving monotherapy and combination vasodilator therapyPulmonary arterial hypertensionCHEST, 2012
Impact of spasticity on healthcare resource utilisation: results of a cross-sectional study in the USAMultiple sclerosisECTRIMS, 2012
Comparison of overactive bladder patients who switch between antimuscarinic therapies with those who persist on the same therapy in the absence of improved outcomesOveractive bladderICS, 2012
Alignment between patients with overactive bladder and their primary care practitioner; real-world observations associated with patient-reported outcomesOveractive bladderICS, 2012
Societal burden associated with neuropathic pain in EuropeNeuropathic painISPOR EU, 2012
Patient burden associated with lack of treatment satisfaction among psoriasis patients receiving traditional systemic therapiesPsoriasisISPOR EU, 2012
Measuring the level and impact of neuropathic pain by disease area in the EUNeuropathic painISPOR EU, 2012
Limitations of current treatment for systemic lupus erythematosus - a patient and physician surveySystemic lupus erythematosus ACR/ARHP, 2012
Impact of patient satisfaction on QoL in psoriasis patients receiving traditional systemic therapyPsoriasisISPOR EU, 2012
Impact of bone metastases on quality of life in patients with castration-resistant prostate cancer at high risk for developing bone metastasesProstate cancerISPOR EU, 2012
Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategyChronic obstructive pulmonary diseaseBTS, 2012
Impact of patient satisfaction with their maintenance inhaler on treatment compliance and health outcomes in chronic obstructive pulmonary disease: an analysis of real-world clinical practice in EuropeChronic obstructive pulmonary diseaseBTS, 2012
Impact of morning symptoms experienced by COPD patients on exacerbation risk, rescue inhaler usage and normal daily activitiesChronic obstructive pulmonary diseaseBTS, 2012
Applying the GOLD 2011 classification to a real-world COPD population in GermanyChronic obstructive pulmonary diseaseBTS, 2012
Impact of Friedreich's ataxia on health-care resource utilization in the UK and GermanyFriedrich's ataxiaView PublicationN/A
Relationship between self-reported low-back pain severity and other patient-reported outcomes: results from an observational studyChronic lower back painView PublicationN/A
Estimation of the 'true' hospital burden of paediatric RSV on the NHS EnglandPediatric respiratory syncytial virusRCPCH, 2013
Mapping EQ-5D utility scores from the incontinence quality of life questionnaire among patients with neurogenic and idiopathic overactive bladderOveractive bladderView PublicationN/A
The impact of satisfaction/dissatisfaction with current medications on the quality of life of patients with neuropathic painNeuropathic painNeuPSIG, 2013
The impact of adherence to current medication on quality of life and pain intensity in patients with peripheral neuropathic painNeuropathic painNeuPSIG, 2013
Impact of ulcerative colitis on patient quality of life in a real-world clinical settingInflammatory Bowel DiseaseDDW, 2013
Impact of bone metastases on the humanistic burden in patients with castration-resistant prostate cancerProstate cancerISPOR US, 2013
Frequency of self-measurement of blood glucose according to diabetes type and treatmentDiabetesISPOR US, 2013
Exploring the real world setting of chronic kidney disease patient and physician behaviours across countries: disease specific programmesChronic kidney diseaseISPOR US, 2013
Impact of rheumatoid arthritis on QoL, work productivity and resource utilisation - an observational, cross-sectional study in BrazilRheumatoid arthritisView PublicationN/A
The association of satisfaction with control, current severity and duration of peripheral neuropathic pain with the likelihood of anxiety or depressionNeuropathic painWONCA, 2013
Neuropathic pain regimens that contain the capsaicin 8% patch: do they have a greater effect on pain reduction than other regimens?Neuropathic painWONCA, 2013
Epidemiology of castration-resistant prostate cancer in 13 medium-sized European countries: data from a routine practice studyProstate cancerMASCC/ISOO, 2013
Burden of bone metastases in patients with castration-resistant prostate cancer: findings from a routine practice study in 13 medium-sized European countriesProstate cancerMASCC/ISOO, 2013
Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis - results of a European cross-sectional observational studyPsoriasisView PublicationN/A
A measure of treatment response - patient and physician satisfaction with traditional NSAIDS for osteoarthritis controlOsteoarthritisView PublicationN/A
Limitations of current treatments for systemic lupus erythematosus - a patient and physician surveySystemic lupus erythematosus View PublicationN/A
Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and GermanyNon-small cell lung cancerView PublicationN/A
Castration-resistant prostate cancer: understanding disease progression and associated diagnostic procedures: findings from a routine practice study in 13 medium-sized European countriesProstate cancerECC, 2013
Relationship between compliance and patient-reported outcomes (PROs) in post herpetic neuralgia with insight into lidocaine medicated plaster useNeuropathic painEFIC, 2013
Physician satisfaction with current psoriasis treatmentPsoriasisLVDS, 2013
Impact of treatment compliance on HbA1c in people with insulin-treated type 2 diabetes in EuropeDiabetesSMDM, 2013
Association of health-related quality of life with side effects in patients with neuropathic painNeuropathic painEFIC, 2013
Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trialDiabetic macular edemaView PublicationN/A
Use of dexa scans in postmenopausal osteoporosis is associated with reduced long term fracture riskOsteoporosisISPOR EU, 2013
Treatment satisfaction and its association with health outcomes in patients with neuropathic painNeuropathic painISPOR EU, 2013
Relationship between COPD assessment test and EQ-5D in a real world patient populationChronic obstructive pulmonary diseaseISPOR EU, 2013
Exploring the burden of illness of hereditary angioedema in the UKAngioedemaISPOR EU, 2013
Evaluating the burden of bone metastases on patients with castration-resistant prostate cancer and their treating physicians: findings from a routine practice study in 13 medium-sized countriesProstate cancerISPOR EU, 2013
Cost of illness of neuropathic pain in Spain in 2012 from a societal perspectiveNeuropathic painISPOR EU, 2013
Burden of hospitalization in patients with advanced lung cancer in the United StatesNon-small cell lung cancerISPOR EU, 2013
Impact of night-time symptoms in COPD: a real-world study in five European countriesChronic obstructive pulmonary diseaseView PublicationN/A
Treatment patterns and characteristics of European patients with castration-resistant prostate cancerProstate cancerView PublicationN/A
Treatment profile and insulin dose as a factor impacting glycaemic control among premix insulin users with T2DM in ChinaDiabetesIDF, 2013
Glycaemic control in patients taking oral antihyperglycaemic medications only or insulin only regimens for patients with T2DM in ChinaDiabetesIDF, 2013
Exploring the cost and burden of illness of hereditary angioedema in the UKAngioedemaUK PIN, 2013
Real world burden of COPD: employed vs not in paid employment patientsChronic obstructive pulmonary diseaseN/A
Real world COPD: association of morning symptoms with clinical and patient reported outcomesChronic obstructive pulmonary diseaseView PublicationN/A
Physician satisfaction with current psoriasis treatmentPsoriasisCDC, 2014
Physician satisfaction with current psoriasis treatmentPsoriasisMaui Derm, 2014
Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbationsChronic obstructive pulmonary diseaseView PublicationN/A
The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional studyNon-small cell lung cancerView PublicationN/A
Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPDChronic obstructive pulmonary diseaseView PublicationN/A
Incremental burden of disease in patients diagnosed with pulmonary arterial hypertension receiving monotherapy and combination vasodilator therapyPulmonary arterial hypertensionView PublicationN/A
Impact of psoriasis severity on clinical symptoms, comorbidities and healthcare resource utilization among US patientsPsoriasisAAD, 2014
Impact of psoriasis disease severity and psoriasis-related itching, pain and scaling on patient reported quality of life and work productivity loss among US patientsPsoriasisAAD, 2014
Evaluation of relationship between IL-288 single nucleotide polymorphisms and SVR after peginterferon ribavirin combination therapy in HCV genotype 1 patients in Taiwan and KoreaHepatitis C virusAPASL, 2014
Description of patient burden observed in treated vs untreated patients with Hepatitis C virus results of a cross sectional study in US and FranceHepatitis C virusAPASL, 2014
Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladderOveractive bladderView PublicationN/A
Real-world disparities between patient- and clinician-reported outcomes: results from a disease-specific program in depression and anxietyAnxiety and depressionView PublicationN/A
Under-diagnosis and sub-optimal treatment of LUTS/BPH: results of a real world survey of patients in EuropeBenign prostatic hypertrophyEAU, 2014
Negative impact of reduced first undisturbed sleep period on utility, productivity and health-related quality of life: results of a real world survey of patients in Europe and USANocturiaEAU, 2014
Negative impact of nocturia on utility, productivity and health-related quality of life: results of a real world survey of patients in Europe and USANocturiaEAU, 2014
Extent to which a voiding diary is used to reach diagnosis in nocturia patients: results of a real world survey of patients in Europe and USANocturiaEAU, 2014
Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivityOveractive bladderView PublicationN/A
Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scoresDiabetic macular edemaView PublicationN/A
Utility values of hepatitis C patients in France: results by liver disease stage and treatment outcomeHepatitis C virusISPOR US, 2014
Understanding the cost of hereditary angioedema in the UKAngioedemaECRD, 2014
The secondary care cost burden to the NHS associated with the 2012 pertussis outbreak in EnglandPertussisESPID, 2014
Physician satisfaction with current psoriasis treatmentPsoriasisSDPA, 2014
Patient satisfaction with current psoriasis treatmentPsoriasisDNA, 2014
Patient satisfaction with current psoriasis treatmentPsoriasisSDPA, 2014
Impact of psoriasis disease severity and psoriasis-related itching, pain and scaling on patient reported quality of life and work productivity loss among US patientsPsoriasisSDPA, 2014
Burden of disease in systemic lupus erythematosus patients treated with corticosteroidsSystemic lupus erythematosus ISPOR US, 2014
Impact of physician specialty on classification of physician-perceived patient severity for patients with osteoarthritisOsteoarthritisView PublicationN/A
Real-world characterization and differentiation of the global initiative for chronic obstructive lung disease strategy classificationChronic obstructive pulmonary diseaseView PublicationN/A
Understanding the GOLD 2011 strategy as applied to a real-world COPD populationChronic obstructive pulmonary diseaseView PublicationN/A
Importance of inhaler device satisfaction and adherence in outcomes measure: real-world observations in US adult asthma patientsAsthmaREG, 2014
Gout patients treated with conventional urate-lowering therapy: association between disease control and work productivityGoutEULAR, 2014
A real-world characterization of moderate-to-severe systemic lupus euythematosusSystemic lupus erythematosus EULAR, 2014
Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older - findings from the Zoster Quality of Life (ZQoL) studyPost-herpetic neuralgiaView PublicationN/A
Evaluation of the consumer assessment of healthcare providers and systems in-center hemodialysis surveyChronic kidney diseaseView PublicationN/A
Burden of herpes zoster in the UK - findings from the zoster quality of life (ZQoL) studyPost-herpetic neuralgiaView PublicationN/A
Gout patients treated with conventional urate-lowering therapy: association between disease control and work productivityGoutWONCA, 2014
Symptom severity, quality of life and work productivity of US psoriasis patients during periods of flare and remissionPsoriasisAAD, 2014
Evidence for validity of a national physician and patient-reported survey in China and UK: the disease specific programmeDiabetesISPOR APAC, 2014
Treatment of lower urinary tract symptoms (LUTS) does not always reflect physician reported diagnosisLower urinary tract symptomsICS, 2014
Quality of life in patients with nocturia: does the study design impact the outcome?NocturiaICS, 2014
Physician satisfaction with current psoriasis treatmentPsoriasisFCDC, 2014
Patient satisfaction with current psoriasis treatmentPsoriasisLVDS, 2014
Nocturia results in work productivity and activity losses comparable with other chronic diseasesNocturiaICS, 2014
Impact of psoriasis disease severity and psoriasis-related itching, pain and scaling on patient reported quality of life and work productivity loss among US patientsPsoriasisFCDC, 2014
Impact of psoriasis disease severity and psoriasis-related itching, pain and scaling on patient reported quality of life and work productivity loss among US patientsPsoriasisLVDS, 2014
Health related quality of life and productivity impairment in chronic hepatitis C patients in GermanyHepatitis C virusVHC, 2014
COPD patients' needs and current treatment optionsChronic obstructive pulmonary diseaseView PublicationN/A
Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia - a retrospective chart review from five EU countriesHepatitis C virusView PublicationN/A
Self-reported health-related quality of life of hepatitis C virus (HCV) genotype 1 patients with and without comorbid conditionsHepatitis C virusISPOR EU, 2014
Inhaler device satisfaction, smoking history, allergic rhinitis and adherence in US adult asthma patients: relationship to health-related outcomesAsthmaACAAI, 2014
Impact of brain metastases on quality of life and estimated life expectancy in patients with advanced non-small cell lung cancerNon-small cell lung cancerISPOR EU, 2014
Establishing the relationship of inhaler satisfaction, adherence, smoking history and allergic rhinitis with patient outcomes: real world observations in US adult asthma patientsAsthmaISPOR EU, 2014
Burden of renal impairment: relative resource use in prostate cancer patients with bone metastasesProstate cancerISPOR EU, 2014
A real-world characterization of patients with moderate to severe systemic lupus erythemotosusSystemic lupus erythematosus ISPOR EU, 2014
A real-world characterization of moderate-to-severe systemic lupus euythematosusSystemic lupus erythematosus ACR/ARHP, 2014
Physician-prescribed asthma treatment regimen does not differ between smoking and non-smoking patients with asthma in Seoul and Gyunggi provinces of KoreaSmokingView PublicationN/A
Severity of liver disease among chronic hepatitis C patients - an observational study of 4594 patients in five EU countriesHepatitis C virusView PublicationN/A
Patient-reported symptom burden among relapsing remitting multiple sclerosis (RRMS) vs secondary progressive multiple sclerosis patients (SPMS) in the United StatesMultiple sclerosisAMCP, 2015
Patient-reported physical function and impact on instrumental activities of daily living in RRMS and SPMS patients in the United StatesMultiple sclerosisAMCP, 2015
Health related quality of life and utility values in chronic hepatitis C patients: a cross sectional study in France, the UK and GermanyHepatitis C virusEASL, 2015
Characterizing gastrointestinal symptoms in HIV patients taking antiretroviral therapyHIVACTHIV, 2015
Burden of illness in relapsing remitting and secondary progressive multiple sclerosis patients in the United StatesMultiple sclerosisAMCP, 2015
Antiviral treatment discontinuation among hepatitis C-infected individuals with thrombocytopeniaHepatitis C virusView PublicationN/A
The evaluation of work productivity in relapsing-remitting (RRMS) and secondary progressive multiple sclerosis (SPMS) patients in EuropeMultiple sclerosisISPOR US, 2015
Matching-adjusted indirect treatment comparison and survival extrapolation in radioiodine-refractory differentiated thyroid cancerThyroid cancerISPOR US, 2015
Impact of walking impairment on healthcare resource utilization in MS patientsMultiple sclerosisISPOR US, 2015
Exploring the real world setting of chronic ideopathic urticaria and physician attitudes towards it in the USUrticariaISPOR US, 2015
Confidence in correct inhaler device technique and its association with overall treatment adherence: a retrospective data analysis of real-world US patientsAsthmaATS, 2015
Increasing body mass index identifies Chinese patients with type 2 diabetes mellitus at risk of poor outcomesDiabetesView PublicationN/A
Unmet needs still remain in the biologic therapy options for psoriatic arthritisPsoriatic arthritisEULAR, 2015
Reasons for discontinuation of GLP-1 receptor agonists: data from a large cross-sectional survey of physicians and type 2 diabetic patientsDiabetesADA, 2015
Prevalence of joint involvement & frequency of joint exams for plaque psoriasis patients without confirmed psoriatic arthritisPsoriatic arthritisEULAR, 2015
Patient-reported symptom burden among relapsing-remitting multiple sclerosis (RRMS) vs secondary progressive multiple sclerosis Patients (SPMS) in EuropeMultiple sclerosisEAN, 2015
Patient-reported physical functioning in relapsin-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients in EuropeMultiple sclerosisEAN, 2015
Evaluation of burden on caregivers associated with relapsing-remitting (RRMS) and secondary progressive multiple sclerosis (SPMS) patients in EuropeMultiple sclerosisEAN, 2015
Differences in physician-reported and DAS28-based assessment of disease remission among rheumatoid arthritis patients in clinical practiceRheumatoid arthritisEULAR, 2015
Clinical outcomes in relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients in EuropeMultiple sclerosisEAN, 2015
Burden of illness associated with non-radiographic axial spondyloarthritis - an EU study from the clinical and healthcare system perspectiveAxial spondyloarthritisEULAR, 2015
Burden of illness associated with non-radiographic axial spondyloarthritis - a European study from the patient and societal perspectiveAxial spondyloarthritisEULAR, 2015
Glycemic control in Chinese patients with type 2 diabetes mellitus receiving oral antihyperglycemic medication-only or insulin-only treatment: a cross-sectional surveyDiabetesView PublicationN/A
Patient health utility, work productivity, and lifestyle impairment in chronic hepatitis C patients in FranceHepatitis C virusView PublicationN/A
Frequency and prevalence of flares in psoriasis in the USPsoriasisWPPA, 2015
Burden of flares on patients with moderate to severe psoriasis in the USPsoriasisWPPA, 2015
Alcohol dependence, co-occurring conditions and attributable burdenAlcohol dependenceView PublicationN/A
Frequency and prevalence of flares in psoriasis in the USPsoriasisAAD, 2015
Direct medical costs of severe hypooglycaemic events amongst type 2 diabetes patients in United Kingdom: a retrospective database studyDiabetesEASD, 2015
Comparison of COPD patients with high and low symptoms from a real-world US surveyChronic obstructive pulmonary diseaseERS, 2015
Bone targeting agent treatment patterns and the impact of bone metastases on prostate cancer patients in a real world settingProstate cancerESMO, 2015
Bone targeting agent treatment patterns and the impact of bone metastases on breast cancer patients in a real world settingBreast cancerESMO, 2015
Bone targeting agent treatment patterns and the impact of bone metastases on advanced breast cancer patients in the USBreast cancerBCS, 2015
Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physiciansAsthmaView PublicationN/A
Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivityPsoriasisView PublicationN/A
Physician-patient concordance in pharmacological management of patients with COPDChronic obstructive pulmonary diseaseView PublicationN/A
Understanding the characteristics of secondary progressive multiple sclerosis to facilitate early identificationMultiple sclerosisECTRIMS, 2015
Relapse rates and QoL among patients receiving disease-modifying therapy for multiple sclerosisMultiple sclerosisECTRIMS, 2015
Quantifying the impact of real world severity and satisfaction with care on productivity in Crohn's disease patientsInflammatory Bowel DiseaseAMCP, 2015
Impact of walking impairment on healthcare resource utilisation in multiple sclerosis patients: an updated analysis from 2015Multiple sclerosisECTRIMS, 2015
Differences in work productivity activity impairment in RRMS patients initiated on oral DMF or platform therapiesMultiple sclerosisECTRIMS, 2015
Confidence in correct inhaler device technique and its association with patient characteristics: a retrospective analysis of real world US COPD patientsChronic obstructive pulmonary diseaseAMCP, 2015
Comparison of the health status of COPD patients with high and low symptoms from a real-world US surveyChronic obstructive pulmonary diseaseCHEST, 2015
Real world data and LUTSLower urinary tract symptomsN/A
Walking impairment and healthcare resource utilisation in multiple sclerosis patients: an updated analysis from 2015Multiple sclerosisPACTRIMS, 2015
Trend and factors associated with switching treatment after initial anti-TNF therapy among patients with rheumatoid arthritisRheumatoid arthritisACR/ARHP, 2015
The relationship between glucose-lowering medications, adherence and outcomes in patients with type 2 diabetesDiabetesISPOR EU, 2015
The burden of nonradiographic axial spondyloarthritis from the employer perspective - a real world European studyAxial spondyloarthritisACR/ARHP, 2015
Symptoms, concomitant conditions and cardiac risk in European hydroxyurea treated polycythemia vera patientsPolycythemia veraISPOR EU, 2015
Standards for the classification of nonradiographic axial spondyloarthritisAxial spondyloarthritisACR/ARHP, 2015
Satisfaction in psoriatic arthritis patients despite active joint diseasePsoriatic arthritisACR/ARHP, 2015
Satisfaction and impact associated with the addition of belimumab to systemic lupus erythematosus treatmentSystemic lupus erythematosus ACR/ARHP, 2015
RRMS patients initiated on oral DMF report a better quality of life compared to patients on platform therapies as measured by EQ-5DMultiple sclerosisISPOR EU, 2015
Relationship between rheumatologist perceptions of rheumatoid arthritis severity and DAS28 measures, patient impact and treatment patternsRheumatoid arthritisACR/ARHP, 2015
Relapse rates and work productivity among patients receiving disease-modifying therapy (DMT) for multiple sclerosisMultiple sclerosisWCN, 2015
Prevalence of joint symptoms and frequency of joint exams for patients with plaque psoriasis without confirmed PSA - a US analysisPsoriasisACR/ARHP, 2015
Misalignment between physician and patient satisfaction with current psoriatic arthritis treatmentPsoriatic arthritisACR/ARHP, 2015
Matching-adjusted indirect treatment comparison and survival extrapolation in radioiodine-refractory differentiated thyroid cancer: updated analysisThyroid cancerISPOR EU, 2015
International differences in the role of payer and administrative controls in prescribing decisionsMultiple myelomaISPOR EU, 2015
Impact of staging and hormone sensitivity on quality of life in US prostate cancer patientsProstate cancerISPOR EU, 2015
Factors influencing treatment adjustments in rheumatoid arthritis patients - biologic DMARD treatment start and optionsRheumatoid arthritisACR/ARHP, 2015
Exploring the real world profile of refractory and non-refractory chronic idiopathic urticaria patients in the USUrticariaACAAI, 2015
Exploring the real world profile of refractory and non-refractory chronic idiopathic urticaria patients in the USUrticariaSDPA, 2015
Differences in disease specific HRQOL in RRMS patients initiated on oral DMF or platform therapies in Europe and USMultiple sclerosisISPOR EU, 2015
Development of a screening tool to support identification of patients with secondary progressive multiple sclerosis (SPMS)Multiple sclerosisISPOR EU, 2015
Delay of optimal nocturia treatment is costly: results of a real world survey of patients in Europe and the USANocturiaISPOR EU, 2015
Cross-sectional descriptive study of the impact of anaemia in chronic kidney disease patients on healthcare resource utilisation and work productivity across EuropeChronic kidney diseaseISPOR EU, 2015
Clinical characteristics and health outcomes of rheumatoid arthritis patients not adequately controlled on current treatmentRheumatoid arthritisACR/ARHP, 2015
Burden of residual skin and joint disease in patients with psoriatic arthritis treated with biologicsPsoriatic arthritisISPOR EU, 2015
Burden of illness associated with nonradiographic axial spondyloarthritis - a European real world database analysis from the clinical and healthcare system perspectiveAxial spondyloarthritisACR/ARHP, 2015
Bone-targeting agent treatment patterns and the impact of bone metastases on advanced breast cancer patients in real world settings in EuropeBreast cancerISPOR EU, 2015
Bone pain and bone-targeting agent treatment patterns in patients with bone metastases from prostate cancer in real world settings in EuropeProstate cancerISPOR EU, 2015
Avoidable burden and unmet need associated with nonradiographic axial spondyloarthritis treatmentAxial spondyloarthritisISPOR EU, 2015
Assessing the level of resistance/intolerance to hydroxyurea therapy among patients with polycythemia vera in EuropePolycythemia veraISPOR EU, 2015
Adoption of treat to target management in the context of achievable goals and satisfaction in rheumatoid arthritisRheumatoid arthritisACR/ARHP, 2015
Characteristics of Chinese patients with uncontrolled type 2 diabetes mellitus who were not initiated on insulinDiabetesCDS, 2015
Understanding remission in real-world lupus patients across five European countriesSystemic lupus erythematosus View PublicationN/A
Management of gout in the real world: current practice versus guideline recommendationsGoutView PublicationN/A
Prevalence and burden of dyspnoea among patients with chronic obstructive pulmonary disease in five European countriesChronic obstructive pulmonary diseaseView PublicationN/A
Use of bone-targeted agents to prevent skeletal-related events in patients with advanced breast cancer and bone metastasesBreast cancerEBCC, 2016
Satisfaction with treatment among IBD patients receiving subcutaneous biologic treatment and infused biologic treatmentInflammatory Bowel DiseaseECCO, 2016
Real-world treatment patterns & factors influencing use of bone-targeted agents in combination with emerging therapeutics in patients with prostate cancer & bone metastasesProstate cancerEAU, 2016
HRQoL, work productivity and satisfaction with treatment among IBD patients receiving adalimumab mono vs combo therapyInflammatory Bowel DiseaseECCO, 2016
Confidence in correct inhaler device technique and its association with health status and patient satisfactionChronic obstructive pulmonary diseaseSHM, 2016
Patient satisfaction with current psoriasis treatment - a real-world study in the USPsoriasisView PublicationN/A
Physician satisfaction with current psoriasis treatment - a real-world study in the USPsoriasisView PublicationN/A
A burden of illness study for neuropathic pain in EuropeNeuropathic painView PublicationN/A
Applying Rasch analysis to evaluate measurement equivalence of different administration formats of the Activity Limitation scale of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)Pulmonary arterial hypertensionView PublicationN/A
The burden experienced by people caring for patients with Alzheimer's disease or mild cognitive impairmentDementiaADI, 2016
Satisfaction in psoriatic arthritis patients despite active joint diseasePsoriasisAMCP, 2016
Misalignment between physician and patient satisfaction with current psoriatic arthritis treatmentPsoriasisAMCP, 2016
Different perceptions of Alzheimer's disease severity and its association with patients' and caregiver's quality of lifeDementiaADI, 2016
Comparison of biologic DMARD rheumatoid arthritis treatment dynamics across 5 EU countriesRheumatoid arthritisBSR, 2016
Burden of Alzheimer's disease or mild cognitive impairment on patients and their caregivers in Europe and the USDementiaADI, 2016
Matching-adjusted indirect treatment comparison in patients with radioiodine-refractory differentiated thyroid cancerThyroid cancerView PublicationN/A
Treatment with intramuscular interferon beta-1a in Brazil is associated with fewer hospitalisations due to relapseMultiple sclerosisISPOR US, 2016
The use of migraine prophylaxis treatment: analysis of clinical practice data from the United States, Germany, France and JapanMigraineISPOR US, 2016
Real-world evidence on health state utilities in metastatic breast cancer: data from a retrospective patient record form study and a cross-sectional patient surveyBreast cancerISPOR US, 2016
Real-world cross-sectional descriptive study of the quality of life of patients with anemia and chronic kidney disease across EuropeChronic kidney diseaseISPOR US, 2016
Quantifying the cost burden of locally advanced basal cell carcinoma not amenable to surgery or radiotherapy in the United KingdomBasal cell carcinomaISPOR US, 2016
Premixed insulin treatment for type 2 diabetes mellitus in China: patient and physician perceptionsDiabetesISPOR US, 2016
International differences in the role of payer and administrative controls in prescribing decisions in type 2 diabetes mellitus (t2dm)DiabetesISPOR US, 2016
Insulin initiation for type 2 diabetes mellitus in China: physicians' preferred HbA1c level at insulin initiation and patients' observed levelsDiabetesISPOR US, 2016
Inhaler preference, attribute importance and satisfaction in patients with asthma COPD or ACOS consulting for routine careChronic obstructive pulmonary diseaseATS, 2016
Factors associated with a history of failure and switching migraine prophylaxis treatmentMigraineISPOR US, 2016
Extent and consequences of inadequate disease control among adults with a history of moderate-to-severe atopic dermatitisAtopic dermatitisSID, 2016
Disagreement between physician and patient-reported disease severity in adults with a history of moderate-to-severe atopic dermatitisAtopic dermatitisSID, 2016
Current treatment and symptomatic burden of COPD patients according to 2014 GOLDChronic obstructive pulmonary diseaseATS, 2016
Characterizing patient reported QoL measures among users and non-users of migraine prophylaxis treatment in USA, Germany, France and JapanMigraineISPOR US, 2016
Characterization and patient-reported perceptions and outcomes of insulin use amongst pre-insulin versus insulin type 2 diabetes mellitus (T2DM) populations in USADiabetesISPOR US, 2016
Characteristics of Chinese patients with uncontrolled type 2 diabetes mellitus who were not initiated on insulinDiabetesISPOR US, 2016
An evaluation of disability progression and quality of life in multiple sclerosis patients in Brazil and MexicoMultiple sclerosisISPOR US, 2016
Use of migraine prophylaxis treatments in USA: analysis of data from clinical practiceMigraineAHS, 2016
Unmet needs and burden of illness in patients currently receiving biologic treatments for rheumatoid arthritisRheumatoid arthritisEULAR, 2016
Unmet need in migraine prophylaxis treatment in the USA: data from clinical practiceMigraineAHS, 2016
Trends in medication use in patients with type 2 diabetes mellitus: a long term view of real world treatment between 2000 and 2015DiabetesADA, 2016
Treatment failure, switching and HR-QoL in patients with ankylosing spondylitis or psoriatic arthritisAnkylosing spondylitisEULAR, 2016
Satisfaction and unmet need among systemic lupus erythematosus patients taking standard of care medications in a real world settingSystemic lupus erythematosus EULAR, 2016
Prevalence, recurrence and cost burden of locally advanced basal cell carcinoma not amenable to surgery or radiotherapy in the United KingdomBasal cell carcinomaASCO, 2016
Minimal important difference in haq - a validation from health economic perspectives in patients with rheumatoid arthritis using real world data from adelphi databaseRheumatoid arthritisEULAR, 2016
Migraine patients with cluster headache: exploratory study of the burden of illnessMigraineAHS, 2016
Key drivers in biosimilar prescription in inflammatory autoimmune disease indications in GermanyBiosimilarsEULAR, 2016
Fatigue in patients with ankylosing spondylitis and low vitality in those with psoriatic arthritisAnkylosing spondylitisEULAR, 2016
Evolution of biologic treatment, satisfaction with control and patient-reported outcomes in European patients with psoriatic arthritisPsoriatic arthritisEULAR, 2016
Disease severity in patients with discoid lupus erythematosus from a real-world settingDiscoid lupus erythematosusEULAR, 2016
Discrepancy between physician and patient satisfaction with rheumatoid arthritis disease controlRheumatoid arthritisEULAR, 2016
Breast cancer specific quality of life in HR+/HER2- advanced/metastatic breast cancer patients in a real world settingBreast cancerASCO, 2016
Association between disease severity and patient-reported outcomes in patients with discoid lupus erythematosus in real-world cllinical practiceDiscoid lupus erythematosusEULAR, 2016
Anxiety and depression among rheumatoid arthritis patients association with clinical measurements and patient-reported disability and treatment satisfactionRheumatoid arthritisEULAR, 2016
A real-world analysis of outcomes in migraineurs receiving preventive migraine treatmentMigraineAHS, 2016
Societal burden of mild cognitive impairment and Alzheimer's disease patients measured by caregivers' productivity lossDementiaAAIC, 2016
Quantifying the cost burden of locally advanced basal cell carcinoma on the health care system in the United KingdomBasal cell carcinomaAAD, 2016
Patients with Alzeimer's disease suffered reduced quality of life relative to general populationDementiaAAIC, 2016
Maintaining mild cognitive impairment patients in milder disease state results in less healthcare resource utilizationDementiaAAIC, 2016
How does the level of patient's cognitive impairment affect their caregiver's quality of lifeDementiaAAIC, 2016
How are cognitive impairment patients being diagnosedDementiaAAIC, 2016
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemiaChronic kidney diseaseView PublicationN/A
Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific ProgrammeDiabetesView PublicationN/A
Health status of patients with chronic obstructive pulmonary disease by symptom levelChronic obstructive pulmonary diseaseView PublicationN/A
Impact of psoriasis flare and remission on quality of life and work productivity - a real-world study in the USPsoriasisView PublicationN/A
Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the USMultiple sclerosisView PublicationN/A
Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USPsoriasisView PublicationN/A
Satisfaction with current psoriasis treatment - misalignment between physician and patient perceptionsPsoriasisView PublicationN/A
Burden of illness associated with non-radiographic AxSpA - a multiperspective European cross-sectional observational studyAxial spondyloarthritisView PublicationN/A
Discrepancy between physician-reported and DAS-28 reported remission in a real world study - unmet needs and boi in RA patients treated with biologicsRheumatoid arthritisRNS, 2016
Differences in satisfaction with RA disease control between physicians and patientsRheumatoid arthritisRNS, 2016
Association of anxiety and depression with clinical measurements and patient-reported disability and treatment satisfaction among rheumatoid arthritis patientsRheumatoid arthritisRNS, 2016
Prevalence and burden of dyspnoea among COPD patients in JapanChronic obstructive pulmonary diseaseView PublicationN/A
Treatment trends of asthma-COPD overlap syndrome patientsChronic obstructive pulmonary diseaseERS, 2016
Treatment patterns in migraine: a real-world analysis in a US populationMigraineEHF, 2016
The disease burden of mild asthma in ChinaAsthmaERS, 2016
The disease burden of mild asthmaAsthmaERS, 2016
Satisfaction with cancer treatments in HR+/HER- metastatic breast cancer patients in a real world settingBreast cancerESMO, 2016
Patient-reported pain severity and interference in HR+/HER- advanced/metastatic breast cancer in a real world settingBreast cancerESMO, 2016
Night-time symptoms and sleep disturbance in patients with COPDChronic obstructive pulmonary diseaseERS, 2016
Migraine prophylaxis treatments patterns in Japan: analysis of data from clinical practiceMigraineEHF, 2016
Migraine prophylaxis treatments patterns in Germany: analysis of data from clinical practiceMigraineEHF, 2016
Migraine prophylaxis treatments patterns in France: analysis of data from clinical practiceMigraineEHF, 2016
Direct medical costs of severe hypoglycemic events among type 2 diabetes patients in EnglandDiabetesEASD, 2016
Association of COPD symptom burden with healthcare resource utilization and impairment on work and activityChronic obstructive pulmonary diseaseERS, 2016
Adherence among type 2 diabetes mellitus (T2DM) patientsDiabetesEASD, 2016
The impact of increasing disability on employment status and caregiver burden among multiple sclerosis patients in BrazilMultiple sclerosisISPOR EU, 2016
Relapse rates and symptom management among patients receiving natalizumab and other disease-modifying therapies for relapsing-remitting multiple sclerosisMultiple sclerosisISPOR EU, 2016
Real-world impact of gender, age and socio-economic status on type 2 diabetes mellitus (T2DM) patients' disease engagement and adherence with treatment regimensDiabetesISPOR EU, 2016
Real world treatment patterns of PCSK9 inhibitors and other lipid lowering therapy among patients with dyslipidemiaDyslipidemiaAMCP, 2016
Quantification of quality of life differences due to age-related diseases in the 50+ age group in the United KingdomAge-related diseasesISPOR EU, 2016
Quality of life of patients with Alzheimer's disease: a comparison with the general populationDementiaISPOR EU, 2016
Perception from patients with ulcerative colitis or Crohn's disease toward the performance of biosimilars versus bio-originatorsBiosimilarsUEGW, 2016
Patient-reported need vs concern around injectable therapy and impact on adherence: a real world survey of 5EU/US type 2 diabetes mellitus (T2DM) patientsDiabetesISPOR EU, 2016
Patient reported health utility in HR+/HER2- advanced/metastatic breast cancerBreast cancerISPOR EU, 2016
Migraine prophylaxis treatment patterns in Japan: analysis of data from clinical practiceMigraineJHS, 2016
Economic and humanistic benefits of maintaining cognitive impairment patients in the early stageDementiaISPOR EU, 2016
Disease severity and control in adults with a history of moderate and-or severe atopic dermatitisAtopic dermatitisISPOR EU, 2016
Cost and resource utilization among multiple sclerosis patients with increasing disability in Latin AmericaMultiple sclerosisISPOR EU, 2016
Correlation between structural damage and work/activity impairment among rheumatoid arthritis patientsRheumatoid arthritisISPOR EU, 2016
Comparison of informal caregiving time required by Alzheimer's disease patients and mild cognitive impairment patientsDementiaISPOR EU, 2016
Burden and work productivity impairment from providing care to Alzheimer's disease patientsDementiaISPOR EU, 2016
Association of anxiety and depression with clinical measurements and patient-reported disability and treatment satisfaction among rheumatoid arthritis patientsRheumatoid arthritisISPOR EU, 2016
Assessment of patient preference in the treatment of relapsing remitting multiple sclerosis in public and private systems in Latin AmericaMultiple sclerosisISPOR EU, 2016
Analysis of costs associated with vitamin K antagonist treatment for stroke prevention in non valvular atrial fibrillation in RussiaAtrial fibrillationISPOR EU, 2016
Analysis of costs associated with vitamin K antagonist treatment for stroke prevention in non valvular atrial fibrillation in MexicoAtrial fibrillationISPOR EU, 2016
A regional analysis of relapsing remitting MS (RRMS) patients treated with natalizumab suggests a need to diagnose and treat early in Latin AmericaMultiple sclerosisISPOR EU, 2016
Patients with gout treated with conventional urate-lowering therapy: association with disease control, health-related quality of life, and work productivityGoutView PublicationN/A
Satisfaction with control of systemic lupus erythematosus and lupus nephritis - physician and patient perspectivesSystemic lupus erythematosus View PublicationN/A
Unhappiness is related to worse outcomes for patients with ankylosing spondylitis and increased impairment in daily life activitiesAnkylosing spondylitisACR/ARHP, 2016
Trends and factors associated with use of biologic agents as monotherapy among US RA patientsRheumatoid arthritisACR/ARHP, 2016
The relationship between physical functioning and work for people with psoriatic arthritis - results from a large real-world study in 16 countriesPsoriatic arthritisACR/ARHP, 2016
The impact of myeloproliferative neoplasms on patient quality of life and productivity - results from the international MPN Landmark studyMyeloproliferative neoplasmsASH, 2016
Psoriatic arthritis limits patients' abilities to undertake activities crucial for normal daily life and impacts happinessPsoriatic arthritisACR/ARHP, 2016
Physician-reported and patient-reported anxiety and depression in rheumatoid arthritisRheumatoid arthritisACR/ARHP, 2016
Patient attitudes towards being prescribed biosimilars in inflammatory autoimmune diseases in GermanyBiosimilarsACR/ARHP, 2016
Impact of pill burden on adherence and patient-reported quality of life - analysis of real world non-dialysis chronic kidney disease patient populationChronic kidney diseaseASN, 2016
Impact of disease flare perception on work productivity and treatment satisfaction in patients with psoriatic arthritisPsoriatic arthritisACR/ARHP, 2016
Discordance between physician-stated remission and DAS28-defined remission in rheumatoid arthritis patientsRheumatoid arthritisACR/ARHP, 2016
Comparison of patients prescribed biosimilar or bio-originators for autoimmune diseases in GermanyBiosimilarsACR/ARHP, 2016
Nocturia is often inadequately assessed, diagnosed and treated by physicians: results of an observational, real-life practice database containing 8659 European and US-American patientsNocturiaView PublicationN/A
The cost of warfarin treatment for stroke prevention in patients with non-valvular atrial fibrillation in MexicoAtrial fibrillationView PublicationN/A
Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015DiabetesView PublicationN/A
Assessing the impact of nocturia on health-related quality-of-life and utility: results of an observational survey in adultsNocturiaView PublicationN/A
The incremental disease burden associated with the persistence of morning daytime and night-time symptoms in COPD patientsChronic obstructive pulmonary diseaseBTS, 2016
The humanistic burden associated with caring for advanced NSCLC patients in Europe - a real world survey of caregiversNon-small cell lung cancerIASLC WCLC, 2016
The humanistic burden associated with advanced NSCLC patients in Europe - a real world surveyNon-small cell lung cancerIASLC WCLC, 2016
Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched studyChronic obstructive pulmonary diseaseView PublicationN/A
The humanistic burden of advanced non-small cell lung cancer on patients and their caregiversNon-small cell lung cancerCSS, 2017
A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPDChronic obstructive pulmonary diseaseView PublicationN/A
COPD symptom burden: impact on health care resource utilization, and work and activity impairmentChronic obstructive pulmonary diseaseView PublicationN/A
Misalignment between physicians and patient satisfaction with psoriatic arthritis disease controlPsoriatic arthritisView PublicationN/A
Assessing physician and patient acceptance of infliximab biosimilars in rheumatid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across GermanyBiosimilarsView PublicationN/A
Understanding disease burden, severity and progression in patients with cutaneous lupus erythematosus in a real world settingCutaneous lupus erythematosusICSLE, 2017
Symptomatic burden of asthma patients adherent to medium or high dose ICS LABAAsthmaAAAAI, 2017
Real-world treatment patterns and characteristics in patients with triple negative breast cancer in the United StatesBreast cancerMBCC, 2017
Real-world disease burden in US adults with moderate-severe atopic dermatitis eligible for treatment with systemic immunosuppressantsAtopic dermatitisAAD, 2017
Real world treatment patterns and characteristics in patients with CLL in the united statesChronic lymphocytic leukemiaASCO QCS, 2017
Patient and physician-perceived disconnects in the communication and disease management of myeloproliferative neoplasmsMyeloproliferative neoplasmsBSH, 2017
Most frequently utilized diagnostic test and scans across two North American and five European countriesDementiaICAPD, 2017
International Landmark survey - UK patient perceptions on the symptomatic and economic burden of myeloproliferative neoplasmsMyeloproliferative neoplasmsBSH, 2017
Impact of patient perceptions of psoriasis and sporiatic arthritis severity on patient-reported outcomes: an analysis from the Adelphi databasePsoriasisAAD, 2017
Health care resource utilization and work impairment for asthma patients adherent to medium or high dosage ICS/LABA fixed combination treatmentAsthmaAAAAI, 2017
Country variations in the duration of the diagnostic processDementiaICAPD, 2017
Country variations in the diagnostic experience of patients with cognitive impairmentDementiaICAPD, 2017
Cardiologist perspectives in treatment of patients with dyslipidemia with proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors and other lipid-lowering therapiesDyslipidemiaACC, 2017
A multinational assessment of work-related productivity loss and indirect costs for patients with psoriasisPsoriasisAAD, 2017
Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across GermanyBiosimilarsView PublicationN/A
Regional variations in the diagnosis of cognitively impaired patientsDementiaADI, 2017
Investigation of HRQoL burden in spondyloarthritis - effects of failure of advanced therapy and fatigueAxial spondyloarthritisJCR, 2017
Increasing cognitive impairment requires significantly more hours of caregivingDementiaADI, 2017
Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis - a US cross-sectional surveyAtopic dermatitisView PublicationN/A
Clinical profile, treatment patterns and outcomes of stage IV SCCHN patients receiving 2nd line active drug treatmentSquamous cell carcinoma of the head and neckAHNS, 2017
Disease burden of mild asthma: findings from a cross-sectional real-world surveyAsthmaView PublicationN/A
A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classificationsChronic obstructive pulmonary diseaseView PublicationN/A
Work productivity and activity impairment in patients with HR+/HER2- advanced/metastatic breast cancerBreast cancerISPOR US, 2017
Treatment patterns, treatment satisfaction and treatment switching in patients with non-radiographic AxSpAAxial spondyloarthritisISPOR US, 2017
Treatment patterns and healthcare resource use of rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs in South Korea: results from HIRA Health Insurance Claims DatabaseRheumatoid arthritisISPOR US, 2017
Treatment failure, treatment switching and HRQoL in patients with psoriatic arthritis - results from a real world sample in the USPsoriatic arthritisISPOR US, 2017
Treatment failure, switching and HRQoL in patients with ankylosing spondylitis - results from a real world sample in the USAnkylosing spondylitisISPOR US, 2017
Time of day of COPD symptoms and their association with work productivity and healthcare resource utilizationChronic obstructive pulmonary diseaseATS, 2017
Squamous cell carcinoma of the head and neck (SCCHN) patient reported satisfaction with cancer therapySquamous cell carcinoma of the head and neckISPOR US, 2017
Rheumatologist and patient-specific factors associated with current advanced therapy use in rheumatoid arthritisRheumatoid arthritisISPOR US, 2017
Real world treatment patterns in glioblastoma multiformeGlioblastoma multiformeWFNOS, 2017
Real world treatment patterns among patients with squamous cell carcinoma of the head and neck in CanadaSquamous cell carcinoma of the head and neckISPOR US, 2017
Patient reported QoL in patients with stage IV squamous cell carcinoma of the head and neck (SCCHN)Squamous cell carcinoma of the head and neckISPOR US, 2017
Inhaler confidence and satisfaction among COPD patients with comorbidities - a comparison of handheld verus nebulized maintenance bronchodilatorsChronic obstructive pulmonary diseaseISPOR US, 2017
Impact of glioblastoma multiforme on patient quality of lifeGlioblastoma multiformeWFNOS, 2017
Humanistic burden of disease in earlier stage metastatic versus late stage metastatic melanoma patients in a real world setting in 5 EU countriesMelanomaISPOR US, 2017
Disease status, symptomatology and remission rates of NrAxSpA and AS patients in the USAxial spondyloarthritisISPOR US, 2017
Discordance of acute myeloid leukemia symptoms reported by US physicians and patientsAcute myeloid leukemiaISPOR US, 2017
Determinants of patient and physician treatment satisfactgion in moderate to severe psoriasis - a multinational assessmentPsoriasisISPOR US, 2017
Delay in treatment progression among diabetics: a real world assessmentDiabetesISPOR US, 2017
Asthma symptoms and health care resource utilization by level of asthma control in patients adherent to ICS/LABA treatmentAsthmaATS, 2017
Direct medical costs of severe hypoglycaemic events in patients with type 2 diabetes in England: a retrospective database studyDiabetesView PublicationN/A
Weight management as a treatment intervention for NAFLD patients - real world practice and physician satisfaction with treatment effectivenessDiabetesICFL, 2017
Understanding the real-world clinical characteristics of multiple myeloma patientsMultiple myelomaEHA, 2017
Treatment and management of patients with MPNs - findings from the International MPN Landmark surveyMyeloproliferative neoplasmsEHA, 2017
Symptomatology, disease status and remission rates of NrAxSpA and AS patients in EuropePsoriatic arthritisEULAR, 2017
Real-world prescribing patterns in acute myeloid leukemia in the United StatesAcute myeloid leukemiaASCO, 2017
Real-world clinical inertia among T2DM patients clinical, physician and patient viewpointsDiabetesADA, 2017
Quality of life of acute myeloid leukemia patients in a real-world settingAcute myeloid leukemiaASCO, 2017
Presence of multiple drivers in the selection of high and low intensity chemotherapy in AMLAcute myeloid leukemiaEHA, 2017
Physician-estimated incidence of NASH in diabetes compared with physician-confirmed diagnosis of NASH in a real world population of diabetes patientsDiabetesICFL, 2017
Physician-estimated incidence of NAFLD in diabetes compared with physician-confirmed diagnosis of NAFLD in a real world population of diabetes patientsDiabetesICFL, 2017
Perception of symptom burden and treatment goals between physicians and patients with MPNSMyeloproliferative neoplasmsEHA, 2017
Patterns of HPV testing and treatment decision in patients with SCCHNSquamous cell carcinoma of the head and neckASCO, 2017
Patient characteristics and treatment patterns in chronic heart failure: results from a real-world cross-sectional survey in Argentina, Brazil, Colombia and MexicoChronic heart failureACC LA, 2017
Pain still remains a high unmet need among psoriatic arthritis patients receiving existing biologic treatmentPsoriatic arthritisEULAR, 2017
Later line drug treatment patterns of classical Hodgkin's lymphoma patients in Canada, France, Germany and the UKHodgkin's lymphomaEHA, 2017
Humanistic burden of disease in earlier stage versus late stage metastatic melanoma patients in the USMelanomaASCO, 2017
Economics of inhaled oxygen use as an acute therapy for cluster headache in the United States of AmericaCluster headacheAHS, 2017
Disease characteristics and treatment patterns of AML patients <60 years old versus >60 years oldAcute myeloid leukemiaEHA, 2017
Comparing adherence levels of CLL treatment from both the patient and physician perspective in the USChronic lymphocytic leukemiaASCO, 2017
Caregiver burden in chronic heart failure: pooled results from a real-world cross-sectional survey in Argentina, Brazil, Colombia and MexicoChronic heart failureACC LA, 2017
Burden of disease on chronic heart failure patients: pooled results from a real-world cross-sectional survey in Argentina, Brazil, Colombia and MexicoChronic heart failureACC LA, 2017
Assessing real-world treatment patterns, outcomes and resource use across Europe in newly diagnosed multiple myeloma patients post autologous stem cell transplantMultiple myelomaEHA, 2017
Frequency, prevalence, and burden of flares on patients with moderate to severe psoriasis - a retrospective cross-sectional analysisPsoriasisView PublicationN/A
Quantifying the benefits of dimethyl fumarate over beta interferon and glatiramer acetate therapies on work productivity outcomes in MS patientsMultiple sclerosisView PublicationN/A
The cost of warfarin treatment for stroke prevention in patients with non-valvular atrial fibrillation in RussiaAtrial fibrillationView PublicationN/A
Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world surveyChronic obstructive pulmonary diseaseView PublicationN/A
Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseaseView PublicationN/A
The race to diagnose - disease severity as a factor of Alzheimer's disease diagnosisAlzheimer's diseaseAAIC, 2017
Real world administration of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog)Alzheimer's diseaseAAIC, 2017
Real-world impact of cardiovascular disease and anemia on quality of life and productivity in patients with non-dialysis-dependent chronic kidney diseaseChronic kidney diseaseView PublicationN/A
Treatment-related burden of illness of castration-resistant prostate cancer with bone metastases in FranceProstate cancerView PublicationN/A
Patient-reported pain severity, pain interference and health status in HR+/HER2- advanced/metastatic breast cancerBreast cancerView PublicationN/A
Patient-reported quality of life and treatment satisfaction in patients with HR+/HER2- advanced/metastatic breast cancerBreast cancerView PublicationN/A
The impact of myeloproliferative neoplasms on patient quality of life and productivity - results from the International MPN Landmark surveyMyeloproliferative neoplasmsView PublicationN/A
Treatment patterns of COPD patients in France: a retrospective analysis of an administrative primary care databaseChronic obstructive pulmonary diseaseERS, 2017
Treatment patterns of chronic heart failure in BrazilChronic heart failureISPOR LA, 2017
Treatment patterns and satisfaction for rheumatoid arthritis patients in Latin America undergoing advanced therapyRheumatoid arthritisISPOR LA, 2017
Treatment patterns and impact of not achieving skin clearance for psoriasis patients in Latin AmericaPsoriasisISPOR LA, 2017
The cost burden of COPD in France: a retrospective analysis of an administrative primary care databaseChronic obstructive pulmonary diseaseERS, 2017
Symptomatic burden of COPD for patients receiving dual or triple therapyChronic obstructive pulmonary diseaseERS, 2017
Real-world productivity, HRU and QoL in patients with advanced gastric cancer in Canada and EuropeGastric cancerESMO, 2017
Psoriatic arthritis limits patient ability to contribute to society as part of the workforce results from multinational survey including Latin AmericaPsoriatic arthritisISPOR LA, 2017
Patient characteristics and treatment patterns of chronic heart failure in MexicoChronic heart failureISPOR LA, 2017
Patient characteristics and treatment patterns of chronic heart failure in ArgentinaChronic heart failureISPOR LA, 2017
Generating patient reported outcome norms for an EU cancer population using real world data (FACT-G)VariousESMO, 2017
Diabetes kidney disease (DKD) severity classifications and therapy impact in a real-world setting across 5EU and USDiabetesEASD, 2017
Delayed biologic switching among psoriatic arthritis patients may result in poor hrqol results from multinational survey including Latin AmericaPsoriatic arthritisISPOR LA, 2017
Delayed biologic switching among ankylosing spondylitis patients in Latin America may result in poor HRQoLAnkylosing spondylitisISPOR LA, 2017
Cost impact of time to initiation of triple therapy in COPD patients in Japan: a retrospective analysis of an administrative primary care databaseChronic obstructive pulmonary diseaseERS, 2017
Characteristics of psoriasis patients in Latin AmericaPsoriasisISPOR LA, 2017
Characteristics of Latin American patients with rheumatoid arthritis receiving advanced therapyRheumatoid arthritisISPOR LA, 2017
Assessing the burden of disease in peripheral and AxSpA in Mexico and BrazilAxial spondyloarthritisISPOR LA, 2017
Assessing the burden of chronic heart failure on patients in MexicoChronic heart failureISPOR LA, 2017
Assessing the burden of chronic heart failure on patients in BrazilChronic heart failureISPOR LA, 2017
Assessing the burden of chronic heart failure on patients in ArgentinaChronic heart failureISPOR LA, 2017
Assessing the burden of chronic heart failure on patients' caregivers in MexicoChronic heart failureISPOR LA, 2017
Assessing the burden of chronic heart failure on patients' caregivers in BrazilChronic heart failureISPOR LA, 2017
Assessing the burden of chronic heart failure on patients' caregivers in ArgentinaChronic heart failureISPOR LA, 2017
Appropriate PsA treatment is delayed for years - results from multi-national survey including Latin AmericaPsoriatic arthritisISPOR LA, 2017
Appropriate ankylosing spondylitis treatment is delayed for years results from multi-national survey including Latin AmericaAnkylosing spondylitisISPOR LA, 2017
Ankylosing spondylitis limits patient ability to contribute to society as part of the workforce - results from multinational survey including Latin AmericaAnkylosing spondylitisISPOR LA, 2017
Patient and physician-reported satisfaction with systemic lupus erythematosus treatment in US clinical practiceSystemic lupus erythematosus View PublicationN/A
Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetesDiabetesView PublicationN/A
Economics of inhaled oxygen use as an acute therapy for cluster headache in the United States of AmericaCluster headacheView PublicationN/A
Psoriatic arthritis patients failing biologic treatment have poor outcomes: survey results including APAC and Middle EastPsoriatic arthritisAPLAR, 2017
Impact of tobacco smoking on humanistic and financial burden of advanced non-small cell lung cancerNon-small cell lung cancerIASLC WCLC, 2017
Impact of multimorbidity on patient-reported QoL analysis of a real world chronic kidney disease patient populationsChronic kidney diseaseASN, 2017
Impact of brain metastases on the humanistic burden incurred by patients with advanced non-small cell lung cancerNon-small cell lung cancerIASLC WCLC, 2017
Changing disease-modifying therapy switching dynamics for relapsing-remitting multiple sclerosis patients Multiple sclerosisECTRIMS, 2017
Burden of heart failure in Saudi Arabia - results from a cross-sectional surveyChronic heart failureACC, 2017
Appropriate psoriatic arthritis treatment is delayed for years - multi-national survey results including APAC and Middle EastPsoriatic arthritisAPLAR, 2017
Appropriate ankylosing spondylitis treatment is delayed for years - multi-national survey results including APAC and Middle EastAnkylosing spondylitisAPLAR, 2017
Ankylosing spondylitis patients failing biologic treatment are less able to work - survey results including APAC and Middle EastAnkylosing spondylitisAPLAR, 2017
A real-world analysis of migraine: a cross-sectional study of disease burden and treatment patternsMigraineView PublicationN/A
Time from first symptom onset to first advanced therapy among rheumatoid patients in Latin AmericaRheumatoid arthritisACR/ARHP, 2017
The impact of disability on activities of daily living, productivity and independency in patients with multiple sclerosis - findings from a 2016 study in Europe and the USMultiple sclerosisISPOR EU, 2017
Real-world treatment patterns in patients with advanced gastric cancer in Western and Asian countriesGastric cancerESMO Asia, 2017
Real-world productivity, HRU and QoL in patients with advanced gastric cancer in Korea and JapanGastric cancerESMO Asia, 2017
Real-world evaluation of physician attitudes to prescription of androgen deprivation therapy for patients with prostate cancerProstate cancerISPOR EU, 2017
Real world treatment patterns of PCSK9 inhibitors among patients with dyslipidemia in Germany, Spain and United KingdomDyslipidemiaISPOR EU, 2017
Predicting EQ-5D utility index scores for gastric cancer patients in Japan: a preliminary modelGastric cancerISPOR EU, 2017
Patient characteristics and treatment patterns in chronic heart failure - results from a multinational cross sectional surveyChronic heart failureISPOR EU, 2017
Patient characteristics and reasons for biologic monotherapy in EU5 markets in rheumatoid arthritisRheumatoid arthritisISPOR EU, 2017
Level of satisfaction with rheumatoid arthritis treatment and associated alignment between rheumatologists and patients across Latin AmericaRheumatoid arthritisACR/ARHP, 2017
Impairment of work ability in patients with rheumatoid arthritisRheumatoid arthritisISPOR EU, 2017
Impact of isocitrate dehydrogenase status on the performance status and QoL of GBM patientsGlioblastoma multiformeISPOR EU, 2017
Health-related quality of life in oncology - are we getting better?VariousISPOR EU, 2017
Flaring among atopic dermatitis patients - the perception of flaring burden between physicians and patientsAtopic dermatitisISPOR EU, 2017
Economic and humanistic burden of illness among diabetes patients experiencing treatment inertiaDiabetesISPOR EU, 2017
Cost effectiveness of dolutegravir in HIV-1 treatment-naive patients in RussiaHIVISPOR EU, 2017
Cost burden associated with advanced non-small cell lung cancer - impact of disease stageNon-small cell lung cancerISPOR EU, 2017
Clinical characteristics and peripheral joint involvement at the time of diagnosis of Nr-AxSpA patients in the US and EuropeAxial spondyloarthritisACR/ARHP, 2017
Characterising the relative impact of established cardiovascular disease and chronic kidney disease on quality of life in diabetes patientsDiabetesISPOR EU, 2017
Burden of disease on chronic heart failure patients - a multinational cross-sectional survey in real world settingChronic heart failureISPOR EU, 2017
Burden of chronic heart failure on caregivers - a multinational cross-sectional survey in real world settingChronic heart failureISPOR EU, 2017
Assessing the disease course and treatment of psoriatic arthritis in CanadaPsoriatic arthritisISPOR EU, 2017
Assessing the burden of disease in peripheral and axial spondyloarthritis in MexicoAxial spondyloarthritisISPOR EU, 2017
Assessing the burden of disease in peripheral and axial spondyloarthritis in BrazilAxial spondyloarthritisISPOR EU, 2017
Assessing the burden of chronic heart failure on patients in ColombiaChronic heart failureISPOR EU, 2017
Assessing the burden of chronic heart failure on caregivers of patients in ColombiaChronic heart failureISPOR EU, 2017
Are there differences in FACT-G scores between different tumour types for an EU population using real world data?VariousISPOR EU, 2017
Access perceptions - a key driver of NSCLC targeted therapy prescription in RussiaNon-small cell lung cancerISPOR EU, 2017
Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitisAtopic dermatitisView PublicationN/A
Therapeutic inertia among real world population with T2DM from 2013-2016: data from 33,203 patients across EU and USDiabetesIDF, 2017
Quantifying levels of physical activity in patients with COPD - a US cross-sectional surveyChronic obstructive pulmonary diseaseBTS, 2017
Impact of active maintenance treatment compared to no maintenance on QoL of mutiple myeloma patients following first autologous stem cell transplantMultiple myelomaASH, 2017
Assessing outcomes, HRU and costs across Europe in newly diagnosed multiple myeloma patients post autologous stem cell transplantMultiple myelomaASH, 2017
Redefining cut-points for high symptom burden of the global initiative for chronic obstructive lung disease classification in 18,577 patients with chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseaseView PublicationN/A
Current later-line drug treatment patterns of patients with classical hodgkin lymphoma (CHL) in GermanyHodgkin's lymphomaDKK, 2018
A survey of caregiver burden in those providing informal care for patients with schizophrenia or bipolar disorder with agitation - results from an EU studyVariousView PublicationN/A
Treatment modification with sunitinib in first-line metastatic renal cell carcinoma: an analysis of the STAR-TOR registryMetastatic renal cell carcinomaASCO GU, 2018
The impact of biologic treatment on patients with psoriasis from Argentina, Brazil, Columbia and MexicoPsoriasisAAD, 2018
The humanistic burden of advanced non-small cell lung cancer: What are the key drivers of caregiver burden?Non-small cell lung cancerCSS, 2018
Nail psoriasis and psoriatic arthritis - assessing the association between these and real world impact of biologic treatmentPsoriasisAAD, 2018
Assessing the impact of patient support programs on patient outcomes in adalimumab-treated patients with psoriasis in EuropePsoriasisAAD, 2018
Quantifying the diagnostic pathway for patients with cognitive impairment: real-world data from seven European and North American countriesDementiaView PublicationN/A
Chart review across EU5 in multiple myeloma post-ASCT patientsMultiple myelomaView PublicationN/A
Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatmentRheumatoid arthritisView PublicationN/A
Real world treatment patterns and clinical outcomes of advanced metastatic breast cancer patient receiving palbociclib in combinationBreast cancerEBCC, 2018
Real world treatment clinical outcomes associated with palbociclib combination therapy in the US - results from the IRIS studyBreast cancerMBCC, 2018
BRCA screening patterns, demographics, and clinical characteristics among women with second line ovarian cancer: results from the Adelphi Disease Specific Cancer ProgrammeOvarian cancerSGO, 2018
Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine careChronic obstructive pulmonary diseaseView PublicationN/A
Characterizing the experience of agitation in patients with bipolar disorder and schizophreniaVariousView PublicationN/A
Disease burden of mild asthma in ChinaAsthmaView PublicationN/A
Treatment beliefs, adherence and outcomes in asthma patients: importance of beliefs in ICS nonadherenceAsthmaSBM, 2018
Rheumatologist perception on switching vs cycling treatment after tumour necrosis factor inhibitor therapy among US rheumatoid arthritis patientsRheumatoid arthritisAMCP, 2018
Physician beliefs regarding the use of biologic DMARD monotherapy vs combination therapy among US rheumatoid arthritis patientsRheumatoid arthritisAMCP, 2018
Pharmacotherapeutic treatment paradigms of osteoarthritis in the United StatesOsteoarthritisOARSI, 2018
Levels of satisfaction with psa treatment and associated alignment between rheumatologists and their patients across Latin AmericaPsoriatic arthritisPANLAR, 2018
Impact of chorea on employment, self-care activities and independency in huntington disease patients in the United StatesHuntington diseaseAMCP, 2018
Burden of disease in immune thrombocytopenia (ITP): The results for UK patients from the ITP World Impact Survey (I-WISh)Immune thrombocytopeniaBSH, 2018
Patient characteristics and real-world treatment patterns among early users of PCSK9 inhibitorsDyslipidemiaView PublicationN/A
Symptomatic burden of COPD for patients receiving dual or triple therapyChronic obstructive pulmonary diseaseView PublicationN/A
The economic burden of skin symptoms in psoriatic arthritisPsoriatic arthritisISPOR US, 2018
Remote reporting of patient outcomes in ulcerative colitis - a prospective real world studyInflammatory Bowel DiseaseISPOR US, 2018
Real-world out-of-pocket expenses among advanced breast cancer patients undergoing treatment in the USBreast cancerISPOR US, 2018
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for Hemophilia A and BHemophiliaECRD, 2018
Quality of life in patients with osteoporosis: a US cross-sectional studyOsteoporosisISPOR US, 2018
Perceptions of heart failure treatment decision-making and side effects of heart failure treatment by patients and cardiologistsChronic heart failureESC-HF, 2018
Perceptions of heart failure symptoms and disease severity by patients and cardiologists: a multinational survey in the real world cardiology settingChronic heart failureESC-HF, 2018
Inhaler use confidence and treatment adherence among COPD patients using neohaler: analysis of physician prescriptions from a US surveyChronic obstructive pulmonary diseaseATS, 2018
Health state utility of patients with CKD and anemia: analysis of EQ-5D in a real world populationChronic kidney diseaseERA-EDTA, 2018
Effect of painful lumbrosacral radiculopathy on employment and quality of life among patients in EuropeNeuropathic painISPOR US, 2018
Association of treatment resistant depression with healthcare resource utilization and physician satisfaction with disease managementDepressionISPOR US, 2018
The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPDChronic obstructive pulmonary diseaseView PublicationN/A
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countriesBreast cancerView PublicationN/A
Burden of heart failure on caregivers in China: results from a cross-sectional surveyChronic heart failureView PublicationN/A
Burden of heart failure on patients from China: results from a cross-sectional surveyChronic heart failureView PublicationN/A
Using real-world data to generate reference values for patient-reported outcome meauresVariousPSI, 2018
Treatment patterns in psoriatic arthritis - results from a real world international studyPsoriatic arthritisEULAR, 2018
The burden of disease and impact of immune thrombocytopenia (ITP) on patient quality of life and productivity: Results from the ITP World Impact Survey (I-WISh)Immune thrombocytopeniaEHA, 2018
The burden associated with temporary worsening of ulcerative colitis symptoms from the patient perspectiveInflammatory Bowel DiseaseDDW, 2018
Real world treatment patterns and clinical outcomes associated with palbociclib combination therapy in Argentina - results from IRIS studyBreast cancerASCO, 2018
Patient-perceived involvement in disease management drives patient-physician alignment in satisfaction with disease control in PSAPsoriatic arthritisEULAR, 2018
Impact of chorea on employment, self-care activities and independency in huntington disease patients in the United StatesHuntington diseasePAS, 2018
Health care resource utilization and lost productivity time due to migraine in the US populationMigraineAHS, 2018
Experience with an anti-IL17a inhibitor in biologic naive and biologic experienced PsA patientsPsoriatic arthritisEULAR, 2018
Evaluation of the impact of migraine on patient function and HRQoL in the US populationMigraineAHS, 2018
Cost-effectiveness of dolutegravir in HIV1 treatment-naive patients in ChinaHIVAPACC, 2018
Clinical outcomes in patients receiving palbociclib and fulvestrant first line for ABC/MBC in the USBreast cancerASCO, 2018
Nocturia is more bothersome than daytime LUTS: results from an observational, real-life practice database including 8659 European and American LUTS patientsNocturiaView PublicationN/A
Care pathways and treatment patterns for patients with heart failure in China: results from a cross-sectional surveyChronic heart failureView PublicationN/A
Real-world, multinational, retrospective observational survey of the ADAS-Cog and associations with healthcare resource utilization in patients with Alzheimer's diseaseDementiaView PublicationN/A
Nocturia diagnosis in LUTS patients is associated with decreased sleep quality, work productivity and daytime tirednessNocturiaICS, 2018
Cost effectiveness of dolutegravir as a first-line treatment option in the HIV-1-infected treatment-naive patients in RussiaHIVView PublicationN/A
Functional performance in patients with COPD: association with treatment regimen, GOLD group, lung function, and symptom burden in a cross-sectional studyChronic obstructive pulmonary diseaseView PublicationN/A
The discrepancy between patient and physician perceptions of pain and treatment satisfaction among PLSR patients in France and GermanyNeuropathic painIASP WCP, 2018
Real world disease burden in patients with dyslipidemia with-without diabetes mellitus in ChinaDyslipidemiaISPOR APAC, 2018
Painful lumbrosacral radiculopathy: current treatment regimens and associated patient satisfaction in France and GermanyNeuropathic painIASP WCP, 2018
Medication use and treatment satisfaction for trigeminal neuralgia patients in France and GermanyNeuropathic painIASP WCP, 2018
Impact of mild or moderate atopic dermatitis on adult patients - results from a real-world study in 3 European countriesAtopic dermatitisEADV, 2018
Health care resource use by disease severity for patients with osteoarthritis in the United StatesOsteoarthritisPain Week, 2018
Exacerbation frequency and eosinophil levels for GOLD C and D COPD patients currently prescribed multiple inhaler triple therapy (MITT)Chronic obstructive pulmonary diseaseERS, 2018
Current and future opportunities for the use of real world data in the Asia Pacific regionVariousISPOR APAC, 2018
Burden of mild and moderate atopic dermatitis - results from a real-world study in the US and EuropeAtopic dermatitisEADV, 2018
Assessment of the benefit of achieving complete vs almost complete skin clearance of psoriasis patients in the US - a patient perspectivePsoriasisEADV, 2018
Adult patients experiencing mild or moderate atopic dermatitis are significantly impacted by their condition - results from a real-world study in the USAtopic dermatitisEADV, 2018
Acute and preventive treatment patterns and associated WPAI among patients with migraine in GermanyMigraineEHF, 2018
A real-world analysis of global patient-reported outcomes in patients with migraineMigraineEHF, 2018
Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current EU rheumatology practiceRheumatoid arthritisView PublicationN/A
Use of DLQI subdomains to measure overall work productivity loss in moderate-severe psoriasis patientsPsoriasisAMCP, 2018
Treatment patterns among patients with moderate to severe ulcerative colitis in Western EuropeInflammatory Bowel DiseaseUEGW, 2018
Treatment patterns among patients with moderate to severe ulcerative colitis in the USInflammatory Bowel DiseaseACG, 2018
The burden of disease and impact of immune thrombocytopenia (ITP) on patient quality of life and productivity: Results from the ITP World Impact Survey (I-WISh)Immune thrombocytopeniaECTH, 2018
The association between disease activity and PROs in patients with moderate to severe ulcerative colitis in the USInflammatory Bowel DiseaseACG, 2018
The association between disease activity and PROs in patients with moderate to severe ulcerative colitis in EuropeInflammatory Bowel DiseaseUEGW, 2018
Real world treatment patterns associated wtih palbociclib combination therapy in Germany - results from the IRIS studyBreast cancerESMO, 2018
Quality of life in CKD patients with hyperkalemia in the US: results from the KDQOL-36Chronic kidney diseaseASN, 2018
Physical and emotional burden on caregivers of patients with heart failure in JapanChronic heart failureJHFS, 2018
Full, partial or modified - understanding relationships between permutations of the Mayo score in real-world ulcerative colitis patientsInflammatory Bowel DiseaseACG, 2018
From onset of symptoms to a diagnosis of hypothyroidism - the real world experienceHypothyroidismATA, 2018
Discordance in symptoms reported by patients with hypothyroidism versus by their patientsHypothyroidismATA, 2018
Clinical atherosclerotic cardiovascular disease (ASCVD): patient attitudes and awareness in CanadaDyslipidemiaCAPT, 2018
Burden of illness among patients with chronic hypoparathyroidism not adequately controlled with standard therapy by self-perceptionHypoparathyroidismASBMR, 2018
Burden of heart failure on patients in JapanChronic heart failureJHFS, 2018
Associations of hemoglobin levels and quality of life in patients with chronic kidney diseaseChronic kidney diseaseASN, 2018
Assessing the relationship between disease severity and pros in psoriasis patients in the USPsoriasisFCDC, 2018
Assessing the impact of hyperkalemia on patient-reported quality of life: a global analysis of the KDQOL-36 in a real-world CKD patient populationChronic kidney diseaseASN, 2018
Anemia treatment patterns in chronic kidney disease - results from three international surveys among physiciansChronic kidney diseaseASN, 2018
HRQoL for multiple myeloma patients according to treatment strategy after autologous stem cell transplant - a cross-sectional study using EORTC, EQ-5D and My-20 scalesMultiple myelomaView PublicationN/A
Treatment patterns and clinical outcomes among patients receiving palbociclib with an aromatase inhibitor or fulvestrant for HR+ HER2- advanced-metastatic breast cancer in real-world settings in the US - results from the IRIS studyBreast cancerView PublicationN/A
Work productivity and EQ-5D utility of CKD patients by anemia severityChronic kidney diseaseISPOR EU, 2018
Reduced relapse rates and improved QoL for relapsing-remitting multiple sclerosis (RRMS) patients treated with natalizumab vs injectable therapiesMultiple sclerosisISPOR EU, 2018
Reduced healthcare resource utilisation for patients treated with delayed release dimethyl fumarate vs injectable therapies: findings from a real-world cross-sectional study of MS patientsMultiple sclerosisISPOR EU, 2018
Real-world treatment patterns and health outcomes in episodic and chronic migraine in JapanMigraineJHS, 2018
Real world treatment patterns of patients with advanced ovarian cancer resistant or refractory to frontline platinum-based therapyOvarian cancerISPOR EU, 2018
Real world bortezomib usage in combination with VMP as FL treatment in SCT ineligible multiple myeloma patients across 5EUMultiple myelomaISPOR EU, 2018
Real world bortezomib usage in combination with thalidomide and dexamathasone as frontline treatment in stem cell transplant eligible MM patientsMultiple myelomaISPOR EU, 2018
Physician reported adherence in MS patients treated with injectable platform therapies versus delayed-release dimethyl fumarate: Findings from a real-world cross-sectional studyMultiple sclerosisISPOR EU, 2018
Peginterferon beta-1a is associated with reduced relapse rates and hospitalisation compared with other first line injectable therapies for multiple sclerosisMultiple sclerosisISPOR EU, 2018
Increased burden of multimorbidity among diabetes patientsDiabetesISPOR EU, 2018
Health resource utilization across stages of Alzheimer'sAlzheimer's diseaseISPOR EU, 2018
Health related quality of live in patients with advanced ovarian cancer resistant or refractory to frontline platinum-based therapyOvarian cancerISPOR EU, 2018
Functional loss across stages of Alzheimer'sAlzheimer's diseaseISPOR EU, 2018
Caregiver needs across stages of Alzheimer'sAlzheimer's diseaseISPOR EU, 2018
Assessing real world usage of PD-1 inhibitors in advanced melanoma across EU5MelanomaISPOR EU, 2018
Perceptions of heart failure symptoms, disease severity, treatment decision-making and side effects by patients and cardiologistsChronic heart failureView PublicationN/A
Sunitinib treatment modification in first-line metastatic renal cell carcinoma: analysis of the STAR-TOR registryRenal cell carcinomaView PublicationN/A
COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitionersChronic obstructive pulmonary diseaseView PublicationN/A
Results from the ITP World Impact Survey (I-WISh): Patients with immune thrombocytopenia experience impaired quality of life regarding daily activities, social interactions, emotional well-being, and working livesImmune thrombocytopeniaASH, 2018
Real world treatment patterns and outcomes of patients receiving palbociclib plus fulvestrant in the US from the IRIS StudyBreast cancerSABCS, 2018
Real world treatment patterns and outcomes of patients receiving palbociclib plus aromatase inhibitor in the US from the IRIS studyBreast cancerSABCS, 2018
Patients with immune thrombocytopenia frequently experience severe fatigue but it is under-recognized by physicians: results from the ITP World Impact Survey (I-WISh)Immune thrombocytopeniaASH, 2018
Adult patients experiencing mild or moderate atopic dermatitis are significantly impacted by their condition - results from a real-world study in the USAtopic dermatitisASHP, 2018
Non-professional caregiver burden is associated with the severity of patients' cognitive impairmentDementiaView PublicationN/A
A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in EuropeBreast cancerView PublicationN/A
Humanistic burden of refractory and non-refractory chronic idiopathic urticaria - a real-world study in the United StatesChronic idiopathic urticariaView PublicationN/A
Treatment patterns, determinants and outcomes of hemophiliaHemophiliaEAHAD, 2019
Physician practice patterns associated with diagnostic evaluation of patients with suspected mild cognitive impairment and Alzheimer's diseaseAlzheimer's diseaseView PublicationN/A
Real-world treatment patterns and outcomes of patients with stage IV squamous cell carcinoma of the head and neckHead and neck cancerView PublicationN/A
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the United StatesBreast cancerView PublicationN/A
Burden of asthma among patients adherent to ICS/LABA - a real-world studyAsthmaView PublicationN/A
Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stageNon-small cell lung cancerView PublicationN/A
Symptom burden and lack of remission among adult patients with ulcerative colitis (UC): retrospective analysis of cross-sectional survey data from the US and GermanyInflammatory Bowel DiseaseECCO, 2019
Physician-recommended and patient-implemented lifestyle interventions among non-alcoholic steatohepatitis (NASH) patients with and without cardiovascular-metabolic (CVM) related comorbidities: A European real-world studyNon?alcoholic steatohepatitisDUKPC, 2019
Physician-recommended and patient-implemented lifestyle interventions among non-alcoholic steatohepatitis (NASH) patients with and without cardiovascular-metabolic (CVM) related comorbidities: A European real-world studyNon?alcoholic steatohepatitisDUKPC, 2019
Opiod use, rebound headache and resource utilization among migraine patients with insufficient response to triptans based on real-world dataMigraineAMCP, 2019
Living with ulcerative colitis in Germany: quantifying the socioeconomic impact of moderate to severe ulcerative colitisInflammatory Bowel DiseaseECCO, 2019
Living with ulcerative colitis in Germany: quantifying the healthcare resource utilisation and direct healthcare costs associated with treatment of moderate to severe ulcerative colitisInflammatory Bowel DiseaseECCO, 2019
BRCA1/2 status and patient characteristics, health utility/health status, and work impairment in HER2- advanced breast cancer: results from a real-world studyBreast cancerMBCC, 2019
Physician-recommended lifestyle interventions and associated effects among NASH patients with and without CV-metabolic related comorbidities - a European real-world studyNon?alcoholic steatohepatitisEASL, 2019
Impact of pain severity among patients with osteoarthritis on health care use in the United StatesOsteoarthritisAPS, 2019
Differences between NASH patient characterisation and management approaches - a multi-national real-world studyNon?alcoholic steatohepatitisEASL, 2019
Cluster analysis of patients with SLE in the Adelphi Lupus Disease Specific ProgrammeSystemic lupus erythematosus ICSLE, 2019
Assessing the differences between psoriasis patients who are aligned with their physician on their current disease severity versus patients who are misalignedPsoriasisSPIN, 2019
Alignment between physician-estimated vs objectively derived fibrosis scores in NASH - RWE suggests clinicians underestimate disease severity in secondary careNon?alcoholic steatohepatitisEASL, 2019
Inhaled corticosteroid use by exacerbations and eosinophils - a real-world COPD populationChronic obstructive pulmonary diseaseView PublicationN/A
Real world impact of physician and patient discordance on HRQoL in US patients with acute myeloid leukemiaAcute myeloid leukemiaView PublicationN/A
Use of an Adelphi Disease Specific Programme to assess the impact of institute for clinical and economic review report publication on specialty category management by US insurers; a physician-based approachPsoriasisISPOR US, 2019
Understanding the real-world clinical characteristics and treatment patterns of follicular lymphoma patients in EU5 marketsFollicular lymphomaISPOR US, 2019
The impact of anxiety and depression in type 1 diabetes mellitus (T1DM) patients who experience severe hypoglycemic episodes (hypos)DiabetesISPOR US, 2019
Real-world productivity, healthcare resource utilization (HCRU) and quality of life (QOL) in patients receiving first-line treatment for advanced gastric cancer (GC) in Canada and EuropeGastric cancerISPOR US, 2019
Real-world experience with dolutegravir-based two-drug regimensHIVISPOR US, 2019
Real world treatment patterns for first line (1L) recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) patientsSquamous cell carcinoma of the head and neckISPOR US, 2019
Psychometric evaluation and score interpretation of the NCCN-FACT ovarian symptom index-18 in patients with advanced ovarian cancer: Real-world evidenceOvarian cancerISPOR US, 2019
Opioid use, rebound headache, and resource utilization among migraine patients with insufficient response to triptans based on real-world dataMigraineAAN, 2019
Impact of chronic hypoparathyroidism on HRQoL, symptoms, employment and relationships - findings from a 13-country patient surveyHypoparathyroidismECE, 2019
Impact of BRCA1/2 mutations status on patient reported outcomes in HER2- advanced breast cancer: Results from a multi-country real-world study Breast cancerESMO BC, 2019
Impact of BRCA1/2 mutation status on patient-reported general health status in HER2- advanced breast cancer: results from a US real-world studyBreast cancerISPOR US, 2019
Healthcare resource use and humanistic burden associated with attack frequency in episodic cluster headache Cluster headacheAAN, 2019
Features of episodic cluster headache in the real world setting: clinical characteristics from a large, multi-national, cross-sectional surveyCluster headacheAAN, 2019
Factors associated with and implications of meeting or not meeting HbA1c targets in type 2 diabetes mellitusDiabetesISPOR US, 2019
Development of a conceptual framework qualitative RWD-based needs assessment of PROs in ulcerative colitisInflammatory Bowel DiseaseISPOR US, 2019
Comparative disease burden for non-radiographic axial spondyloarthritis and ankylosing spondylitis: results from a large multi-national real world databaseVariousISPOR US, 2019
BRCA status, treatment patterns and outcomes in HER2- advanced breast cancer (ABC): A multi-country real-world studyBreast cancerESMO BC, 2019
Assessment of outcomes in partially versus fully compliant schizophrenia patientsSchizophreniaISPOR US, 2019
Assessment of outcomes and symptom severity in schizophrenia patients according to physician perception of illnessSchizophreniaISPOR US, 2019
An Assessment of the humanistic impact of schizophrenia in relation to caregiver and productivity burdenSchizophreniaISPOR US, 2019
Acute and preventive treatment patterns in episodic cluster headache: findings from the United States, United Kingdom and GermanyCluster headacheAAN, 2019
A real world assessment of outcomes in schizophrenia patients according to treatment responseSchizophreniaISPOR US, 2019
Physician perceptions about barriers to prompt diagnosis of mild cognitive impairment and Alzheimer's DiseaseAlzheimer's diseaseView PublicationN/A
Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world surveyAcute myeloid leukemiaView PublicationN/A
A real-world cross-sectional community survey of symptoms and health-related quality of life of adults with acute myeloid leukemiaAcute myeloid leukemiaView PublicationN/A
Treatment approaches in myelofibrosis: a survey of haematologists in AustraliaMyelofibrosisESH, 2019
Relative impact of joint and skin symptoms on quality of life and work productivity in psoriatic arthritis (PsA) patientsPsoriatic arthritisEULAR, 2019
Real world physician satisfaction with secukinumab in psoriatic arthritis and ankylosing spondylitis in EuropeVariousEULAR, 2019
Quantifying the relative importance of COPD symptoms to patientsChronic obstructive pulmonary diseaseHTAi, 2019
Patient perceptions on splenectomy outcomes: results from the ITP World Impact Survey (I-WISh)Immune thrombocytopeniaEHA, 2019
Lack of consistent standard of care in systemic lupus erythematosus patients in real worldSystemic lupus erythematosus EULAR, 2019
Impact of myeloproliferative neoplams (MPNs) and perceptions of treatment goals among physicians and patients in 6 countires - an expansion of the MPN Landmark Survey Myeloproliferative neoplasmsEHA, 2019
Impact of hypoglycemic episodes (Hypos) on type 1 diabetes mellitus (T1DM)DiabetesADA, 2019
Gender differences in disease status, quality of life and treatment patterns in axial spondyloarthritis patients: findings from a global surveyAxial spondyloarthritisEULAR, 2019
Features of episodic cluster headache in the real world setting - clinical characteristics from a large, multi-national cross-sectional surveyCluster headacheEAN, 2019
Enthesitis, dactylitis, and axial disease in psoriatic arthritis (PsA): impact on patient quality of life and work productivityPsoriatic arthritisEULAR, 2019
Disease course and treatment patterns in progressive supranuclear palsyProgressive supranuclear palsyIAPRD, 2019
Differences in perceptions on treatment approaches between physicians and ITP patients: Results from the ITP World Impact Survey (I-WISh)Immune thrombocytopeniaEHA, 2019
Differences in clinical characteristics, quality of life, disability, and work productivity in psoriatic arthritis patients by gender: findings from a cross-sectional survey in the US and EuropePsoriatic arthritisEULAR, 2019
Cluster profiling of patients in a real-world data set with systemic lupus erythematosus and their associated treatments Systemic lupus erythematosus EULAR, 2019
Assessing the prevalence and use of validated systemic lupus erythematosus disease activity metrics in real world practiceSystemic lupus erythematosus EULAR, 2019
Acute and preventive treatment patterns in episodic cluster headache: findings from the United States, United Kingdom and GermanyCluster headacheEAN, 2019
Acute and preventive treatment patterns among patients with migraine in Spain MigraineAES, 2019
Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programmeMigraineView PublicationN/A
Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world studyPsoriatic arthritisView PublicationN/A
Awareness of and compliance with Domperidone revised labelling after a risk-minimization in EuropeNauseaView PublicationN/A
Features of episodic cluster headache in the real world setting - clinical characteristics from a large, multi-national cross-sectional surveyCluster headacheAHS, 2019
Behavioural symptoms and disturbances in dementa - a highly prevalent conditionDementiaAAIC, 2019
Acute and preventive treatment patterns in episodic cluster headache - findings from the United States, United Kingdom and Germany Cluster headacheAHS, 2019
A real-world assessment of the impact on the health-related quality of life and work productivity of triptan non-responders compared with responders: results from a global studyMigraineAHS, 2019
Mapping the kidney disease QoL 36-item short form survey (KDQOL-36) to EQ5D-3L and EQ5D-5L in patients undergoing dialysisChronic kidney diseaseView PublicationN/A
The prevalence and type of discordance between physician perception and objective data from standardized measure of rheumatoid arthritis disease activity in the USRheumatoid arthritisView PublicationN/A
Exploring the real-world profile of refractory and non-refractory chronic idiopathic urticaria in the USA - clinical burden and healthcare resource UseChronic idiopathic urticariaView PublicationN/A
UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPNMyeloproliferative neoplasmsView PublicationN/A
What matters most in diagnosis and monitoring of osteoarthritis by physician specialtyOsteoarthritisPain Week, 2019
Triptan use and associated patient reported outcomes in migraine patientsMigraineIHC, 2019
The impact of progressive supranuclear palsy disease severity on HCRUProgressive supranuclear palsyICPDMD (MDS), 2019
The impact of progressive supranuclear palsy disease severity on caregiversProgressive supranuclear palsyICPDMD (MDS), 2019
The impact of osteoarthritis disease severity on current healthcare resource utilisation in the EU - Results from a real-world studyOsteoarthritisEFIC, 2019
The impact of osteoarthritis disease severity on current healthcare resource utilisation in Japan - Results from a real world studyOsteoarthritisEFIC, 2019
Relationship between progressive supranuclear palsy and caregiver burdenProgressive supranuclear palsyICPDMD (MDS), 2019
Physician and patient reporting of depression and anxiety in a US pulmonary arterial hypertension populationPulmonary arterial hypertensionERS, 2019
Physician and patient concordance of perceived asthma control - a US real world studyAsthmaERS, 2019
Patient and physician perspectives on the care and assistance needs in Huntingdon's diseaseProgressive supranuclear palsyICPDMD (MDS), 2019
Opiod use for the treatment of osteoarthritis among PCPs, rheumatologists and orthopedic surgeonsOsteoarthritisPain Week, 2019
Medication use and reasons for switching biologic therapy in patients with non-radiographic axial spondyloarthritis: findings from a global surveyAxial spondyloarthritisISPOR LA, 2019
Measuring the severity of osteoarthritis - do patients and physicians agreeOsteoarthritisPain Week, 2019
Impact of caring for patients with Huntington's disease on work statusProgressive supranuclear palsyICPDMD (MDS), 2019
Current treatment patterns among patients with osteoarthritis in Japan: analysis of a real-world datasetOsteoarthritisEFIC, 2019
Current treatment patterns among patients in Japan with chronic low back pain: analysis of real-world dataChronic lower back painEFIC, 2019
Current treatment patterns among patients in Europe with chronic low back pain: analysis of real world dataChronic lower back painEFIC, 2019
Current treatment patterns among European patients with osteoarthritis: analysis of a real-world datasetOsteoarthritisEFIC, 2019
Comparing quality of life, symptoms, and treatment patterns of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients: findings from a global surveyVariousISPOR LA, 2019
Comorbidities, hypersensitivity and biomarkers in a real-world US nasal polyps populationNasal polypsERS, 2019
Clinical characteristics and PROs among chronic rhinosinusitis with nasal polyps patients with a history of sinus surgeryNasal polypsARS, 2019
Burden of comorbid depression and anxiety on HRQOL in adult migraine patients in the USMigraineIHC, 2019
BRCA 1/2 testing in HER2 advanced breast cancer - results from the European component of a multi-country real world studyBreast cancerESMO, 2019
Adherence to ESMO 2014 guidelines on bone-targeting agent initiation for breast and prostate cancer patients - real world insights from practising European physiciansBreast cancerESMO, 2019
Acute and preventive treatment patterns in episodic cluster headache - findings from the United States, United Kingdom and GermanyCluster headacheIHC, 2019
A real-world study of the patient experience of osteoporosis following treatment with abaloparatideOsteoporosisASBMR, 2019
A real-world study of the patient experience of osteoporosis following treatment with abaloparatideOsteoporosisASBMR, 2019
Remote monitoring of patient-reported outcomes in ulcerative colitis - a prospective real world studyInflammatory Bowel DiseaseView PublicationN/A
Characteristics of patients with dyslipidemia treated in routine care setting in ChinaDyslipidemiaView PublicationN/A
Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional surveyOsteoporosisView PublicationN/A
Work productivity loss and associated indirect costs for patients with ulcerative colitis in the USInflammatory Bowel DiseaseAMCP, 2019
Work productivity loss and associated indirect costs for patients with Crohn's Disease in the USInflammatory Bowel DiseaseAMCP, 2019
To assess the level of unmet need within ulcerative colitis (UC) patients currently prescribed biologic treatment and patients prescribed conventional treatments in Europe and the USAInflammatory Bowel DiseaseACG, 2019
Relationship between progressive supranuclear palsy and caregiver burden and quality of lifeProgressive supranuclear palsyNORD, 2019
Relationship between partial Mayo Score and patient-reported outcomes for UC patients in the US using the Adelphi Real-World Disease Specific ProgrammeInflammatory Bowel DiseaseACG, 2019
Real world experience with dolutegravir plus rilpivirine two-drug regimenHIVID Week, 2019
Living with ulcerative colitis in Germany - estimating the frequency and extent of dose escalations among patients with moderate to severe ulcerative colitisInflammatory Bowel DiseaseUEGW, 2019
Impact of myeloproliferative neoplasms (MPNs) and perceptions of treatment goals among physicians and patients in 6 countries: an expansion of the MPN Landmark SurveyMyeloproliferative neoplasmsEHOC, 2019
Impact of atopic dermatitis lesion location on quality of life in adult patients - results from a real-world studyAtopic dermatitisEADV, 2019
Health-related quality of life based on response to triptans in people with migraineMigraineAMCP, 2019
Assessing the level of unmet need amongst ulcerative colitis patients in the US and EUInflammatory Bowel DiseaseACG, 2019
Adult patients with mild or moderate atopic dermatitis are significantly impacted by their condition: results from a real-world study in the United StatesAtopic dermatitisAMCP, 2019
The diagnostic pathway from cognitive impairment to dementia in Japan: quantification using real-world dataDementiaView PublicationN/A
The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis arthritisRheumatoid arthritisView PublicationN/A
Exacerbation frequency and eosinophil counts among patients with COPD currently prescribed triple therapycurrently prescribed multiple inhaler triple therapy (MITT)Chronic obstructive pulmonary diseaseView PublicationN/A
What are the prescribing trends and satisfaction levels with analgesics for osteoarthritis as reported by US rheumatologists, orthopedic surgeons, and primary care physicians?OsteoarthritisACR, 2019
Variations in BRCA screening and treatment patterns among ovarian cancer patients in Europe and the United StatesOvarian cancerESGO, 2019
Treatment patterns and clinical characteristics of COPD patients in South Korea An analysis of the Korea COPD Subgroup Study (KOCOSS) CohortChronic obstructive pulmonary diseaseAPSR, 2019
The relationship between pruritus, sleep disruption and quality of life among patients with moderate-to-severe atopic dermatitisAtopic dermatitisWCI, 2019
Real world multi-country retrospective study of treatment travel time and work productivity and activity impairment among HER2 negative advanced breast cancer patients and BRCA1/2 mutation(s)Breast cancerISPOR EU, 2019
Real world health related quality of life for first line recurrent/metastases squamous cell carcinoma of the head and neck patientsHead and neck cancerISPOR EU, 2019
Real world effectiveness of secukinumab in patients with ankylosing spondylitis: findings from a recent cross-sectional survey of rheumatologists and patients in EuropeAnkylosing spondylitisACR, 2019
Physician rationale for prescribing tyrosine kinase inhibitors and immuno-oncology treatments in the first-line treatment of advanced renal cell carcinoma in the United States: results from a cross-sectional real-world surveyRenal cell carcinomaIKCS, 2019
Patient-reported quality of life in dialysis compared with non-dialysis CKD patients with hyperkalemia in the USA and EU5: results from the KDQOLChronic kidney diseaseASN, 2019
Medication use and reasons for switching biologic therapy in patients with non-radiographic axial spondyloarthritis: findings from a US surveyAxial spondyloarthritisACR, 2019
Living with ulcerative colitis in Japan - biologic persistence and healthcare resource utilizationInflammatory Bowel DiseaseJDDW, 2019
Inter-regional inequality in Italian healthcare delivery affects choice of selective estrogen receptor modulators (SERMS) for the treatment of hormone-receptor-positive breast cancerBreast cancerISPOR EU, 2019
Impact of the follicular lymphoma (FL) treatment continuum on patient quality of life (QoL) in Europe (EU5)Follicular lymphomaISPOR EU, 2019
Impact of enthesitis on patient reported outcomes and physician satisfaction with treatment: data from a multinational patient and physician surveyPsoriatic arthritisACR, 2019
Healthcare resource utilisation (HCRU) associated with transcatheter arterial chemoembolisation (TACE) treatment in intermediate stage hepatocellular carcinoma (HCC) patients in EuropeHepatocellular carcinomaISPOR EU, 2019
Exploring pre and post agenzia italiana del farmaco (AIFA) reimbursed access to immunotherapy for the treatment of squamous cell carcinoma of the head and neck (SCCHN) Squamous cell carcinoma of the head and neckISPOR EU, 2019
European real-world treatment patterns of systemic therapies for second line (2L) hepatocellular carcinoma (HCC) patients who previously received sorafenibHepatocellular carcinomaISPOR EU, 2019
Enthesitis, dactylitis, and axial disease in psoriatic arthritis (PsA): impact on patient quality of life and work productivityPsoriatic arthritisACR, 2019
Enthesitis frequency and treatment patterns in patients with psoriatic arthritis in Europe and JapanPsoriatic arthritisACR, 2019
Differences in clinical characteristics, quality of life, disability, and work productivity in psoriatic arthritis patients by gender: findings from a cross-sectional survey in the US and EuropePsoriatic arthritisACR, 2019
Differences across heart failure patients' characteristics, disease experience and quality of life in Shanghai compared with the rest of ChinaChronic heart failureISPOR EU, 2019
Data availability and quality in Asia Pacific: assessment and implications for horizon scanningVariousHTAi, 2019
Comparing symptoms, treatment patterns, and quality of life of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients: findings from a US surveyAxial spondyloarthritisACR, 2019
Cluster profiling of patients in a real-world data set with systemic lupus erythematosus and their associated treatments Systemic lupus erythematosus ACR, 2019
Characteristics and treatment patterns of a real-world lupus nephritis cohort based on primary physician specialtyLupus nephritis ASN, 2019
Burden of comorbid depression and anxiety on work productivity in adult migraine patients in the USMigraineISPOR EU, 2019
Burden of comorbid depression and anxiety on HRQOL in adult migraine patients in the USMigraineISPOR EU, 2019
BRCA screening and burden of treatment in patients receiving active therapy for ovarian cancerOvarian cancerESGO, 2019
Assessing the impact of hyperkalemia on the quality of life of dialysis patients compared with non-dialysis patients: results from a real world study in the US and EU5Chronic kidney diseaseASN, 2019
Assessing the humanistic and economic burden of enthesitis among patients with peripheral and axial spondyloarthritis: results from a multi-national real world survey databaseAxial spondyloarthritisACR, 2019
A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United KingdomDepressionISPOR EU, 2019
Improving access to antiretrovirals in China - economic analyses of dolutegravir in HIV-1 patientsHIVView PublicationN/A
Treatment patterns of patients with advanced renal cell carcinoma receiving first-line treatment: results from a cross-sectional real-world studyRenal cell carcinomaESMO, 2019
Patient characteristics, treatment outcomes and healthcare resource utilization across Europe in multiple myeloma patients ineligible for stem cell transplantation who received lenalidomide or bortezomib-base regimensMultiple myelomaASH, 2019
Management strategies and satisfaction levels in patients with sickle cell disease: final results from the International Sickle Cell World Assessment Survey (SWAY)Sickle cell diseaseASH, 2019
Real-world bevacizumab utilization and outcomes in first line ovarian cancerOvarian cancerASCO, 2019
Patterns of genetic testing in Huntington's diseaseHuntington diseaseHSG, 2019
Patient and physician perspectives on the care and assistance needs in Huntingdon's diseaseHuntington diseaseHSG, 2019
Impact on work status of people caring for someone with Huntington's diseaseHuntington diseaseHSG, 2019
Impact of atopic dermatitis lesion location on quality of life in adult patients - results from a real-world studyAtopic dermatitisWCD, 2020
The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and EuropeInflammatory Bowel DiseaseView PublicationN/A
Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and EuropeInflammatory Bowel DiseaseView PublicationN/A
A mixed methods approach towards understanding key disease characteristics with the progression of RRMS to SPMS - physicians and patients viewsMultiple sclerosisView PublicationN/A
Burden of illness in not adequately controlled chronic hypoparathyroidism - findings from a 13 country patient and caregiver surveyHypoparathyroidismView PublicationN/A
Triptan use and associated patient-reported outcomes in patients with migraineMigrainePPADHP, 2020
Treatment duration and response in patients with advanced renal cell carcinoma who have completed first-line treatment: results from a cross-sectional real-world studyRenal cell carcinomaASCO GU, 2020
Impact of increasing disease symptom concordance between patients with inflammatory bowel disease and their physicians: insights from US, France, Germany, Italy, Spain, and UK (5EU) Inflammatory Bowel DiseaseECCO, 2020
Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South KoreaRheumatoid arthritisView PublicationN/A
Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world dataChronic kidney diseaseView PublicationN/A
Treatment patterns and clinical outcomes in patients receiving palbociclib combinations as first line treatment for aBC/mBC in real-world settings in Latin AmericaBreast cancerMBCC, 2020
Real-world clinical outcomes associated with palbociclib combination therapy in Canada: results from the IRIS studyBreast cancerMBCC, 2020
Nasal polyp symptoms: how well do physicians know their patients?Nasal polypsAAAAI, 2020
Heart failure hospitalizations and urgent heart failure visits for patients with heart failure in a real world population in the USChronic heart failureACC, 2020
Availability of fractional exhaled nitric oxide (FeNO) and eosinophil (EOS) count data among patients with severe asthma in five European countriesAsthmaAAAAI, 2020
Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world studyAnkylosing spondylitisView PublicationN/A
A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medicationMigraineView PublicationN/A
A novel, integrative approach for evaluating progression in multiple sclerosis: development of a scoring algorithmMultiple sclerosisView PublicationN/A
UK results from the International Sickle Cell World Assessment Survey (SWAY): patients with sickle cell disease (SCD) experience work impairment and decreased productivity Sickle cell diseaseBSH, 2020
UK patient perceptions on the symptomatic and emotional burden of vaso-occlusive crises resulting from sickle cell diseaseSickle cell diseaseBSH, 2020
The impact of immune thrombocytopenia (ITP) on activities of daily living: findings reported by UK patients and physicians from the ITP World Impact Survey (I-WISh) Immune thrombocytopeniaBSH, 2020
Symptom burden in immune thrombocytopenia (ITP): findings reported by UK patients and physicians from the ITP World Impact Survey (I-WISh) Immune thrombocytopeniaBSH, 2020
Health-related quality of life based on response to triptans in people with migraine - analysis of real-world dataMigraineAAN, 2020
Effect of genotype on the impact of sickle cell disease and burden of vaso-occlusive crises: results from the International Sickle Cell World Assessment Survey (SWAY)Sickle cell diseaseGCSCD, 2020
Direct healthcare costs among heart failure patients with reduced and preserved ejection fraction in the USChronic heart failureAMCP, 2020
Burden of comorbid depression and anxiety on work productivity in adult migraine patients in the United StatesMigraineAMCP, 2020
Burden of comorbid depression and anxiety on HRQOL in adult migraine patients in the USMigraineAMCP, 2020
Assessing the relationship between patient-reported psoriasis treatment satisfaction and work productivityPsoriasisAMCP, 2020
Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costsInflammatory Bowel DiseaseView PublicationN/A
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and BHemophiliaView PublicationN/A
Work productivity impact across four types of cancer: real-world evidenceVariousISPOR US, 2020
Treatment outcomes in locally advanced squamous cell carcinoma of head and neck patients who subsequently progressed: real-world evidence from Europe and the USHead and neck cancerISPOR US, 2020
The impact of severe vasomotor symptoms on work productivity and activity impairment: findings from a US real world studyMenopauseISPOR US, 2020
Relationship between progressive supranuclear palsy and healthcare resource utilizationProgressive supranuclear palsyISPOR US, 2020
Real-world treatment patterns and outcomes in US patients newly diagnosed with glioblastoma multiforme (GBM) by O6-methylguanine DNA methyltransferase promotor (MGMT) statusGlioblastoma multiformeISPOR US, 2020
Real-world experience of subcutaneous belimumab treatment for systemic lupus erythematosus - a cross-sectional survey of rheumatologists and their patientsSystemic lupus erythematosus ICA, 2020
Real world evidence on patient characteristics and frontline treatment patterns in locally advanced squamous cell carcinoma of the head and neck from Europe and USHead and neck cancerISPOR US, 2020
Poor prognostic factors and their impact on treatment patterns and outcomes for women with hormone receptor-positive, human epidermal growth factor receptor-negative (HR+/HER2-) advanced breast cancer (aBC) in CanadaBreast cancerISPOR US, 2020
Physician assessment of alopecia areata disease severity: results from a real-world studyAlopecia areataSID, 2020
Patient-reported concern, understanding and lifestyle management of non alcoholic steatohepatatis patients: a 12-country real world studyNon?alcoholic steatohepatitisISPOR US, 2020
Patient-reported and cancer-specific health-related quality of life among patients with early stage HR+/HER2- breast cancer (BC)Breast cancerESMO BC, 2020
Patient (pt) demographics, treatment patterns (tx) and hematologic (heme) toxicities among pts with HER2? advanced breast cancer (ABC) and BRCA1/2 mutation(s) (BRCA1/2mut): A multi-country real-world (RW) studyBreast cancerESMO BC, 2020
Latent class analysis (LCA) to identify and describe clinically relevant subgroups in a multinational study of patients with HR+/HER2- early breast cancer (eBC)Breast cancerESMO BC, 2020
Impact of sickle cell disease symptoms on patients' daily lives in the US - patients from the sickle cell world assessment survey (SWAY)Sickle cell diseaseISPOR US, 2020
Healthcare resource utilisation and health outcomes among young patients with heart failure: a contemporary real-world US studyChronic heart failureESC-HF, 2020
Health related quality of life among patients with early breast cancer: a multinational studyBreast cancerISPOR US, 2020
Germline BRCA1/2 (gBRCA1/2) testing patterns among oncologists (ONC) treating HER2- advanced breast cancer (ABC): results from a multi-country real-world studyBreast cancerESMO BC, 2020
First line treatment with natalizumab reduces healthcare resource use and impairment of work productivity and activity impairment in relapsing-remitting Multiple Sclerosis (RRMS) patients compared to natalizumab delayed useMultiple sclerosisISPOR US, 2020
Discordance between psychiatrists and their patients on disease severity and treatment outcomes in schizophreniaSchizophreniaACCP, 2020
Discordance between psychiatrists and their patients on disease severity and treatment outcomes in schizophreniaSchizophreniaISPOR US, 2020
Development of a cross-walk of the Assessment of Spondyloarthritis International Society Health Index (ASAS HI) and Ankylosing Spondylitis Quality of Life (ASQoL) scores using data from patients with ankylosing spondylitis and non-radiographic axial spondyloarthritisAnkylosing spondylitisISPOR US, 2020
Describing patients with primary sjogren's syndrome - analysis of real-world data from the Adelphi Disease Specific ProgrammeSjogren's syndromeICA, 2020
Deleterious impact of advanced nonalcoholic steatohepatitis on multiple patient-relevant outcomes: an international, cross-sectional, real-world studyNon?alcoholic steatohepatitisDDW, 2020
Comparing work productivity and activity impairment outcomes among patients with Multiple Sclerosis treated with ocrelizumab vs other disease-modifying therapiesMultiple sclerosisISPOR US, 2020
Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: european subanalysis of a global patient surveyHypoparathyroidismECE, 2020
Alignment of IBD symptoms reported by patients and their treating physicians in the USInflammatory Bowel DiseaseDDW, 2020
A real-world study of the patient experience with abaloparatideOsteoporosisISPOR US, 2020
A multinational study of real-world treatment patterns among patients with early stage HR+/HER2- breast cancer (BC)Breast cancerESMO BC, 2020
Multinational, cross-sectional survey of healthcare resource utilisation in patients with all stages of cognitive impairment, analysed by disease severity, country and geographical regionDementiaView PublicationN/A
Quantifying the diagnostic pathway for patients with cognitive impairment: real-world data from AustraliaDementiaView PublicationN/A
Real-world treatment patterns in patients with advanced (stage III IV) ovarian cancer in the United States and EuropeOvarian cancerView PublicationN/A
Levels of satisfaction with rheumatoid arthritis treatment and associated alignment between physicians and patients across Latin America Rheumatoid arthritisView PublicationN/A
Utilization of low vs high dose of newer antihyperglycemic agentsDiabetesADA, 2020
Use of opioids in patients with sickle cell disease (SCD): a country and age analysis of the International Sickle Cell World Assessment Survey (SWAY)Sickle cell diseaseEHA, 2020
Usage of C-reactive protein testing in the diagnosis and monitoring of psoriatic arthritis (PsA): results from a real-world survey in the US and EuropePsoriatic arthritisEULAR, 2020
Understanding current prescription drug treatment paradigms for patients with osteoarthritis in EuropeOsteoarthritisEULAR, 2020
Treatment and disease management practices in patients with MPNs in 6 countries: an expansion of the MPN Landmark SurveyMyeloproliferative neoplasmsEHA, 2020
The impact of osteoarthritis disease severity on healthcare resource use: analysis of real-world European dataOsteoarthritisEULAR, 2020
The impact of high disease activity as measured by SLEDAI and drug burden-on healthcare utilization, quality of life and work productivity in systemic lupus erythematosus patientsSystemic lupus erythematosus EULAR, 2020
Skin involvement in psoriatic arthritis (PsA) - the incremental impact of psoriasis on quality of life, disability and work productivity: real-world survey in US and EuropePsoriatic arthritisEULAR, 2020
Physician attitudes towards diagnosing anaemia, treatment initiation and the current unmet need in the management and treatment of anaemia: interim results from a cross-sectional real-world survey in Germany, Italy and the UKChronic Kidney DiseaseERA-EDTA, 2020
Patient-reported physical, emotional and economic impact of myeloproliferative neoplasms in an expansion of the MPN Landmark SurveyMyeloproliferative neoplasmsEHA, 2020
Patient journey to diagnosis of Ankylosing Spondylitis (AS) and its treatment patterns across Central Eastern Europe and the United StatesAnkylosing spondylitisEULAR, 2020
Patient and healthcare professional perceptions of the impact of sickle cell disease on daily life, symptom burden and treatment: results from the International Sickle Cell World Assessment Survey (SWAY)Sickle cell diseaseEHA, 2020
Incidence and management of vaso-occlusive crises in patients with sickle cell disease: a country and age analysis of the International Sickle Cell World Assessment Survey (SWAY)Sickle cell diseaseEHA, 2020
Impact of flares on healthcare resource usage and PROs in systemic lupus erytematosus patientsSystemic lupus erythematosus EULAR, 2020
How does osteoarthritis pain impact function, mobility and requirement for help in daily activities in European patients?OsteoarthritisEULAR, 2020
Higher symptom burden in patients with immune thrombocytopenia experiencing fatigue: results from the ITP World Impact Survey (I-WISh)Immune thrombocytopeniaEHA, 2020
Flares among patients with psoriatic arthritis (PsA) - Frequency and impact on patient outcomes: real-world survey in the US and EuropePsoriatic arthritisEULAR, 2020
Diagnostic cluster profiling of patients in a real-world data set with systemic lupus erythematosusSystemic lupus erythematosus EULAR, 2020
Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis patients and non-radiographic axial spondyloarthritis in JapanVariousEULAR, 2020
Burden of joint-related complications in moderate to severe hemophilia A and B without inhibitorsHemophiliaWFH, 2020
Anxiety and depression in psoriatic arthritis (PsA) - Prevalence and impact on patient reported outcomes: real-world survey in the US and EuropePsoriatic arthritisEULAR, 2020
Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America Psoriatic arthritisView PublicationN/A
Use and switching of biologic therapy in patients with non-radiographic axial spondyloarthritis: a patient and provider survey in the United StatesAxial spondyloarthritisView PublicationN/A
A Real-world analysis of patient characteristics, treatment patterns and level of impairment in patients with migraine who are insufficient responders versus responders to acute treatmentMigraineView PublicationN/A
Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific ProgrammeMigraineView PublicationN/A
Opioid use, rebound headache, and resource utilization among migraine patients with insufficient response to triptans based on real-world dataMigraineAHS, 2020
Health-related quality of life based on response to triptans in people with migraine: analysis of real-world dataMigraineAHS, 2020
A real-world observational study to describe NHS resource use for the management of moderate-to-severe atopic dermatitis in secondary care for children and adolescents aged 6 to 17Atopic dermatitisBAD, 2020
Real-world experience with dolutegravir-based two-drug regimensHIVView PublicationN/A
The relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world studyPsoriatic arthritisView PublicationN/A
Assessment of real-life outcomes in schizophrenia patients according to complianceSchizophreniaView PublicationN/A
Patients with heart failure and a LVEF less than 40% present an overall lower health related quality of life than those with LVEF between 40% and 60%: a multinational real-world survey in EUChronic heart failureESC, 2020
Patient-reported benefits for future non-alcoholic steatohepatitis therapy; a global real-world study among 1,035 patients across 12 countriesNon?alcoholic steatohepatitisEASL, 2020
Female patients with heart failure and a LVEF less than or equal to 60% present an overall lower health related quality of life than males: a multinational real-world survey in EUChronic heart failureESC, 2020
Deleterious impact of advanced non-alcoholic steatohepatitis on multiple patient-relevant outcomes: an international, cross-sectional, real-world studyNon?alcoholic steatohepatitisEASL, 2020
Concordance between patient and physician reported symptoms in patients with heart failure and a LVEF equal to or less than 60%: a multinational real-world survey in EUChronic heart failureESC, 2020
Caregiver burden of patients with heart failure with a left ventricular ejection fraction (LVEF) less than or equal to 60%: a multinational real-world survey in EUChronic heart failureESC, 2020
A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasisPsoriasisView PublicationN/A
Biologic disease-modifying antirheumatic drug prescription patterns among rheumatologists in Europe and JapanRheumatoid arthritisView PublicationN/A
Disease characteristics and the burden of joint and skin involvement amongst people with psoriatic arthritis: a population surveyPsoriatic arthritisView PublicationN/A
Drug treatment patterns and work productivity in chronic kidney disease patients with anemia in China: cross sectional analysis of real-world data Chronic Kidney DiseaseView PublicationN/A
Living with Ulcerative Colitis Study (LUCY) in England: A retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitisInflammatory Bowel DiseaseView PublicationN/A
Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps and atopic dermatitisVariousERS, 2020
Treatment sequencing In HR+/HER2- locally advanced or metastatic breast cancer: a real-world retrospective study In France, Germany, Italy, And SpainBreast cancerESMO, 2020
The humanistic burden reported by patients with unresectable locally advanced or metastatic (adv/met) gastric cancer (GC), gastroesophageal junction cancer (GEJC) and esophageal adenocarcinoma (EAC): an international real-world survey Gastric cancerESMO, 2020
Real-world multi-country study of treatment trends among patients (pts) with HER2? BRCA1/2 mutated (BRCA1/2mut) advanced breast cancer (ABC)Breast cancerESMO, 2020
Real-world (RW) multi-country study of BRCA1/2 testing in adult patients (pts) with HER2?advanced breast cancer (ABC)Breast cancerESMO, 2020
Real-world (RW) multi-country study of BRCA1/2 mutation (BRCA1/2mut) testing trends among adult patients (pts) with HER2? advanced breast cancer (ABC)Breast cancerESMO, 2020
Real world data availability and quality in Asia Pacific. Assessment and implications for research and healthcare decision-makingVariousISPOR APAC, 2020
Individualized glycemic control in type 2 diabetes in Europe and the United StatesDiabetesICPE, 2020
Impact on work productivity in unresectable locally advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma patients and their caregivers Gastric cancerESMO, 2020
Impact of clinical characteristics, patients' perception of treatment goals and endocrine therapy history on HRQOL in HR+, HER2- early stage breast cancer patientsBreast cancerESMO, 2020
Idiopathic pulmonary fibrosis (IPF): the patient journeyIdiopathic pulmonary fibrosisERS, 2020
Genomic/genetic testing (GT) patterns for patients with metastatic castrate-resistant prostate cancer (mCRPC): interim results from a real-world study in Europe (EU5)Prostate cancerESMO, 2020
Genomic testing, biomarkers, and treatment patterns in early breast cancerBreast cancerESMO, 2020
First-line treatment patterns in HR+/HER2- locally advanced or metastatic breast cancer in EuropeBreast cancerESMO, 2020
Economic impact of delayed multiple-inhailer triple therapy initiation in COPD patientsChronic obstructive pulmonary diseaseERS, 2020
Drivers of prescribing long-acting injectable antipsychotics to patients with schizophreniaSchizophreniaPsych Congress , 2020
Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perceptionIdiopathic pulmonary fibrosisERS, 2020
Characterization and treatment goals of patients treated with long-acting injectable antipsychotics versus oral antipsychotics: results from a patient/caregiver/psychiatrist surveySchizophreniaASCP, 2020
Burden of illness in patients With chronic hypoparathyroidism not adequately controlled with conventional therapy: european subanalysis of a global patient surveyHypoparathyroidismECE, 2020
Burden of idiopathic pulmonary fibrosis (IPF) on quality of life (QoL), work productivity, and healthcare useIdiopathic pulmonary fibrosisERS, 2020
A multinational real-world study on HR+, HER2- early stage breast cancer patients' disease awareness, satisfaction, and involvement in treatment decisionsBreast cancerESMO, 2020
Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2? advanced breast cancer in five European countriesBreast cancerView PublicationN/A
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): impact of ITP on health-related quality of lifeImmune thrombocytopeniaView PublicationN/A
What can patient-reported treatment satisfaction and dissatisfaction tell us about unmet needs in psoriasis?PsoriasisEADV, 2020
Treatment patterns for moderate-to-severe atopic dermatitis among patients in EuropeAtopic dermatitisEADV, 2020
The relationship between pruritus, sleep disruption, and quality of life (QoL) among patients with moderate-to-severe atopic dermatitis (AD) in EuropeAtopic dermatitisEADV, 2020
Risk factors of satisfaction with treatment in Chinese rheumatoid arthritis patients and rheumatologists: findings from a cross-sectional surveyRheumatoid arthritisAPLAR, 2020
Real world effectiveness of secukinumab in patients with ankylosing spondylitis: findings from a recent cross sectional survey of rheumatologists and patients in EuropeAnkylosing spondylitisSCR, 2020
Physician attitudes towards diagnosis, treatment initiation, and unmet needs in the management of anemia due to CKD: results from a real world survey in Germany, Italy, and the United KingdomChronic Kidney DiseaseASN, 2020
Management and unmet need amongst mild And moderate/ severe CD and UU patients: findings from a cross sectional study in the US and France, Germany, Italy, Spain, UK (EU5).Inflammatory Bowel DiseaseUEGW, 2020
Health-related quality of life and its predictors in patients receiving first-line treatment for newly diagnosed glioblastoma multiforme in EU5: a real-world studyGlioblastoma multiformeASCO QCS, 2020
Cross-sectional survey to assess chronic obstructive pulmonary disease (COPD) medication use by United States (US) physiciansChronic obstructive pulmonary diseaseACCP, 2020
Patient-physician alignment in satisfaction with psoriatic arthritis treatment: analysis from a cross-sectional survey in the United States and EuropePsoriatic arthritisView PublicationN/A
A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United KingdomDepressionView PublicationN/A
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatmentImmune thrombocytopeniaView PublicationN/A
Work productivity and activity impairment in HR+/HER2- early stage breast cancerBreast cancerISPOR EU, 2020
Work productivity and activity impairment among patients with HR+/HER2- locally advanced or metastatic breast cancer in France, Germany, Israel, Italy, Spain, and the United StatesBreast cancerISPOR EU, 2020
Treatment patterns and performance status in unresectable advanced or metastatic (ADV/MET) gastric cancer (GC), gastroesophageal junction cancer (GEJC) and esophageal adenocarcinoma (EAC) patients receiving first line (1L) treatment Gastric cancerISPOR EU, 2020
The impact of PsA disease control status on patient treatment satisfaction: real-world survey in US and EuropePsoriatic arthritisACR, 2020
The impact of high disease activity as measured by SLEDAI and drug burden on healthcare utilization, quality of life and work productivity in systemic lupus erythematosus patientsSystemic lupus erythematosus ACR, 2020
The burden of caring for patients with glioblastoma multiforme (GBM): a real-world study conducted in EU5 and USAGlioblastoma multiformeISPOR EU, 2020
Skin involvement in psoriatic arthritis (PsA) - the incremental impact of psoriasis on quality of life, disability and work productivity: real-world survey in US and EuropePsoriatic arthritisACR, 2020
Real-world multi-country study of germline BRCA1/2 mutation (Gbrca1/2mut) testing and genetic counseling (GC) among patients (Pts) with human epidermal growth factor receptor 2- negative (HER2-) advanced breast cancer (ABC)Breast cancerNSGC, 2020
Real world burden and impact of brain metastases on quality of life and healthcare resource utilization among metastatic breast cancer patientBreast cancerISPOR EU, 2020
Qualitative interviews to explore drivers and behaviours associated with medication non-adherence across a range of diseases, treatment modalities, and countries VariousISPOR EU, 2020
Osteoarthritis patient hopes and satisfaction with prescription NSAIDs and opioidsOsteoarthritisISPOR EU, 2020
Impact of flares on healthcare resource usage and PROs in systemic lupus erythematosus patientsSystemic lupus erythematosus ACR, 2020
Health status/utilities in adult patients with germline BRCA1/2 mutated (gBRCA1/2mut) HER2- advanced breast cancer (ABC) treated with poly(ADP-ribose) polymerase inhibitors (PARPi) versus chemotherapy in a real world (RW) settingBreast cancerISPOR EU, 2020
Flares among patients with psoriatic arthritis (PsA) - frequency and impact on patient outcomes: real-world survey in the US and EuropePsoriatic arthritisACR, 2020
First line treatment with natalizumab reduces healthcare resource use and impairment of work productivity and activity impairment in relapsing-remitting multiple sclerosis (RRMS) patients compared to natalizumab delayed useMultiple sclerosisISPOR EU, 2020
Fatigue in psoriatic arthritis (PsA): prevalence in patients from the US and Europe, and impact on quality of life and work productivityPsoriatic arthritisACR, 2020
Direct and indirect costs associated with unresectable advanced or metastatic (ADV/MET) gastric cancer (GC), gastroesophageal junction cancer (GEJC) and esophageal adenocarcinoma (EAC) for patients and their caregivers Gastric cancerISPOR EU, 2020
Current practice and future thinking on the multidisciplinary management of osteoarthritis painOsteoarthritisPCRMM, 2020
Characterization and treatment goals of patients on long-acting injectable antipsychotics vs oral antipsychotics: results from a patient/caregiver/psychiatrist surveySchizophreniaNEI MAX!, 2020
Burden of idiopathic pulmonary fibrosis (IPF) on quality of life (QoL), work productivity and healthcare useIdiopathic pulmonary fibrosisISPOR EU, 2020
Association of atypical treatment switches with outcomes in patients with schizophreniaSchizophreniaISPOR EU, 2020
Anxiety and depression in psoriatic Arthritis (PsA) - prevalence and impact on patient reported outcomes: real-world survey in the US and EuropePsoriatic arthritisACR, 2020
Analysis of treatment goals for patients with schizophrenia: a US survey of psychiatrists, patients with schizophrenia and caregiversSchizophreniaNEI MAX!, 2020
A multinational assessment of direct and indirect costs from a survey of patients with idiopathic pulmonary fibrosis (IPF)Idiopathic pulmonary fibrosisISPOR EU, 2020
A comparison of characteristics of patients with osteoarthritis of the hip or knee who are willing or not to undergo total joint replacement surgeryOsteoarthritisISPOR EU, 2020
Real-world effectiveness of belimumab in the treatment of systemic lupus erythematosus: pooled analysis of multi-country data from the OBSErve studiesSystemic lupus erythematosus View PublicationN/A
Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experienceInflammatory Bowel DiseaseView PublicationN/A
A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and EuropeMigraineView PublicationN/A
A real-world assessment of outcomes in schizophrenia patients according to treatment responseSchizophreniaView PublicationN/A
Multimodal treatment patterns for osteoarthritis and their relationship to patient-reported pain severity: a cross-sectional survey in the United StatesOsteoarthritisView PublicationN/A
The association between schizophrenia relapses and real-world psychosocial outcomes in patients with schizophreniaSchizophreniaASHP, 2020
Real-world psychosocial outcomes and disease burden in patients with schizophrenia and their caregiversSchizophreniaASHP, 2020
Presence of comorbidities and use of concomitant medications associated with QTc prolongation/torsades de pointes In patients with HR+/HER2- advanced breast cancerBreast cancerSABCS, 2020
Physician and patient satisfaction with poly(ADP-Ribose) polymerase inhibitors (PARPi) versus chemotherapy in adult patients with germline BRCA1/2 mutated (Gbrca1/2mut) HER2- advanced breast cancer (ABC): results from a multi-country real-world (RW) studyBreast cancerSABCS, 2020
Patient reported outcomes (PROs) with Poly(ADP ribose) polymerase inhibitors (PARPi) versus chemotherapy (CTX) in patients (pts) with germline BRCA 1/2 mutated (gBRCA1/2 mut) HER2 advanced breast cancer (ABC): results from a multi country real world (RW) studyBreast cancerSABCS, 2020
Multi-country study of the use of genomic assays in HR+, HER2- early breast cancer and characteristics of patients testedBreast cancerSABCS, 2020
Impact of sickle cell disease symptoms on patients daily lives - final results from SWAYSickle cell diseaseASH, 2020
Treatment patterns, outcomes and clinical characteristics in advanced renal cell carcinoma: a real-world US studyRenal cell carcinomaView PublicationN/A
Unmet needs in Japanese patients who report insufficient efficacy with triptans for acute treament of migraine: retrospective analysis of real-world dataMigraineView PublicationN/A
International perspectives on management of inflammatory bowel disease: opinion differences and similarities between patients and physicians from the IBD GAPPS surveyInflammatory Bowel DiseaseView PublicationN/A
Pain severity and healthcare resource utilization in patients with osteoarthritis in the United StatesOsteoarthritisView PublicationN/A
Abaloparatide real-world patient experience studyOsteoporosisView PublicationN/A
Characterizing the role of, and physical and emotional burden on caregivers of patients with heart failure: results from a cross-sectional survey in JapanChronic heart failureView PublicationN/A
Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist surveyVariousView PublicationN/A
Disease burden and economic impact of diagnosed non?alcoholic steatohepatitis in five European countries in 2018: a cost?of?illness analysisNon?alcoholic steatohepatitisView PublicationN/A
Disease course and treatment patterns in progressive supranuclear palsy: a real-world studyProgressive supranuclear palsyView PublicationN/A
Full, partial, and modified permutations of the Mayo Score: characterizing clinical and patient-reported outcomes in ulcerative colitis patientsInflammatory Bowel DiseaseView PublicationN/A
Genomic/genetic testing patterns for patients with metastatic castrate-resistant prostate cancer: results from a real-world study in the United StatesProstate cancerASCO GU, 2021
Real-world symptoms, disease burden, resource use and quality of life in US patients with advanced renal cell cancerRenal cell carcinomaView PublicationN/A
Contemporary economic burden in a real-world heart failure population with commercial and Medicare supplemental plansChronic heart failureView PublicationN/A
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018Non?alcoholic steatohepatitisView PublicationN/A
Treatment patterns and unmet need in multiple myeloma in Europe: a real-world surveyMultiple myelomaEBMT, 2021
The real-world use of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor mutated (EGFRm) advanced (stage IIIb / IIIc / IV) non-small cell lung cancer (NSCLC) patients Non-small cell lung cancerELCC, 2021
The burden of progressive supranuclear palsy on patients and caregivers by PSP phenotype: a cross-sectional study Progressive supranuclear palsyADPD, 2021
Symptom burden and loss of independence in activities of daily living among patients with amyotrophic lateral sclerosisAmyotrophic lateral sclerosisMDA, 2021
Physician perceptions of barriers to epidermal growth factor receptor mutation (EGFRm) testing in advanced (stage IIIb / IIIc / IV) non-small cell lung cancer (NSCLC) Non-small cell lung cancerELCC, 2021
Delays in epidermal growth factor receptor mutation (EGFRm) testing in advanced (stage IIIb / IIIc / IV) non-small cell lung cancer (NSCLC) patients and their impact on the use of first line tyrosine kinase inhibitor (TKIs) in a real-world setting Non-small cell lung cancerELCC, 2021
Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in ankylosing spondylitis and non-radiographic axial spondyloarthritis patientsAnkylosing spondylitisView PublicationN/A
Extent and impact of inadequate disease control in US adults with a history of moderate to severe atopic dermatitis following introduction of new treatmentsAtopic dermatitisView PublicationN/A
Long-acting bronchodilator use in chronic obstructive pulmonary disease in primary care in New Zealand: a retrospective study of treatment patterns and evolution using the HealthStat databaseChronic obstructive pulmonary diseaseView PublicationN/A
Osteoarthritis in Italy: impact on health-related quality of life and health care resourcesOsteoarthritisView PublicationN/A
The patient-reported burden of alopecia areata by current severity: a real-world study in the United StatesAlopecia areataAAD, 2021
Real-world outcomes for schizophrenia patients and caregivers by disease severitySchizophreniaSIRS, 2021
Quantifying the healthcare resource utilisation in the management of moderate-to-severe chronic pain among patients with chronic lower back pain in England: retrospective analysis of linked primary & secondary care dataChronic Lower Back PainBPS, 2021
Quantifying the healthcare resource utilisation in the management of moderate-to-severe chronic pain among patients in England with concomitant chronic low back pain and osteoarthritisOsteoarthritisBPS, 2021
Quantifying the healthcare resource utilisation for the management of moderate to severe chronic pain among patients with osteoarthritis in England: a retrospective analysis of linked primary and secondary care dataOsteoarthritisOARSI, 2021
Physician-reported satisfaction with treatment and pain reduction in endometriosis patients receiving elagolix compared with other prescribed treatmentsEndometriosisACOG, 2021
Patient- and dermatologist-reported impacts of alopecia areata on patients stratified by disease severity: results from a real-world study in the United States Alopecia areataAAD, 2021
Characterising the morbidity and mental health profile of patients with moderate-to-severe chronic pain in osteoarthritis: a retrospective analysis of linked primary and secondary care data in EnglandOsteoarthritisBPS, 2021
Cardiovascular risk profiles: How do eligibility criteria of the glucagon-like peptide-1 receptor agonist cardiovascular outcomes trials REWIND, LEADER and SUSTAIN-6 translate to a real-world population with Type 2 diabetes in the UK?DiabetesDUKPC, 2021
A characterisation of the pharmacological management of moderate-to-severe chronic pain in patients with osteoarthritis in clinical practice in England: a retrospective analysis of primary care dataOsteoarthritisBPS, 2021
Physician-patient concordance in the assessment of asthma controlAsthmaView PublicationN/A
The value of optional alarms in continuous glucose monitoring devices: a survey on patients and their physiciansDiabetesView PublicationN/A
Caregivers of patients with heart failure: burden and the determinants of health-related quality of lifeChronic heart failureView PublicationN/A
Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: a retrospective database study DepressionView PublicationN/A
Health-related quality of life and lifestyle changes in patients with chronic kidney disease and hyperkalaemia: real-world data from the US, five European countries and ChinaChronic Kidney DiseaseView PublicationN/A
Treatment patterns and real-world outcomes among patients with episodic migraine in China: results from the Chinese Adelphi Disease Specific Programme MigraineISPOR US, 2021
The impact of COVID-19 on patient management across the EU and US Covid-19ISPOR US, 2021
Real-world outcomes associated with cognitive impairment among patients with schizophreniaSchizophreniaAPA, 2021
Real-world evidence of reported symptoms and quality of life burden associated with chronic rhinosinusitis with nasal polyposis across disease severity and regionChronic rhinosinusitis with nasal polyposisATS, 2021
Physician reported reasons for advanced therapy treatment switches in rheumatoid arthritis patients: results from a cross-sectional survey in the USARheumatoid arthritisISPOR US, 2021
Patients with COPD prefer improvement of cough and mucus over shortness of breath and improvement of combined daily symptoms over the reduction of exacerbations: A multi-country patient preference studyChronic obstructive pulmonary diseaseATS, 2021
Healthcare resource utilization (HCRU) for early-, middle- and late-stage amyotrophic lateral sclerosis (ALS) patients: results from a real-world point-in-time surveyAmyotrophic lateral sclerosisISPOR US, 2021
Atopic dermatitis: patient characteristics and patient-reported outcomes on topical therapyAtopic dermatitisSID, 2021
A real-world analysis of treatment patterns and clinical characteristics among patients with COPD who initiated multiple-inhaler triple therapy in New ZealandChronic obstructive pulmonary diseaseView PublicationN/A
Impact of dementia-related behavioral symptoms on healthcare resource use and caregiver burden: real-world data from Europe and the United StatesDementiaView PublicationN/A
Patient-reported outcomes for migraine in the US and Europe: burden associated with multiple preventive treatment failuresMigraineView PublicationN/A
Patient-reported pain severity and health-related quality of life in patients with multiple myeloma in real world clinical practiceMultiple myelomaView PublicationN/A
Physical, emotional and social pain communication by patients diagnosed and living with multiple myelomaMultiple myelomaView PublicationN/A
The impact of COVID-19 on patient management and prescribing strategy across the EU and US: a real-world survey of rheumatologists, dermatologists, and gastroenterologistsCovid-19EULAR, 2021
The burden of sickle cell disease (SCD) on patients in Ghana and Nigeria compared with other low-/middle-income and high-income countries: results from the Sickle Cell World Assessment Survey (SWAY)Sickle cell diseaseEHA, 2021
Quantifying the economic burden prior to total joint replacement among patients with moderate-to-severe chronic pain in osteoarthritis: a retrospective analysis of linked primary and secondary care data in EnglandOsteoarthritisBHS, 2021
Physician and patient perceptions of surgical procedures for knee OA across Japan, the US and 5 EU countries: results of a real-world studyOsteoarthritisEULAR, 2021
Physician and patient attitudes towards treat-to-target, its implementation and stated treatment goals in patients with rheumatoid arthritis in a real-world setting across EuropeRheumatoid arthritisEULAR, 2021
Onabotulinumtoxin A treatment satisfaction among patients with chronic migraineMigraineEAN, 2021
Inadequate disease control, treatment dissatisfaction, and quality-of-life impairments among US patients receiving topical therapy for atopic dermatitis Atopic dermatitisRAD, 2021
Impact of sickle cell disease on daily life in patients managing vaso-occlusive crises at home vs the emergency room/hospital: results from the international sickle cell world assessment survey (SWAY)Sickle cell diseaseEHA, 2021
Humanistic and healthcare resource use burden in Japanese chronic kidney disease patients with anemia Chronic Kidney DiseaseJSN, 2021
Effectiveness of ixekizumab in patients with psoriatic arthritis: results from a real-world European surveyPsoriatic arthritisEULAR, 2021
Does fibrosis severity or diabetes status influence patient-reported lifestyle changes and degree of success among non-alcoholic steatohepatitis patients?Non?alcoholic steatohepatitisEASL, 2021
Characterization and treatment goals of patients on long-acting injectable antipsychotics vs oral antipsychotics: results from a patient/caregiver/psychiatrist surveySchizophreniaASCP, 2021
Assessment of how modifiable and non-modifiable factors can impact fibrosis outcomes in non-alcoholic steatohepatitis patients: a 12-country real-world assessmentNon?alcoholic steatohepatitisEASL, 2021
Analysis of treatment goals for patients with schizophrenia: a US survey of psychiatrists, patients with schizophrenia and caregiversSchizophreniaASCP, 2021
Burden and quality of life among female and male patients with heart failure in Europe: a real-world cross-sectional studyChronic heart failureView PublicationN/A
Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real?world data analysisOsteoarthritisView PublicationN/A
Health related quality of life among patients with HR+/HER2- early stage breast cancerBreast cancerView PublicationN/A
Inadequate disease control, treatment dissatisfaction, and quality-of-life impairments among US patients receiving topical therapy for atopic dermatitisAtopic dermatitisView PublicationN/A
Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in central eastern Europe and the United States: a real-world studyAnkylosing spondylitisView PublicationN/A
Unmet clinical needs of paediatric psoriasis patients based on real-world data from the EU5 and USPsoriasisSPD, 2021
Treatment patterns of paediatric patients with moderate to severe psoriasis based on real-world data from the EU5 and USPsoriasisSPD, 2021
Exploring differences in clinical burden between adult and pediatric psoriasis patients: results from a real world surveyPsoriasisSPD, 2021
Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countriesPsoriatic arthritisView PublicationN/A
Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in EuropeSquamous cell carcinoma of the head and neckView PublicationN/A
Reliability, validity, and important difference estimates for the NCCN-FACT Ovarian Symptom Index-18 (NFOSI-18)Ovarian cancerView PublicationN/A
Agitation in dementia: real-world impact and burden on patients and the healthcare systemDementiaView PublicationN/A
Quantifying the employer burden of persistent musculoskeletal pain at a large employer in the United Kingdom: a non interventional, retrospective study of Rolls Royce employee dataMusculoskeletal painWCO IOF ESCEO, 2021
Fatigue in psoriatic arthritis: Prevalence in patients from the US and Europe, and impact on quality of life and work productivityPsoriatic arthritisPANLAR, 2021
Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2? advanced breast cancer patients with poor prognostic factors: data from an international studyBreast cancerView PublicationN/A
Biologic and targeted synthetic DMARD utilization in the United States: Adelphi Real World Disease Specific Programme for rheumatoid arthritisRheumatoid arthritisView PublicationN/A
Factors leading to discontinuation of biologic therapy in patients with severe asthmaAsthmaView PublicationN/A
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and USHidradenitis suppurativaEADV, 2021
Understanding the diagnostic and treatment landscape in EGFRm advanced non-small dell lung cancer (aNSCLC) patients with exon 20 insertion mutations (Ex20ins)Non-small cell lung cancerESMO, 2021
The relationship between employment status, WPAI and HRQoL for patients with HR+/HER2- early-stage breast cancerBreast cancerESMO, 2021
Suboptimal clinical and quality of life outcomes in psoriasis patients undertreated with systemic oral therapies: evidence from an international physician and patient surveyPsoriasisEADV, 2021
Receipt of neoadjuvant treatment and impact of types of surgery on HRQoL among patients with early-stage HR+/HER2 - breast cancerBreast cancerESMO, 2021
Real-world study of Rearranged during transfection [RET] testing in patients with papillary thyroid cancer [PTC] in Europe [EU5]Thyroid cancerESMO, 2021
Real-world study of REarranged during transfection [RET] testing in patients with medullary thyroid cancer [MTC] in Europe [EU5]Thyroid cancerESMO, 2021
Real-world evidence of reported symptoms and quality of life burden associated with chronic rhinosinusitis with nasal polyposis and comorbid asthma atatusChronic rhinosinusitis with nasal polyposisERS, 2021
Real-world evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United StatesMenopauseEMAS, 2021
Real-world adherence to single-inhaler vs multiple-inhaler triple therapy among patients with COPD in a primary care treated UK populationChronic obstructive pulmonary diseaseERS, 2021
Real world study of treatments received and treatment satisfaction among HER2- advanced breast cancer (ABC) patients in EU3 and USBreast cancerESMO, 2021
Real world health-related quality of life (HRQoL) among HER2-negative (HER2-) advanced breast cancer (ABC) patients in EU3 and USBreast cancerESMO, 2021
Physician considered treatment attributes for 3rd line diffuse-large B-cell lymphoma treatment decision-making: physician perspectives from a survey across western Europe and USDiffuse large B-cell lymphomaESMO, 2021
Osteoarthritis medication satisfactionOsteoarthritisAAFP, 2021
Characteristics and treatment patterns in patients with medullary thyroid cancer [MTC] with and without Rearranged during transfection [RET] mutations in EuropeThyroid cancerESMO, 2021
Characteristics and treatment pathways of patients with COPD receiving an inhaled corticosteroid/long-acting ?2-agonist (ICS/LABA) in the UKChronic obstructive pulmonary diseaseERS, 2021
Characteristics and treatment pathways of patients with COPD receiving a long-acting muscarinic antagonist/long-acting ?2-agonist (LABA/LAMA) in the UKChronic obstructive pulmonary diseaseERS, 2021
A real-world observational study to describe NHS resource use for the management of moderate to severe atopic dermatitis in secondary care for children and adolescents aged 6 to 17Atopic dermatitisBAD, 2021
Burden of illness in patients with chronic rhinosinusitis with nasal polyps in a real-world setting in EuropeChronic rhinosinusitis with nasal polyposisERS, 2021
Real-world treatment patterns and outcomes in patients with head and neck cancer: point-in-time survey of oncologists in Italy and SpainHead and neck cancerView PublicationN/A
Associations between relapses and psychosocial outcomes in patients with schizophrenia in real-world settings in the United StatesSchizophreniaView PublicationN/A
Determinants of patient and physician treatment satisfaction in moderate to severe psoriasis: a multinational survey of psoriasis patientsPsoriasisView PublicationN/A
Idiopathic pulmonary fibrosis: physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burdenIdiopathic pulmonary fibrosisView PublicationN/A
Quantifying the economic impact of delayed multiple-inhaler triple therapy initiation in patients with COPD: a retrospective cohort study of linked electronic medical record and hospital administrative data in EnglandChronic obstructive pulmonary diseaseView PublicationN/A
The burden of sickle cell disease on patients in Ghana and Nigeria compared with other low-/middle-income and high-income countries: results from the sickle cell world assessment survey (SWAY)Sickle cell diseaseSCDAA, 2021
Symptom and quality of life burden among patients with eosinophilic oesophagitis in a real-world settingEosinophilic oesophagitisUEGW, 2021
Real-world experience of subcutaneous belimumab treatment for systemic lupus erythematosus: a cross-sectional survey of rheumatologists and their patientsSystemic lupus erythematosus LUPUS & CORA, 2021
Real-world effectiveness of ustekinumab in patients with Crohn's disease: findings from a survey of gastroenterologists in the USInflammatory Bowel DiseaseACG, 2021
Real-world clinical presentation of patients with portopulmonary hypertension in comparison with idiopathic/hereditary pulmonary arterial hypertension in the USAVariousCHEST, 2021
Functional class and physician-perceived severity are similar in treated and untreated patients with pulmonary arterial hypertension: a real-world surveyPulmonary arterial hypertensionCHEST, 2021
Perspectives on myasthenia gravis: the quality of life and productivity of caregiversMyasthenia gravisAANEM, 2021
Perspectives on myasthenia gravis: the impact on quality of life, productivity and employment in the United StatesMyasthenia gravisAANEM, 2021
Outcomes of early and late advanced therapy use in patients with ulcerative colitis: findings from a European real-world studyInflammatory Bowel DiseaseUEGW, 2021
MRI activity versus relapses as markers of disease activity in SPMS: data from real world and pivotal clinical studiesMultiple sclerosisECTRIMS, 2021
High prevalence of intolerability with interferon beta and glatiramer acetate in patients with MSMultiple sclerosisECTRIMS, 2021
Healthcare insurance coverage and treatment patterns among patients with amyotrophic lateral sclerosis in the United StatesAmyotrophic lateral sclerosisAMCP Nexus, 2021
Frequency of diagnosed concomitant conditions among patients with rare diseases: analysis of real-world patient data from Europe and the United StatesVariousNORD, 2021
Epidemiology and treatment patterns of the patients with locally advanced or metastatic urothelial carcinoma: a retrospective analysis of real-world data in JapanUrothelial carcinomaJSCO, 2021
Effects of COVID-19 on treatment and patient management in inflammatory bowel disease: findings from a real-world survey in EuropeInflammatory Bowel DiseaseUEGW, 2021
Discordance between neurologists and people living with multiple sclerosis on the perception of the presence and burden of cognitive impairmentMultiple sclerosisECTRIMS, 2021
Concordance in perceptions of the impact of subcutaneous belimumab treatment for systemic lupus erythematosus between patients and their physicians: a cross-sectional, real-world surveySystemic lupus erythematosus LUPUS & CORA, 2021
Characteristics and real world treatment history of patients treated with tofacitinib for ulcerative colitis in EuropeInflammatory Bowel DiseaseUEGW, 2021
Burden among caregivers of patients with amyotrophic lateral sclerosis in the United StatesAmyotrophic lateral sclerosisANA, 2021
A comparison of treatment patterns and healthcare resource utilization in portopulmonary hypertension and idiopathic/hereditary pulmonary arterial hypertension in the USAVariousCHEST, 2021
Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation who received lenalidomide- or bortezomib-based regimensMultiple myelomaView PublicationN/A
Treatment goals in schizophrenia: a real-world survey of patients, psychiatrists, and caregivers in the United States, with an analysis of current treatment (long-acting injectable vs oral antipsychotics) and goal selectionSchizophreniaView PublicationN/A
Living with ulcerative colitis in Japan: biologic persistence and health-care resource useInflammatory Bowel DiseaseView PublicationN/A
Treatment trends among men with metastatic castration sensitive prostate cancer (mCSPC): results from the European component of an international study Prostate cancerEMUC, 2021
Treatment patterns among men with metastatic castration resistant prostate cancer (mCRPC): results from a European international studyProstate cancerEMUC, 2021
Real-world assessment of healthcare resource utilisation and direct medical costs in patients with COPD receiving LAMA/LABA Therapy in EnglandChronic obstructive pulmonary diseaseISPOR EU, 2021
Real-world assessment of healthcare resource utilisation and direct medical costs in patients with COPD receiving ICS/LABA Therapy in EnglandChronic obstructive pulmonary diseaseISPOR EU, 2021
Real-world (RW) patient-reported outcomes (PROs) in frontline maintenance therapy for advanced Non-Small Cell Lung Cancer (aNSCLC) in France, Germany, and the UKNon-small cell lung cancerISPOR EU, 2021
Real world treatment patterns and clinical outcomes associated with palbociclib combination therapy across Europe, North and South America, and Asia: a pooled analysis from the IRIS studyBreast cancerISPOR EU, 2021
Physician perception and assessment of alopecia areata severity and the corresponding patient-reported QoLAlopecia areataJDA, 2021
Patient characteristics, diagnostic testing and treatment patterns in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+, HER2-), node-positive, high-risk early breast cancer (EBC) in Italy: A real-world studyBreast cancerISPOR EU, 2021
Machine learning: Identifying lupus nephritis within systemic lupus erythematosus in the real worldSystemic lupus erythematosus ACR, 2021
Evaluating real-world health-related quality of life in a survey of patients with advanced renal cell carcinoma receiving first-line treatment in the USRenal cell carcinomaISPOR EU, 2021
Characterisation of the management pathway for muscle-invasive urothelial carcinoma (MIUC) from physician perspectives in France, Germany, Italy, Spain, UK (EU5), US, Canada, China, and JapanUrothelial carcinomaISPOR EU, 2021
Characterisation of existing treatment patterns in muscle-invasive urothelial carcinoma (MIUC) across North America, Europe, and EAST ASIAUrothelial carcinomaISPOR EU, 2021
Are patients with COPD more adherent to fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with multiple-inhaler triple therapy in a real-world UK primary care treated population?Chronic obstructive pulmonary diseaseBTS, 2021
Approaches to immune checkpoint inhibitor (ICI) first-line maintenance therapy (1L-MT) in unresectable locally advanced (LA) or metastatic urothelial cancer (mUC) in France, Germany, Italy, Spain, and the UK (EU5)Urothelial carcinomaISPOR EU, 2021
A real world evaluation to describe resource use for the management of moderate to severe atopic dermatitis in secondary care for children and adolescents aged 6 to 17 in the Republic of IrelandAtopic dermatitisISPOR EU, 2021
Real-world effectiveness and rheumatologist satisfaction with secukinumab in the treatment of patients with axial spondyloarthritis.Axial spondyloarthritisView PublicationN/A
Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regionsNon?alcoholic steatohepatitisView PublicationN/A
Pain and fatigue in patients with ankylosing spondylitis treated with TNF inhibitors: multi-national real-world findingsAnkylosing spondylitisView PublicationN/A
Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the USSchizophreniaView PublicationN/A
Variation in age of onset and disease progression among genetic subsets of amyotrophic lateral sclerosis (ALS) patients: results from a real-world point-in-time surveyAmyotrophic lateral sclerosisALS/MND, 2021
Treatment patterns of patients with metastatic castrate-resistant prostate cancer: results from a real-world study in JapanProstate cancerJUA, 2021
The burden of moderate-to-severe atopic dermatitis: results from a real-world study in SpainAtopic dermatitisAEDV, 2021
Real-world health-related quality of life in patients with diffuse large B-cell lymphoma: information comparisons with reference populations and by line of therapyDiffuse large B-cell lymphomaASH, 2021
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United StatesOvarian cancerView PublicationN/A
Patterns of genetic testing among patients with amyotrophic lateral sclerosis (ALS): real-world results from the United States and EuropeAmyotrophic lateral sclerosisALS/MND, 2021
Genomic and genetic testing patterns for patients with metastatic castrate resistant prostate cancer: real world study results in JapanProstate cancerJUA, 2021
Exploring the real-world impact of COVID-19 on first line (1L) treatment and management of EGFR-wild type (EGFR-WT) and ALK-wild type (ALK-WT) metastatic non-small cell lung cancer (mNSCLC) across EuropeNon-small cell lung cancerESMO IO, 2021
Experiences of sickle cell disease (SCD) reported by healthcare professionals (HCPs) across different regions: International Sickle Cell World Assessment Survey (SWAY)Sickle cell diseaseASH, 2021
Current clinical practice and decision-making in multiple myeloma treatment in the United States of America: A real-world surveyMultiple myelomaASH, 2021
Children in the United States with sickle cell disease experience greater educational burden than those living in low/middle income and other high-income countriesSickle cell diseaseASH, 2021
Care and mobility aid dependence in activities of daily living among patients with ALS in the US: results from a real-world studyAmyotrophic lateral sclerosisAPF, 2021
Real-world impact of flaring on patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosusSystemic lupus erythematosus View PublicationN/A
Symptom burden of patients with moderate-to-severe atopic dermatitisAtopic dermatitisView PublicationN/A
Impact of day-to-day itch frequency on the burden of disease in adult patients with moderate-to-severe atopic dermatitisAtopic dermatitisEADV, 2021
Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice in EuropeProstate cancerView PublicationN/A
Patient and caregiver socioeconomic burden of first-line systemic therapy for advanced gastroesophageal adenocarcinomaGastric cancerView PublicationN/A
Regional assessment of the experiences of healthcare professionals (HCPs) treating patients with sickle cell disease (SCD): the international Sickle Cell World Assessment Survey (SWAY)Sickle cell diseaseASCAT, 2022
Real world utilization of adalimumab biosimilar (ABP 501) in patients with inflammatory bowel disease in EuropeInflammatory Bowel DiseaseCCC, 2022
Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and JapanProstate cancerView PublicationN/A
Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancerBreast cancerView PublicationN/A
Real-world study of regional differences in patient demographics, clinical characteristics, and BRCA1/2 mutation testing in patients with human epidermal growth factor receptor 2?negative advanced breast cancer in the United States, Europe, and IsraelBreast cancerView PublicationN/A
Satisfaction with medications prescribed for osteoarthritis: a cross-sectional survey of patients and their physicians in the United StatesOsteoarthritisView PublicationN/A
Usage of C-reactive protein testing in the diagnosis and monitoring of psoriatic arthritis (PsA): results from a real-world survey in the US and EuropePsoriatic arthritisView PublicationN/A
Validity of a single item indicator of treatment side effect bother in a diverse sample of cancer patientsVariousView PublicationN/A
Cardiovascular risk profiles: a cross-sectional study evaluating the generalizability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trial populations in REWIND, LEADER and SUSTAIN-6 against a real-world type 2 diabetes population in the United KingdomDiabetesView PublicationN/A
Use of perioperative treatment among patients undergoing radical resection for muscle invasive urothelial cancer in France, Germany, Italy, Spain, UK, US, Canada, China, and JapanUrothelial carcinomaASCO GU, 2022
Treatment trends among men with metastatic castration sensitive prostate cancer (mCSPC): results from the US component of an international studyProstate cancerASCO GU, 2022
Treatment patterns among men with metastatic castration-resistant prostate cancer (mCRPC) in the United States (US)Prostate cancerASCO GU, 2022
Treatment (tx) patterns among men with metastatic castration resistant prostate cancer (mCRPC) in the United States (US)Prostate cancerASCO GU, 2022
Real-world health-related quality of life and caregiver need in patients with metastatic hormone-sensitive and metastatic castration-resistant prostate cancerProstate cancerASCO GU, 2022
Insights from patients with ulcerative colitis on disease burden: findings from a real-world survey in Europe Inflammatory Bowel DiseaseECCO, 2022
Do real-world diagnostic, management and speciality approaches differ in NASH patients with/without cardiovascular-metabolic comorbiditiesNon?alcoholic steatohepatitisICFL, 2022
Criteria used to determine platinum eligibility and first-line (1L) treatment patterns among platinum-eligible (PE) and -ineligible (PI) patients with metastatic urothelial cancer (mUC) in France, Germany, Spain, Italy, and the UK (Eu5)Urothelial carcinomaASCO GU, 2022
Characteristics and outcomes of rheumatoid arthritis patients treated with upadacitinib in real-world Canadian clinical practice Rheumatoid arthritisCRA, 2022
Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and JapanProstate cancerView PublicationN/A
Patient and physician perspectives on alopecia areata: a real-world assessment of severity and burden in JapanAlopecia areataView PublicationN/A
Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time surveySchizophrenia View PublicationN/A
Quantifying the employer burden of persistent musculoskeletal pain at a large employer in the United Kingdom: a non interventional, retrospective study of Rolls-Royce employee dataMusculoskeletal painView PublicationN/A
Physician behaviour and perceptions around genetic biomarker test utilisation for the management of newly diagnosed advanced ovarian cancer patients - US Physician SurveyOvarian cancerSGO, 2022
Prescription patterns for patients with hereditary angioedema in the United StatesHereditary angioedemaAMCP, 2022
Impact of day-to-day sleep disruption on the burden of disease in moderate-severe adult atopic dermatitis patientsAtopic dermatitisAAD, 2022
Current clinical practices and patient-reported outcomes in frontline maintenance for advanced non-small cell lung cancer in France, Germany and the UK: real-world evidence from the Adelphi Disease Specific ProgrammeNon-small cell lung cancerAMCP, 2022
Atopic dermatitis treatment patterns and patient burden in Russia and PolandAtopic dermatitisAAD, 2022
Real-world treatment patterns in metastatic castration-resistant prostate cancer across Europe (France, Germany, Italy, Spain, and the United Kingdom) and JapanProstate cancerView PublicationN/A
BRCA screening, treatment patterns and response among patients with ovarian cancer in the second line treatment setting: results from a real-world surveyOvarian cancerView PublicationN/A
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: a comparative analysis of high? and low? to middle?income countries for the international Sickle Cell World Assessment Survey (SWAY)Sickle cell diseaseView PublicationN/A
Real-world clinical characteristics and treatment patterns in patients with advanced renal cell carcinoma treated with first-line immunotherapy + axitinib in Germany Renal cell carcinomaIKCS, 2022
Treatment patterns for chronic obstructive pulmonary disease (COPD) in the United States: results from an observational cross sectional physician and patient surveyChronic obstructive pulmonary diseaseView PublicationN/A
Unmet clinical needs and burden of disease in hidradenitis suppurativa: 2 Real-world experience from EU5 and USHidradenitis suppurativaView PublicationN/A
Atypical treatment switches in schizophrenia patients: drivers and associated outcomesSchizophreniaView PublicationN/A
Factors associated with physician-reported treatment status of patients with osteoarthritis painOsteoarthritisView PublicationN/A
Understanding patient characteristics and healthcare resource utilization in HAE patients currently prescribed prophylactic treatment Hereditary angioedemaISPOR US, 2022
The patient journey in patients With CRSwNP in the United States and EuropeChronic rhinosinusitis with nasal polyposisATS, 2022
Pulmonary arterial hypertension treatment patterns and patient health related quality of life: findings from a multinational real world databasePulmonary arterial hypertensionATS, 2022
Physicians' reasons for prescribing Janus kinase inhibitors (JAKi) in patients with rheumatoid arthritis, and associated alignment between physicians and patients in a real-world clinical setting Rheumatoid arthritisSER, 2022
Operationalizing the 2019 GINA Asthma treatment steps for application to real-world data from the UK AsthmaISPOR US, 2022
Physician-reported characterization and treatment utilization of patients with alopecia areata using survey dataAlopecia areataEADV, 2022
Extent and use of ICS-LABA (maintenance only and MART) in routine clinical practice and associated clinical and symptom unmet need in the USAsthmaATS, 2022
Comparative analysis of Hidradenitis Suppurativa Quality Of Life (HiSQOL) and Dermatology Life Quality Index (DLQI) scores using data from patients with hidradenitis suppurativaHidradenitis suppurativaISPOR US, 2022
Characteristics and outcomes of patients with severe eosinophilic asthma treated with Benralizumab enrolled in the connect 360 patient support programme Eosinophilic asthma ATS, 2022
Burden of antibiotic use among pediatric patients with varicella infection: a retrospective cohort analysis of real-world data in England VaricellaESPID, 2022
The impact of osteoarthritis disease severity on treatment patterns and healthcare resource use: analysis of real-world data OsteoarthritisView PublicationN/A
Burden of moderate to severe atopic dermatitis in adults from France, Italy, and the UK: patient-reported outcomes and treatment patternsAtopic dermatitisView PublicationN/A
Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United StatesMenopauseView PublicationN/A
Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophreniaSchizophreniaView PublicationN/A
Malignant pleural mesothelioma: treatment patterns and humanistic burden of disease in Europe MesotheliomaView PublicationN/A
People living with moderate-to-severe COPD prefer improvement of daily symptoms over the improvement of exacerbations: a multicountry patient preference studyChronic obstructive pulmonary diseaseView PublicationN/A
Unmet medical needs and burden of disease in hidradenitis suppurativa: real clinical practice experience in SpainHidradenitis suppurativaEADV, 2022
Treatment attributes for 3rd line follicular lymphoma treatment decision-making: physician perspectives from a survey across Western Europe and the United StatesFollicular lymphomaEHA, 2022
Reasons for oncologist and urologist treatment choice in metastatic castration-sensitive prostate cancer (mCSPC): a physician survey linked to patient chart reviews in the United States Prostate cancerASCO GU, 2022
Quality of life, work impairment, and daily activity impairment of patients with psoriasis versus psoriatic arthritis: a real-world survey in US and EuropePsoriatic arthritisEULAR, 2022
Prevalence of comorbid conditions amongst myasthenia gravis patients: analysis of real world data from the Adelphi Disease Specific ProgrammeMyasthenia gravisEAN, 2022
Physicians' reasons for prescribing Janus kinase inhibitors (JAKi) in patients with rheumatoid arthritis, and associated alignment between physicians and patients in a real-world clinical setting Rheumatoid arthritisEULAR, 2022
Physicians and patients have different perspectives on burden of hidden symptoms of multiple sclerosis to patientsMultiple sclerosisCMSC, 2022
Overall cancer survival inequalities in the state of Sao Paulo: a comparison between public and private systemsVariousASCO, 2022
Management of early-stage HR+, HER2- breast cancer in a real-word setting in Germany: a patient perspectiveBreast cancerDGS, 2022
Management and impact of vitiligo on patient lives: survey of US dermatologistsVitiligoMaui Derm, 2022
Impact of generalised myasthenia gravis on activities of daily living and employment for patients and caregivers: analysis of real-world data from the Adelphi Disease Specific ProgrammeMyasthenia gravisEAN, 2022
Fatigue in active and nonactive primary and secondary progressive multiple sclerosis patients in the United StatesMultiple sclerosisCMSC, 2022
Concordance of physician and patient reported presence and severity of pulmonary arterial hypertension symptoms: findings from a real-world survey in Latin AmericaPulmonary arterial hypertensionSIAC, 2022
Clinical characteristics and burden among patients with SLE stratified by SLEDAI derived severity: results from a real-world study in the USSystemic lupus erythematosus EULAR, 2022
Clinical characteristics and burden among patients with SLE and musculoskeletal organ involvement: results from a real-world study in the USSystemic lupus erythematosus EULAR, 2022
Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients Atopic dermatitisView PublicationN/A
Physician-reported perspectives on myasthenia gravis in the United States: a real-world surveyMyasthenia gravisView PublicationN/A
Treatment by line in patients with persistent and chronic immune thrombocytopenia: a real-world point-in-time study immune thrombocytopenia: A real-world point-in-time studyThrombocytopeniaISTH, 2022
Real-world treatment experience of single tablet dolutegravir/lamivudine in the US: results from the Tandem study HIVIAS, 2022
Prescription patterns for patients with hereditary angioedema in the United StatesHereditary angioedemaEAACI, 2022
Frequency of HAE attacks, clinical outcomes, and quality of life for patients prescribed lanadelumab and other prophylaxis: analysis of real?world patient dataHereditary angioedemaEAACI, 2022
Disease burden and diagnosis pathways among patients with EoE in five European countries: evidence from real-world clinical practiceEosinophilic oesophagitisEAACI, 2022
The burden of nocturnal symptoms in patients with chronic obstructive pulmonary disease: results of a real-world survey in the USAChronic obstructive pulmonary diseaseView PublicationN/A
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting ?2-agonist dual therapy in a primary care setting in EnglandChronic obstructive pulmonary diseaseView PublicationN/A
Characterization of patients with chronic obstructive pulmonary disease initiating single-inhaler long-acting muscarinic antagonist/long-acting ?2-agonist dual therapy in a primary care setting in EnglandChronic obstructive pulmonary diseaseView PublicationN/A
Effect of fatigue on health-related quality of life and work productivity in psoriatic arthritis: findings from a real-world surveyPsoriatic arthritisView PublicationN/A
Real-world health outcomes in US adult patients with mild to moderate plaque psoriasis taking topical therapy Psoriasis View PublicationN/A
Health-related quality of life among patients with hemophilia A receiving prophylactic therapyHemophiliaNHF, 2022
Frequency of HAE attacks, clinical outcomes, and quality of life for patients prescribed lanadelumab and other prophylaxis: analysis of real-world patient dataHereditary angioedemaIWAA , 2022
Effectiveness of ixekizumab in patients with psoriatic arthritis: results from a real-world European surveyPsoriatic arthritisDGRh, 2022
Work Productivity, Activity Impairment (WPAI) and quality of life in patients treated for asthma in ChinaAsthmaCTS, 2022
Differences in asthma severity definitions impact disease burden and healthcare resource utilization outcomes in China AsthmaCTS, 2022
The impact of agitation in dementia on caregivers: a real-world surveyDementiaView PublicationN/A
Women with psoriatic arthritis experience higher disease burden than men: findings from a real-world survey in the United States and EuropePsoriatic arthritisView PublicationN/A
A real-world retrospective observational study exploring NHS resource use in England for the management of moderate-to-severe atopic dermatitis in secondary care for children and adolescentsAtopic dermatitisView PublicationN/A
Comparative adherence and persistence of single and multiple inhaler triple therapies among patients with chronic obstructive pulmonary disease in an English real-world primary care settingChronic obstructive pulmonary diseaseView PublicationN/A
Implementation of the treat-to-target approach and treatment satisfaction in patients with rheumatoid arthritis: perspectives of Chinese rheumatologistsRheumatoid arthritisView PublicationN/A
Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinomaHepatocellular carcinomaView PublicationN/A
VOCAL (views of ovarian cancer patients-how maintenance therapy affects their lives) study: a lens into the financial and quality of life (QoL) impact of disease burden and ethnic disparities reported directly by the patientOvarian cancerASCO QCS, 2022
VOCAL (Views of ovarian cancer patients - how maintenance therapy affects their lives) study: patient preference for treatment formulation and administrationOvarian cancerIGCS, 2022
Unmet needs among hidradenitis suppurativa patients receiving biologic therapy in the United States of America and Europe by response status: analysis of a real-world datasetHidradenitis suppurativa EADV, 2022
Unmet needs among atopic dermatitis patients receiving biologic therapy in the United States and Europe by response status: analysis of a real-world datasetAtopic dermatitisEADV, 2022
Treatment patterns, outcomes, and physician decision-making in multiple myeloma: a real-world European studyMultiple myelomaESMO, 2022
The impact of osteoporotic fractures on activities of daily living and the indirect economic measures in five countries OsteoporosisASBMR, 2022
Rescue medication use in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterolin EnglandChronic obstructive pulmonary diseaseERS, 2022
Reduced exacerbations following switch from multiple inhaler to once daily single inhaler triple therapy in COPD patients in a real world primary care setting in EnglandChronic obstructive pulmonary diseaseERS, 2022
Treatment patterns of patients with alopecia areata based on physician assessed severity: results from a real-world survey in 5 European countries Alopecia areataEADV, 2022
Real-world treatment patterns and clinical outcomes for patients with non-segmental vitiligo in the United States and EuropeVitiligoEADV, 2022
Physician behaviour and perceptions of genetic biomarker test use for the management of newly diagnosed advanced ovarian cancer patientsOvarian cancerESMO, 2022
Patient-reported burden of alopecia areata: results from a real-world survey in 5 European countriesAlopecia areataBHM, 2022
Patient characteristics, disease profile and treatment patterns in mild and moderate PsO patients in European real world practicesPsoriasisESDR, 2022
Patient characteristics, disease profile and treatment patterns in mild and moderate PsO Patients in Europe and US Real World Practices (PROSPECT Study)PsoriasisEADV, 2022
Misalignment between nurse practitioners and physician assistants and their adult atopic dermatitis patients on severity, disease progression and satisfaction: results of a real-world study in the United StatesAtopic dermatitisMaui Derm, 2022
Impact of scalp hair loss on treatment patterns and physician satisfaction with disease control for alopecia areata patients in EuropeAlopecia areataEADV, 2022
ICS-LABA prescribing in asthma (maintenance only and MART), clinical and symptom unmet need in JapanAsthmaERS, 2022
Exploring triptan use & treatment sequencing for the management of migraine in adults in the UK: a feasibility study using the Clinical Practice Research Datalink (CPRD)MigraineMTIS, 2022
Frequency and impact of retreatment in relapsed refractory multiple myeloma: real-world survey conducted in 5 European countries (France, Germany, Italy, Spain, and the United Kingdom)Multiple myelomaESMO, 2022
COVID 19 incidence and hospitalisation in routine clinical practice among COPD patients in England in 2020Chronic obstructive pulmonary diseaseERS, 2022
Comparative effectiveness of umeclidinium/vilanterol versus indacaterol/glycopyrronium on acute exacerbations in patients with chronic obstructive pulmonary disease in EnglandChronic obstructive pulmonary diseaseERS, 2022
Evaluating real-world caregiver involvement from a survey of patients (pts) with metastatic urothelial cancer (mUC) receiving systemic anticancer treatment in France, Germany, Italy, Spain, and the UK (Eu5)Urothelial carcinomaESMO, 2022
Combination therapy prescribing in pulmonary arterial hypertension patients in a real-world setting in Latin AmericaPulmonary arterial hypertensionERS, 2022
Benefit of prompt initiation of single-inhaler triple therapy in COPD patients in England following an exacerbationChronic obstructive pulmonary diseaseERS, 2022
Biomarker testing and associated treatment patterns in advanced non-small cell lung cancer in the USNon-small cell lung cancerNACLC, 2022
Association between Hurley state and patient-reported outcomes in patients with hidradenitis suppurativa in the United States of America and Europe: analysis of a real-world datasetHidradenitis suppurativa EADV, 2022
Adherence to umeclidinium/vilanterol versus inhaled corticosteroids/long-acting ?2-agonist in patients with chronic obstructive pulmonary disease in EnglandChronic obstructive pulmonary diseaseERS, 2022
Association between EASI score and patient-reported outcomes in patients with atopic dermatitis in the United States and Europe: analysis of a real-world datasetAtopic dermatitisEADV, 2022
Patient characteristics and treatment patterns of newly diagnosed locally advanced head and neck squamous cell carcinoma (LA HNSCC): a retrospective cohort analysis of real-world data in EnglandSquamous cell carcinoma of the head and neckESMO, 2022
Disease burden and treatment patterns among patients with asthma in ChinaAsthmaERS, 2022
Disease burden and treatment patterns among patients with asthma on GINA 4/5 therapies in ChinaAsthmaERS, 2022
Symptom burden and health-related quality of life in moderate to severe chronic rhinosinusitis with nasal polyposisChronic rhinosinusitis with nasal polyposisView PublicationN/A
Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2?Negative advanced breast cancer: patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and IsraelBreast cancerView PublicationN/A
Understanding flaring in pediatric and adolescent patients with moderate or severe atopic dermatitis: a real-world study in the United States and Europe Atopic dermatitisFCDC, 2022
The utilization of clinical assessment tests in pulmonary arterial hypertension: findings from a real world survey in Latin AmericaPulmonary arterial hypertensionPVRI PH LA, 2022
Real-world treatment patterns and clinical outcomes in radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients treated with lenvatinib monotherapyThyroid cancer ATA, 2022
Real-world treatment experience of single-tablet dolutegravir/rilpivirine in the United States: results from the TANDEM StudyHIVAMCP Nexus, 2022
Reasons for choice of advanced therapies (biologics and JAKis) for the treatment of ulcerative colitis in EuropeInflammatory Bowel DiseaseUEGW, 2022
Real-world evidence characterizing the burden of disease in alpha- and beta-thalassemia patients in the USA: an interim analysisThalassemiaASCAT, 2022
Real-world evaluation of physician-reported symptoms and burden of vasomotor symptoms associated with menopause in the United States and EuropeVasomotor symptoms IMS, 2022
Real-world effectiveness of Ixekizumab in psoriatic arthritis patients: a real-world survey in the United States Psoriatic arthritis CCR-west, 2022
Real-world effectiveness of Ixekizumab in axial spondyloarthritis patients: a global survey Axial spondyloarthritisCCR-West, 2022
Physician-documented symptoms and treatment among patients with eosinophilic esophagitis in the United States: evidence from real-world clinical practiceEosinophilic oesophagitisACG, 2022
Physician-documented symptoms and treatment among patients with eosinophilic esophagitis in five European countries: evidence from real-world clinical practiceEosinophilic oesophagitisUEGW, 2022
Physician reported disease severity and diagnostic delays in patients with rare neurological diseases: differences by sex from a real-world survey across Europe and the United States of AmericaVariousNORD, 2022
Patient-reported symptoms of eosinophilic esophagitis in five European countries: evidence from real-world clinical practiceEosinophilic oesophagitisUEGW, 2022
Patient-reported symptom burden and treatment satisfaction in patients with metastatic urothelial cancer (mUC) in France, Germany, Italy, Spain, and the UK (Eu5)Metastatic urothelial cancerBLADDR, 2022
Patient and physician alignment on symptoms of menopause: findings from the real-world REALISE study in the United States and EuropeVasomotor symptoms IMS, 2022
How often do clinical and non-clinical factors impact physician-reported prescribing for neovascular AMD in real-world clinical practiceAge-related diseasesAMCP Nexus, 2022
Frequency of HAE attacks, clinical outcomes, and quality of life for patients prescribed lanadelumab and other prophylaxis: analysis of a real-world patient dataHereditary angioedemaAMCP Nexus, 2022
Describing the burden of moderate exacerbations in patients with asthma participating in the Extended Salford Lung Study (Ex-SLS)AsthmaCHEST, 2022
Describing asthma control and adherence in patients with Extended Salford Lung Study (Ex-SLS) prescribed inhaled corticosteroids/long-acting beta agonists (ICS/LABAs) AsthmaCHEST, 2022
Disease burden and diagnosis pathways among patients with EoE in the United States: evidence from real-world clinical practiceEosinophilic oesophagitisACG, 2022
Assessment of patient-reported pain relief in treated endometriosis patients: findings from a real-world study in the United StatesEndometriosisASRM , 2022
Age-related differences in quality of life outcomes of people living with HIV HIVHIV Glasgow, 2022
Patient-reported symptoms of eosinophilic oesophagitis in five European countries: evidence from real-world clinical practiceEosinophilic oesophagitisUEGW, 2022
VOCAL (Views of Ovarian Cancer Patients - how maintenance therapy affects their lives) study: patient preference for treatment formulation and administrationOvarian cancerAMCP Nexus, 2022
VOCAL (Views of Ovarian Cancer Patients - how maintenance therapy affects their lives) study: patient preference for treatment formulation and administrationOvarian cancerESGO, 2022
Real world utilisation of doravirine among people living with HIV in England (DRIVE-REAL) HIVHIV Glasgow, 2022
Physician-documented symptoms and treatment among patients with eosinophilic oesophagitis in five European Countries: evidence from real-world clinical practiceEosinophilic oesophagitisUEGW, 2022
Disagreement between the perception of physicians and patients about the presence and severity of symptoms of Pulmonary Arterial HypertensionPulmonary arterial hypertensionSBPT, 2022
World health organization functional class and health-related quality of life In patients with pulmonary arterial hypertension: real-world findings In Latin AmericaPulmonary arterial hypertensionCHEST, 2022
BRCA1/2 mutation testing in patients with HER2-negative advanced breast cancer: real-world data from the United States, Europe, and IsraelBreast cancerView PublicationN/A
Impact of physician-defined flares on quality of life and work impairment: an international survey of 2238 patients with psoriatic arthritisPsoriatic arthritisView PublicationN/A
Real-world treatment patterns and clinical outcomes associated with palbociclib combination therapy: a multinational, pooled analysis from the Ibrance real world insights studyBreast cancerView PublicationN/A
VOCAL (Views of Ovarian Cancer patients and their caregivers-how maintenance therapy Affects their Lives) study: cancer-related burden and quality of life of caregiversOvarian cancerISPOR EU, 2022
Understanding flares in pediatric and adolescent patients with moderate or severe atopic dermatitis: a real-world Study in the United States and EuropeAtopic dermatitisPEDRA, 2022
Treatment-related and non-treatment-related out-of-pocket costs by amyotrophic lateral sclerosis disease stage: a cross-sectional patient survey and retrospective chart reviewAmyotrophic lateral sclerosis ISPOR EU, 2022
Treatment and patient-reported outcomes among people with ALS in the US: results from a real- world studyAmyotrophic lateral sclerosisNEALS, 2022
The disease burden of invasive candidiasis in Germany: a non-interventional, retrospective cohort analysis of real-world dataInvasive candidiasisISPOR EU, 2022
The real-world diagnostic pathway in patients with IgANImmunoglobulin A nephropathy ASN, 2022
Reduced health care resource utilisation and costs following a switch from multiple-inhaler to once-daily single-inhaler triple therapy in COPD patients in a real-world primary care setting in EnglandChronic obstructive pulmonary diseaseISPOR EU, 2022
Reasons for choice and areas for improvement in advanced therapies (biologics and JAKis) for patients with ulcerative colitis in the United KingdomInflammatory Bowel DiseaseISPOR EU, 2022
Real-world utilization of adalimumab biosimilar (ABP 501) in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in EuropeRheumatoid arthritisACR, 2022
Real-world treatment pathways of patients with diffuse large B-cell lymphoma receiving second line treatment or later in the UK, Canada, France, Germany, Italy and Spain: A prospective survey of physiciansDiffuse Large B-Cell LymphomaISPOR EU, 2022
Quantifying the impact of persistent musculoskeletal pain on employees at rolls-royce: a cross-sectional surveyMusculoskeletal painISPOR EU, 2022
Real-world outcomes among episodic migraine patients with migraine preventive medications in China: results from the Chinese Adelphi Disease Specific ProgrammeMigraineISPOR EU, 2022
Physician and patient reported outcomes by hereditary angioedema type: data from a real-world studyHereditary angioedemaACAAI, 2022
Persistence of signs and symptoms in treated patients with IgAN: evidence from real-world dataImmunoglobulin A nephropathy ASN, 2022
Patient-reported outcomes across disease stages among people with amyotrophic lateral sclerosis: results from a real-world surveyAmyotrophic lateral sclerosisNEALS, 2022
Measuring the burden of alopecia areata with the European Quality of Life-5 Dimensions (EQ-5D): Results from a real-world survey in 5 European countries Alopecia AreataISPOR EU, 2022
Health-related quality of life among men receiving treatment for metastatic castration-resistant prostate cancer: results from an international real-world studyProstate cancer EMUC, 2022
Health-related quality of life (HRQOL) by line of treatment, treatment history, and disease status in patients with metastatic urothelial carcinoma (MUC) in EU-4 and the United Kingdom: Results from a disease specific programmeMetastatic urothelial cancerISPOR EU, 2022
Functional class and health-related quality of life in patients with pulmonary arterial hypertension associated with congenital heart disease: findings from a real-world study in the USPulmonary arterial hypertensionISPOR EU, 2022
Equity and outcome events in patients with hidradenitis suppurativa: exploring effect modifiers associated with HS diagnostic delayHidradenitis suppurativa ISPOR EU, 2022
Diagnostic testing for non-alcoholic steatohepatitis (NASH) across specialty, comorbidity, and fibrosis stage: a real world assessment in the United StatesNon?alcoholic steatohepatitisAASLD, 2022
Delayed diagnosis amongst gMG patients: results from a European real-world studyMyasthenia gravisISPOR EU, 2022
Clinical and economic benefits of prompt initiation of single-inhaler triple therapy in COPD patients in England following an exacerbationChronic obstructive pulmonary diseaseISPOR EU, 2022
Clinical differences and patient reported outcomes between Insufficient responders and responders to prescribed acute migraine treatment: results from a real-world patient survey in China MigraineISPOR EU, 2022
Changing priorities among physician reported reasons for choice of pharmacological gMG treatments across 5 European countriesMyasthenia gravisISPOR EU, 2022
Application processes for international classification of disease (ICD)-11 update and revision proposalsVariousISPOR EU, 2022
Impact of the COVID-19 pandemic on health care resource utilisation and costs in COPD in England: a population-based studyChronic obstructive pulmonary diseaseISPOR EU, 2022
Impact of the COVID-19 pandemic on health care resource utilisation and costs in asthma in England: a population-based studyAsthmaISPOR EU, 2022
COVID-19 incidence and hospitalisation in routine clinical practice among asthma patients in England in 2020AsthmaBTS, 2022
Asthma exacerbations in routine clinical practice during COVID-19 in England in 2020AsthmaBTS, 2022
COPD exacerbations in routine clinical practice during COVID-19 in England in 2020Chronic obstructive pulmonary diseaseBTS, 2022
Characteristics and outcomes of patients with rheumatoid arthritis treated with upadacitinib in a global real-world settingRheumatoid arthritisACR, 2022
Characterization of patients with eosinophilic esophagitis managed by gastroenterologists and allergists: real-world clinical practice evidenceEosinophilic oesophagitisACAAI, 2022
Patient-reported symptoms of eosinophilic esophagitis in the United States: evidence from real-world clinical practiceEosinophilic oesophagitisACAAI, 2022
Misdiagnoses and the impact on disease severity in immunoglobulin A nephropathy patients: a real world studyImmunoglobulin A nephropathy ASN, 2022
Physician and patient reported outcomes by hereditary angioedema type: data from a real-world studyHereditary angioedemaACAAI, 2022
Impact of COVID-19 pandemic on the management of patients with rheumatoid arthritis: a survey of rheumatologists in six European countriesRheumatoid arthritisView PublicationN/A
Impact of patient and physician disconnect on satisfaction with treatment for atopic dermatitis in JapanAtopic dermatitisView PublicationN/A
Physician and patient perceptions of surgical procedures for osteoarthritis of the knee in the United States, Europe, and Japan: results of a real-world studyOsteoarthritisView PublicationN/A
First-line (1L) treatment (tx) patterns and criteria used to determine platinum eligibility (PE) in platinum-eligible and -ineligible (PI) patients (pts) with metastatic urothelial cancer (mUC) in South Korea (KR) and Taiwan (TW)Metastatic urothelial cancerESMO Asia, 2022
Systemic lupus erythematosus symptom clusters and their association with patient?reported outcomes and treatment: analysis of real?world dataSystemic lupus erythematosus View PublicationN/A
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity, and advanced therapy use in EuropeRheumatoid arthritisView PublicationN/A
Treatment patterns in metastatic urothelial cancer (mUC): a real-world survey in France, Germany, Italy, Spain, and the UK (Eu5)Urothelial carcinomaISPOR US, 2022
Management of myelofibrosis with ruxolitinib in AustraliaMyelofibrosisN/A
A real-world retrospective observational study exploring resource use for secondary care management of moderate-to-severe atopic dermatitis in children and adolescents at a single site in IrelandAtopic dermatitisView PublicationN/A
Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countriesInflammatory Bowel DiseaseView PublicationN/A
Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatmentGastric cancerView PublicationN/A
Impact of key manifestations of psoriatic arthritis on patient quality of life, functional status, and work productivity: findings from a real-world study in the United States and Europe Psoriatic arthritisView PublicationN/A
Opioid prescribing for osteoarthritis: cross-sectional survey among primary care physicians, rheumatologists, and orthopaedic surgeonsOsteoarthritisView PublicationN/A
Prevalence and severity distribution of type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitisVariousView PublicationN/A
Tyrosine kinaseiInhibitor (TKI) real-world use in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) patientsNon-small cell lung cancerLALCA, 2023
Therapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary careDiabetesView PublicationN/A
Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: an international observational studyNon-small cell lung cancerView PublicationN/A
Alignment of physician-stated vs clinically derived reference fibrosis score in patients with non-alcoholic steatohepatitis: a real-world European surveyNon?alcoholic steatohepatitisView PublicationN/A
Clinical unmet needs and treatment patterns of paediatric psoriasis patients: a real world evidence study in SpainPsoriasisView PublicationN/A
Prevalence and severity distribution of type 2 inflammation?related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitisAsthmaView PublicationN/A
Real-world analysis of clinical characteristics, treatment patterns and patient-reported outcomes of insufficient responders and responders to prescribed acute migraine treatment in ChinaMigraineView PublicationN/A
Real-world treatment trends among patients with metastatic castration-sensitive prostate cancer: results from an international studyProstate cancerView PublicationN/A
Disease and treatment burden of Hereditary Angioedema (HAE) in pediatric patients: assessment by caregiversHereditary angioedemaAAAAI, 2023
Frequency of HAE attacks, clinical outcomes, and quality of life for patients prescribed lanadelumab and other prophylaxis: analysis of real-world patient dataHereditary angioedemaWSAAI, 2023
Clinical burden of hidradenitis suppurativa (HS) with draining tunnelsHidradenitis suppurativaEHSF, 2023
Clinical outcomes and physician-patient alignment in patients with psoriatic arthritis receiving ixekizumab Psoriatic arthritis CRA, 2023
Real-world homologous recombination repair mutation testing patterns in patients with metastatic castration-sensitive prostate cancer in the USProstate cancerASCO GU, 2023
Comparison of hereditary angioedema among patients of different races and ethnicities in the United States: data From a real-world studyHereditary angioedemaAAAAI, 2023
Disease burden and physician-reported outcomes in pediatric patients with hereditary angioedema: data From a real-world studyHereditary angioedemaAAAAI, 2023
Treatment management of type two diabetes mellitus patients in routine clinical practice in the United Arab Emirates: a real world studyDiabetesEDEC, 2023
Demographics and clinical characteristics of patients with type two diabetes mellitus in the United Arab Emirates: a real-world studyDiabetesEDEC, 2023
Treatment patterns, healthcare utilization and clinical outcomes of patients with chronic obstructive pulmonary disease initiating single-inhaler long-acting ?2-agonist/long-acting muscarinic antagonist dual therapy in primary care in EnglandChronic obstructive pulmonary diseaseView PublicationN/A
The burden of Fabry disease in the United States: Results from the Adelphi Fabry disease specific programmeFabry diseaseWORLDSymposium, 2023
Caregivers of patients with malignant pleural mesothelioma: who provides care, what care do they provide and what burden do they experience? MesotheliomaView PublicationN/A
Quantifying the burden of persistent musculoskeletal pain in employees at Rolls-Royce in the United Kingdom: a real-world cross-sectional surveyMusculoskeletal painView PublicationN/A
Symptom burden of patients with IgA nephropathy in a real-world setting across geographiesImmunoglobulin A nephropathy WCNeph, 2023
Prognosis, dialysis and transplantation in patients with immunoglobulin A nephropathy: evidence from real-world dataImmunoglobulin A nephropathy WCNeph, 2023
Persistence of signs and symptoms in treated patients with IgAN: evidence from real-world dataImmunoglobulin A nephropathy WCNeph, 2023
The patient-reported impact of itch and sleep interference on pediatric and adolescent patients with moderate and severe atopic dermatitis: a real-world study in the United States and EuropeAtopic dermatitisAAD, 2023
Impact of immunoglobulin A nephropathy on healthcare resource utilization in the United States: results from a real-world studyImmunoglobulin A nephropathy AMCP, 2023
Disease severity and symptom control in patients with IgA nephropathy: results from a United States analysis of a real-world studyImmunoglobulin A nephropathy AMCP, 2023
Treatment patterns and outcomes in patients with immunoglobulin A nephropathy: results from a United States data analysis of a real-world studyImmunoglobulin A nephropathy AMCP, 2023
Impact of immunoglobulin A nephropathy on work, productivity, and activity impairment in the United States: results from a real-world study Immunoglobulin A nephropathy AMCP, 2023
The impact of remission on healthcare resource utilisation and costs amongst patients with inflammatory bowel disease in France, Germany, Italy, Spain, and the United KingdomInflammatory Bowel DiseaseECCO, 2023
Association of uncontrolled disease with quality of life and healthcare resource utilisation in ulcerative colitis patients treated with advanced therapy in the United StatesInflammatory Bowel DiseaseECCO, 2023
Time from amyotrophic lateral sclerosis onset to key disease milestones: analysis of patient data from a real-world cross-sectional surveyAmyotrophic lateral sclerosisMDA, 2023
Treatment patterns of patients with alopecia areata based on physician assessed severity: results from a real-world survey in 5 European countries Alopecia areataEDS, 2023
Development of a cross-walk of the chronic liver disease questionnaire for nonalcoholic steatohepatitis (CLDQ-NASH) and EuroQol Five Dimension (EQ-5D-5L) scores using data from patients with nonalcoholic steatohepatitisNon?alcoholic steatohepatitisAMCP, 2023
Patient burden of nonsegmental vitiligo: perspectives from US patientsVitiligoGVF, 2023
Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting ?2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in EnglandChronic obstructive pulmonary diseaseView PublicationN/A
Opioids for osteoarthritis: cross-sectional survey of patient perspectives and satisfactionOsteoarthritisView PublicationN/A
Immunoglobulin A nephropathy patient reported health utility and quality of life: evidence from US real-world dataImmunoglobulin A nephropathy NKF SCM, 2023
Evaluation of prompt initiation of triple inhaler therapy on exacerbations and healthcare resource use among patients with COPD in JapanChronic obstructive pulmonary diseaseJRS, 2023
The impact of generalized myasthenia gravis severity on work and daily activities: a real world studyMyasthenia gravisAAN, 2023
Treatment patterns in congenital heart disease associated pulmonary arterial hypertension: results from a real-world PAH-CHD study in the United States.Pulmonary arterial hypertensionISHLT, 2023
Patient-gastroenterologist disconnect on remission status and symptom burden in ulcerative colitis patients in the United States, France, Germany, Italy, and SpainInflammatory Bowel DiseaseDDW, 2023
Diagnosing celiac disease in the United States of America, Germany, Italy and Spain: findings from a real-world surveyCeliac diseaseDDW, 2023
Physician management of celiac disease: a comparison of disease knowledge, diagnosis, and patient management between gastroenterologists and primary care physicians in Germany, Italy, Spain, and the United States - findings from a real world surveyCeliac diseaseDDW, 2023
Antibiotic use and economic burden of varicella infection among pediatric patients: a retrospective cohort analysis of real-world data in FranceVaricellaESPID, 2023
Healthcare resource utilization and costs associated with acute COVID in pediatric patients managed in the community or hospital setting in England: a population-based studyCovid-19ESPID, 2023
Describing renal function test use in real-world diagnosis and monitoring of lupus nephritis patients in EuropeLupus nephritis EULAR, 2023
Disease burden and unmet need in patients with systemic lupus erythematosus treated with advanced therapy: results from a real-world survey in Europe and the United StatesSystemic lupus erythematosus EULAR, 2023
Understanding the impact of HAE attacks on patient reported quality-of-life - analysis of real-world patient dataHereditary angioedemaC1IDAW, 2023
Menopausal symptom burden and quality of life in women with breast cancer on endocrine adjuvant therapy: findings from the REALISE studyVasomotor symptoms EMAS, 2023
Menopause management: real-world analysis of treatment patterns by vasomotor symptom severity and concomitant symptoms from the US and EuropeVasomotor symptoms EMAS, 2023
Recognition gap between patient and physician on disease severity and treatment satisfaction level for alopecia areataAlopecia areataISID, 2023
Real-world weight loss patterns and challenges among people living with obesity in CanadaObesityCOS, 2023
Drivers of physician decision-making and patient perspectives across lines of therapy in multiple myeloma in the USMultiple myelomaView PublicationN/A
Impact of fragility fractures on activities of daily living and productivity of community-dwelling women: a multi?national studyOsteoporosisView PublicationN/A
Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world surveyMyasthenia gravisView PublicationN/A
Real-world clinical profile, treatment patterns and patient-reported outcomes for thyroid cancer in JapanThyroid CancerView PublicationN/A
Real?world patient?reported outcomes and concordance between patient and physician reporting of side effects across lines of therapy in multiple myeloma within the USAMultiple MyelomaView PublicationN/A
Suboptimal clinical and quality of life outcomes in patients with psoriasis undertreated with oral therapies: international physician and patient surveyPsoriasisView PublicationN/A
Clinical characteristics and disease outcomes in previously treated patients with haemophilia: results from a real-world study in Europe and United StatesHemophiliaISTH, 2023
Clinical characteristics of patients with lupus nephritis class III-V: analysis of international real-world dataLupus nephritis ERA, 2023
Clinical effectiveness, treatment use, satisfaction and impact on quality-of-life of pegcetacoplan treatment for patients with paroxysmal nocturnal haemoglobinuria (PNH)Paroxysmal nocturnal hemoglobinuria EHA, 2023
Prevalence of clinically significant extravascular hemolysis in stable c5 inhibitor-treated patients with PNH and its association with disease control, quality of life and treatment satisfactionParoxysmal nocturnal hemoglobinuria EHA, 2023
Physician attitudes towards the use of pre-exposure prophylaxis (PrEP): findings from a real-world survey in EuropePre-exposure prophylaxisAIDSImpact, 2023
Real-world signs and symptoms at diagnosis in patients with C3 glomerulopathy - interim results from a multi-country studyC3 glomerulopathy ERA, 2023
C3 glomerulopathy current therapy and real-world management - interim results from a multi-country studyC3 glomerulopathy ERA, 2023
Lennox-Gastaut Syndrome characteristics: interim results from a European real-world point-in-time studyLennox-Gastaut syndromeEPNS, 2023
Immunoglobulin A nephropathy: patient-reported symptoms prior to first consultation and diagnosis - results from a real-world surveyImmunoglobulin A nephropathy ERA, 2023
The diagnostic journey of patients with Immunoglobulin A nephropathy: data analysis of a real-world surveyImmunoglobulin A nephropathy ERA, 2023
IgA nephropathy: a real-world comparison between disease severity, symptom burden, and treatment satisfaction reported by patients and nephrologistsImmunoglobulin A nephropathy ERA, 2023
Symptom control with currently available Immunoglobulin A nephropathy treatment: results from a real-world survey in eight countriesImmunoglobulin A nephropathy ERA, 2023
Clinical outcomes and quality of life in patients with HAE receiving lanadelumab long-term prophylaxis: interim analysis of 3-year real-world dataHereditary angioedemaEAACI, 2023
Patients with moderate-to-severe atopic dermatitis experience heterogeneous disease course phenotypes: results of a real-world study in the United StatesAtopic dermatitisFCPANP, 2023
The impact of hepatitis D virus infection on health-related quality of life and fatigue in patients untreated for HDV: descriptive results from a cross-sectional study across Italy, Germany, Spain and the USHepatitis D virusEASL, 2023
Qualitative interviews to assess the impact of chronic hepatitis delta virus infection on health-related quality of life in untreated patients from the US, Italy, Spain, and GermanyHepatitis D virusEASL, 2023
Key treatment attributes for moderate-to-severe atopic dermatitis: preference results for patients and APPs from a US real-world, cross-sectional study Atopic dermatitisMaui Derm, 2023
Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence surveyNon-small cell lung cancerView PublicationN/A
Real-world effectiveness of lenvatinib monotherapy in radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients with confirmed BRAF mutationstatusThyroid cancer WCTC, 2023
Treatment patterns and clinical outcomes of newly diagnosed early-stage and locally advanced triple negative breast cancer (TNBC): a retrospective cohort analysis of national real-world data in England Breast cancerASCO, 2023
Real world characteristics, symptom burden and treatment patterns of anaemia of CKD in Egypt, Saudi Arabia, South Africa and TurkeyChronic Kidney DiseaseERA, 2023
Treatment patterns and clinical outcomes of newly diagnosed locally advanced head and neck squamous cell carcinoma (LA HNSCC): a retrospective cohort analysis of national real-world data in England.Head and neck cancerASCO, 2023
Assessment of joint health in patients receiving prophylaxis for haemophilia A in five European countries: a cross sectional surveyHemophiliaEHA, 2023
Clinical burden of hidradenitis suppurativa with draining tunnelsHidradenitis suppurativaMaui Derm, 2023
Impact of draining tunnels on patient- and physician-reported burden in patients with hidradenitis suppurativaHidradenitis suppurativaMaui Derm, 2023
Patient characteristics, disease profile and treatment patterns in mild and moderate psoriasis patients in real world practices (prospect study) PsoriasisMaui Derm, 2023
Comparison of rescue medication prescriptions in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in routine clinical practice in EnglandChronic obstructive pulmonary diseaseView PublicationN/A
Economic burden of alopecia areata: a study of direct and indirect cost in Japan using real-world dataAlopecia areataView PublicationN/A
Patient characteristics, testing and treatment patterns, and outcomes in EGFR-mutated advanced non-small cell lung cancer: a multinational, real-world studyNon-small cell lung cancerView PublicationN/A
Time from ALS symptom onset to key disease milestones for slow, intermediate, and fast progressors: a real-world cross-sectional surveyAmyotrophic lateral sclerosis ENCALS, 2023
Fatigue among generalised myasthenia gravis patients: real-world data from physicians and patients across five European countriesMyasthenia gravisEAN, 2023
Early-onset generalised myasthenia gravis in women aged 18-50: results from a real-world study in five European countries.Myasthenia gravisEAN, 2023
The generalized myasthenia gravis (gMG) diagnostic journey and treatment initiation: European and US real-world perspectives from physician and patient surveysMyasthenia gravisEAN, 2023
Disease burden and physician-reported outcomes in pediatric patients with hereditary angioedema: data from a real-world study Hereditary angioedemaHAEA, 2023
Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: real-world experience from SpainHidradenitis suppurativaView PublicationN/A
Clinical characteristics and treatment patterns of patients with episodic cluster headache: results from the United States, United Kingdom and GermanyMigraineN/A
Clinical profiles and outcomes in patients with ulcerative colitis receiving standard and higher-than-standard doses of vedolizumab: findings from a real-world study in EuropeInflammatory Bowel DiseaseView PublicationN/A
Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: results from a real-world surveyAmyotrophic lateral sclerosisView PublicationN/A
Clinician perceptions and reasons for non-use of guideline-directed medical therapy for heart failure with reduced ejection fraction in the United StatesChronic heart failureESC, 2023
Comparative effectiveness of umeclidinium/vilanterol versus indacaterol/glycopyrronium on moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease in clinical practice in EnglandChronic obstructive pulmonary diseaseView PublicationN/A
Validation of an EMR derived algorithm to identify moderate asthma exacerbations in the UKAsthmaERS, 2023
Characteristics and treatment pathways of COPD patients initiating single-inhaler dual or triple therapy in EnglandChronic obstructive pulmonary diseaseERS, 2023
Adherence to single and multiple inhaler triple therapies among patients with COPD in the real world in JapanChronic obstructive pulmonary diseaseERS, 2023
Persistence to inhaled long-acting maintenance therapy in patients with COPD in UK routine clinical practiceChronic obstructive pulmonary diseaseERS, 2023
Healthcare resource utilisation in Lennox-Gastaut syndrome: interim results from a European real-world point-in-time studyLennox-Gastaut syndromeIEC, 2023
Work, productivity, and activity impairment in patients with immunoglobulin A nephropathy: results from a real-world studyImmunoglobulin A nephropathy IIGAAN, 2023
Diagnostic pathways in immunoglobulin A nephropathy in Japan: results from a real-world studyImmunoglobulin A nephropathy IIGAAN, 2023
IgA nephropathy: a real-world comparison between disease severity, symptom burden, and treatment satisfaction reported by patients and nephrologistsImmunoglobulin A nephropathy IIGAAN, 2023
Characteristics of patients with asthma in China by blood eosinophil levelAsthmaERS, 2023
Characteristics of patients with asthma on GINA 4/5 therapies in China AsthmaERS, 2023
Systemic therapy for patients with atopic dermatitis results in increased advanced practice provider disease control satisfaction and decreased frequency of flares: a real-world studyAtopic dermatitisMaui Derm, 2023
Diagnosing pulmonary arterial hypertension in the Real WorldPulmonary arterial hypertensionERS, 2023
Health related quality of life in pulmonary arterial hypertension in the US, Europe, and JapanPulmonary arterial hypertensionERS, 2023
Concordance between physician and patient reported presence of symptoms in patients with pulmonary arterial hypertension in the US, Europe and JapanPulmonary arterial hypertensionERS, 2023
Analysis of the impact, patterns of care, and perspectives of patients and physicians about moderate-to-severe menopausal vasomotor symptoms in Spain Vasomotor symptoms View PublicationN/A
Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASHNon?alcoholic steatohepatitisView PublicationN/A
Misdiagnosis of amyotrophic lateral sclerosis in clinical practice in Europe and the USA: a patient chart review and physician surveyAmyotrophic lateral sclerosisView PublicationN/A
The clinical and economic burden of antibiotic use in pediatric patients with varicella Infection: a retrospective cohort analysis of real-world data in EnglandVaricellaView PublicationN/A
Treatment for vasomotor symptoms in women on adjuvant endocrine therapy after breast cancer: real-world findings from the REALISE studyVasomotor symptoms ESMO, 2023
Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United StatesPre-exposure prophylaxisIDWeek, 2023
Adherence to antiretroviral therapy and its effect on quality of life among persons with HIV in the United States using real-world dataHIVIDWeek, 2023
Factors driving decisions in the use of HIV pre-exposure prophylaxis: data from a real-world study in the United States Pre-exposure prophylaxisIDWeek, 2023
Healthcare resource utilisation and treatment usage among flaring and non-flaring patients with ulcerative colitis - a real-world global studyInflammatory Bowel DiseaseUEGW, 2023
Patient-reported adherence: differences by education, employment and socioeconomic status from three cross-sectional studies in GermanyVariousISOQOL, 2023
Patient-reported cost-driven adherence: differences by ethnicity and socioeconomic status from seven cross-sectional studies in the United StatesVariousISOQOL, 2023
Healthcare resource utilisation and treatment usage among flaring and non-flaring patients with ulcerative colitis - a real-world global studyInflammatory Bowel DiseaseACG, 2023
Burden of illness among Japanese paroxysmal nocturnal hemoglobinuria patients: a real-world studyParoxysmal nocturnal hemoglobinuria JSH, 2023
Disease control and physician satisfaction with ruxolitinib cream in US adults with mild to moderate atopic dermatitisAtopic dermatitisAMCP Nexus, 2023
Prevalence of misdiagnosis and time to diagnosis amongst NMOSD and MOGAD patientsVariousECTRIMS, 2023
Drivers of discontinuation of oral PrEP within Europe: Findings from a real-world survey of PrEP usePre-exposure prophylaxisEACS, 2023
Drivers of satisfaction and health-related quality of life of people living with HIV within Europe: Findings from a real-world survey of people living with HIVHIVEACS, 2023
Clinical burden of hidradenitis suppurativa with draining tunnelsHidradenitis suppurativa EADV, 2023
Clinical burden of hidradenitis suppurativa with draining tunnelsHidradenitis suppurativaSHSA, 2023
Impact of draining tunnels on patient- and physician-reported burden in patients with hidradenitis suppurativaHidradenitis suppurativaSHSA, 2023
Burden of bowel urgency among pediatric patients with ulcerative colitis: results from a physician and patient surveyUlcerative colitisACG, 2023
Profili clinici dei pazienti affetti da colite ulcerosa che ricevono dosi standard e intensificate di targeted therapies in Italia: risultati da uno studio real-worldUlcerative colitisSIFO, 2023
Patient characteristics, disease profile and treatment patterns in mild and moderate psoriasis patients in real world practices (prospect study)Psoriasis AMCP Nexus, 2023
Patient characteristics, disease profile and treatment patterns in mild and moderate psoriasis patients in real world practices (prospect study)PsoriasisFCDC, 2023
Characteristics of progressive myasthenia gravis patients in real world practice in the USA and five European countriesMyasthenia gravisN/A
Real world insights into differing presentation of myasthenia gravis patients on pharmacological treatment in the USA and five European countriesMyasthenia gravisN/A
Impact of lifestyle changes on quality of life in patients with chronic kidney disease: results from a real-world studyChronic kidney diseaseN/A
Predictors of disease progression in patients with chronic kidney disease: results from a real-world studyChronic kidney diseaseN/A
Signs and symptoms at diagnosis in patients with C3 glomerulopathy - results from a real-world multi-country studyC3 glomerulopathy N/A
Real-world time to diagnosis in C3GC3 glomerulopathy N/A
C3 glomerulopathy current treatment options and real-world management - results from a multi-country studyC3 glomerulopathy N/A
Persistence of signs and symptoms in treated patients with C3G: evidence from real-world dataC3 glomerulopathy N/A
Treatment satisfaction with ravulizumab in patients with atypical hemolytic uremic syndrome in a real-world settingAtypical hemolytic uremic syndromeN/A
Ravulizumab is associated with positive clinical and quality of life outcomes in patients with atypical hemolytic uremic syndrome in a real-world settingAtypical hemolytic uremic syndromeN/A
The Impact of duchenne muscular dystrophy on caregiver employment: a survey in Europe, Japan, and the United States Duchenne muscular dystrophy N/A
Characteristics of individuals living with obesity in Germany, weight-loss methods attempted and healthcare resource use over a 12-month periodObesityN/A
Demographics of patients and societal burden of obstructive hypertrophic cardiomyopathy: results from a real-world survey in Italy and SpainObstructive hypertrophic cardiomyopathyN/A
Healthcare resource utilization for pediatric and adolescent duchenne muscular dystrophy patients: analysis of real-world dataDuchenne muscular dystrophy N/A
Humanistic burden of paroxysmal nocturnal hemoglobinuria from the patient perspective: results from a cross-sectional study Paroxysmal nocturnal hemoglobinuria N/A
Impact of paroxysmal nocturnal haemoglobinuria on employment and activity: results from a real-world study Paroxysmal nocturnal hemoglobinuria N/A
EQ-5D utilities for patients with nonalcoholic steatohepatitis (NASH): a comparison of historical utilities to a recent real-world multi-country patient surveyNon?alcoholic steatohepatitisN/A
Impact and management of comorbidities in people with obesity: a multinational surveyObesityN/A
Impact of amyotrophic lateral sclerosis on work and daily living: results from a real-world surveyAmyotrophic lateral sclerosis N/A
Healthcare resource utilization (HCRU), quality of life (QoL), and employment changes for early, middle and late-stage people with amyotrophic lateral sclerosis (pALS) in Italy: results from a real-world surveyAmyotrophic lateral sclerosis N/A
Physician reported reasons for CIDP treatment choice across 5 european countries: results from a real-world surveyChronic inflammatory demyelinating polyradiculoneuropathyN/A
Deriving caregiver health utilities from patient endpoints: a predictive modelling approach using real-world survey dataVariousN/A
Understanding the reasons not to treat all HAE attacks and satisfaction for on-demand treatmentHereditary angioedemaN/A
Changing priorities among physician reported reasons for choice of pharmacological generalized myasthenia gravis treatments across five European countriesMyasthenia gravisN/A
Delayed diagnosis amongst generalized myasthenia gravis patients: results from a European real world studyMyasthenia gravisN/A
The generalized myasthenia gravis (gMG) diagnostic journey and treatment initiation: European and US real-world perspectives from physician and patient surveysMyasthenia gravisN/A
Impact of up to 24 months intravenous (IV) belimumab (BEL) treatment on steroid use and disease activity in patients with SLE in clinical practice: additional post hoc pooled analysis of multicountry OBSErve cohort data Systemic lupus erythematosus N/A
Assessing the impact of relapses on patient outcomes in neuromyelitis optica spectrum disorder Neuromyelitis optica spectrum disorderN/A
Assessing the impact of relapses on burden to the patient and caregiver in neuromyelitis optica spectrum disorderNeuromyelitis optica spectrum disorderN/A
Treatment satisfaction and health-related quality of life in people living with HIV receiving DTG/3TC who are treatment experienced or treatment naive in EuropeHIVN/A
COVID-19 related work absenteeism and Its associated lost productivity cost in Germany: a population-based study Covid-19N/A
Impact of haemophilia severity on healthcare resource usage: results from a multinational real-world surveyHemophiliaN/A
Impact of bleeds on the quality of life of patients with haemophilia: results from a multinational real-world surveyHemophiliaN/A
Patient characteristics and treatment patterns in patients with mantle cell lymphoma in Spain: a real-world, cross-sectional studyMantle cell lymphoma N/A
Treatment patterns and adverse even in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma in France, Italy, and the United KingdomChronic lymphocytic leukemiaN/A
Physician-reported treatment attributes considered in first-line or later-line settings and perceptions around BTKi treatment in CLL/SLL in the United StatesChronic lymphocytic leukemiaN/A
Association between health-related quality of life and requirement for non-professional care in adults with rare diseases: a real-world studyVariousN/A
Treatment of IgA Nephropathy in Chinese Patients: Evidence from Real-World Data Immunoglobulin A nephropathy N/A
Association of a treat-to-target management approach with physician and patient-reported outcomes among real-world patients with rheumatoid arthritis receiving advanced therapy in EuropeRheumatoid arthritisN/A
Real-world rearranged during transfection [RET]-alteration testing and treatment patterns of patients with medullary and papillary thyroid cancer [MTC, PTC] in AustraliaThyroid cancerN/A
Real-world experience of adalimumab biosimilar (ABP 501) use in patients with inflammatory bowel disease in EuropeInflammatory Bowel DiseaseView PublicationN/A
Effectiveness of esketamine as a treatment for depression: a real-world survey of disease improvementDepressionN/A
Chronic low back pain with and without concomitant osteoarthritis: a retrospective, longitudinal cohort study of patients in EnglandOsteoarthritisView PublicationN/A
Social care data in the UK; current landscape, challenges, and future recommendationsVariousView PublicationN/A
Real world characteristics, symptom burden and treatment patterns of anaemia of CKD in Egypt, Saudi Arabia, South Africa and TurkeyChronic Kidney DiseaseN/A
Real world characteristics, symptom burden and treatment patterns of anaemia of CKD in Egypt, Saudi Arabia, South Africa and TurkeyChronic Kidney DiseaseSATS, 2023
Clinical profiles and outcomes in patients with inflammatory bowel disease receiving standard and escalated doses of targeted therapies: findings from a global real-world studyInflammatory Bowel DiseaseView PublicationN/A
Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care dataOsteoarthritisView PublicationN/A
Real world utilisation of doravirine among people living with HIV in England (DRIVE-REAL).HIVView PublicationN/A
Treatment patterns and outcomes among patients with Lennox-Gastaut Syndrome from real-world clinical practice settings across the USA, Europe, and AsiaLennox-Gastaut syndromeN/A
Real world treatment patterns and outcomes among patients with Dravet syndromeDravet syndromeN/A
Real-world clinical burden of non-seizure symptoms on patients with Dravet or Lennox-Gastaut Syndromes: results from a global multinational surveyVariousN/A
Investigating geographical differences in time from ALS symptom onset to key disease milestones: data from a real-world surveyAmyotrophic lateral sclerosisN/A
Real-world evidence of clinical outcomes of third line treatments for relapsed or refractory diffuse large B-Cell lymphoma in United States Diffuse large B-cell lymphomaN/A
Passive flow: a real-world US study characterizing the Fontan patient with elevated pulmonary vascular resistancePulmonary arterial hypertensionN/A
Lost in transition: pulmonary arterial hypertention associated with congenital heart disease (PAH-CHD): real world survey findings in the USPulmonary arterial hypertensionN/A
Health economic impact of moderate-to-severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data OsteoarthritisView PublicationN/A
Treatment patterns and clinical outcomes of newly diagnosed early-stage and locally advanced triple negative breast cancer (TNBC): a retrospective cohort analysis of national real-world data in England.Breast cancerN/A
Healthcare resource utilization and costs associated with acute COVID in adult patients managed in the community or hospital setting in England: a population-based study Covid-19N/A
Patient reported outcomes in psoriasis over time: differences by sex from three cross-sectional, real world studies in the United States PsoriasisN/A
Impact of clinical features on patient reported outcomes and treatment satisfaction in psoriatic arthritisPsoriatic arthritisN/A
Patient and physician satisfaction of treatment with eculizumab or ravulizumab in paroxysmal nocturnal hemoglobinuria: results from a real-world disease-specific programmeParoxysmal nocturnal hemoglobinuria N/A
Real-world differences between people living with HIV receiving B/FTC/TAF and those receiving other single tablet regimens (STR) in the United StatesHIVN/A
Understanding the real-world clinical effectiveness of pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria (PNH)Paroxysmal nocturnal hemoglobinuria N/A
Persons diagnosed with COVID-19 in the Clinical Practice Research Datalink (CPRD) primary care dataset: a cohort descriptionCovid-19N/A
Patient and physician concordance in treatment satisfaction and symptom severity among male and female myasthenia gravis patients in the United States and five European countriesMyasthenia gravisN/A
Correlation between myasthenia gravis disease severity and impairment of daily living activities of real-world patients in the United States and five European countriesMyasthenia gravisN/A
Impact of amyotrophic lateral sclerosis disease progression on health care resource use and health-related quality of life using MiToS staging and ALSFRS-R: analysis of a real-world cross-sectional surveyAmyotrophic lateral sclerosisN/A
Differences in healthcare resource utilization for the management of immunoglobulin A nephropathy in Europe, the US, China and JapanImmunoglobulin A nephropathy N/A
Immunoglobulin A nephropathy patient reported health utility and quality of life: evidence from real-world dataImmunoglobulin A nephropathy N/A
Work, productivity, and activity impairment in patients with immunoglobulin A nephropathy: results from a real-world studyImmunoglobulin A nephropathy N/A
Impact of draining tunnels on patient- and physician-reported burden in patients with hidradenitis suppurativa (HS)Hidradenitis suppurativaN/A
Virological status in people living with HIV-1 (PLWH) was similar across age subgroups despite older PLWH having increased rates of comorbidities and polypharmacy (TANDEM subgroup analysis)HIVN/A
PAIRED - patient reported experiences and perceived benefit of treatment with DOVATO (dolutegravir/lamivudine): interim analysis (n=100)HIVN/A
Healthcare resource utilization in patients with hidradenitis suppurativa in five European Countries and the USA using real world evidenceHidradenitis suppurativaN/A
Real-world rearranged during transfection [RET]-alteration testing, treatment and referral patterns of patients with medullary and papillary thyroid cancer [MTC, PTC] in Taiwan Thyroid cancer N/A
Disease burden, treatment landscape, and health related quality of life outcomes in myasthenia gravis: results from the adelphi real world disease specific programme in the United States and EuropeMyasthenia gravisN/A
Real-world outcomes, characteristics and ability to work of patients with treatment-resistant depression in the United States DepressionN/A
Benefit of prompt vs delayed initiation of triple therapy following an exacerbation in patients with COPD in Japan: a retrospective cohort studyChronic obstructive pulmonary diseaseN/A
Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activitySystemic lupus erythematosus N/A
Physician- and patient-reported burden of alopecia areata: results from a real-world survey in five European countriesAlopecia areataN/A
Real-world analysis of treatment patterns and platinum-based treatment eligibility of patients with metastatic urothelial cancer in 5 European countriesUrothelial carcinomaView PublicationN/A
Pegcetacoplan in paroxysmal nocturnal haemoglobinuria: its use, its clinical effectiveness, and its influence on health-related quality of life and productivityparoxysmal nocturnal haemoglobinuriaView PublicationN/A
A real world study of cough burden and quality of life of UK patients who have undergone evaluation for chronic cough Chronic CoughView PublicationN/A
Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world surveyAmyotrophic lateral sclerosisN/A
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line Lenvatinib monotherapy in the United StatesThyroid cancerN/A
Factors associated with chronic spontaneous urticaria diagnostic and treatment delay in real-world clinical practiceUrticariaAAAAI, 2024
Timing of single inhaler triple therapy (SITT) initiation following an initial asthma exacerbation: Japanese claims database analysesAsthmaJRS, 2024
The diagnostic journey of pulmonary arterial hypertension patients: Results from a multinational real-world surveyPulmonary arterial hypertensionN/A
Healthcare resource utilization and costs associated with COVID-19 among pediatrics managed in the community or hospital setting in England: a population-based cohort studyCovid-19N/A